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 VII 
Exosomal and non-exosomal circulatory miRNAs in bovine follicular fluid: potential role of 
exosomal miRNAs in oocyte development 
Growth and development of bovine follicle and oocyte is the result of series of complex and 
coordinated processes that involves extensive cell-to-cell communication in the follicle. This 
phenomenon involves enormous complex and heterogeneous biochemical substances existing in 
the oocytes and its surrounding cells and the follicular fluid. Cell-cell communication within the 
follicle involves many signaling molecules, and this process may be mediated by secretion and 
uptake of exosomes that contain several bioactive molecules including extra-cellular miRNAs. 
The molecular mechanism of oocytes development and interaction between oocyte and 
follicular cells in the follicular micro-environment remains vague. Follicular fluid and cells 
from individual follicles of cattle were grouped based on Brilliant Cresyl Blue Pro staining of 
the corresponding oocytes. Both Exoquick
TM
 precipitation and differential ultracentrifugation 
were used to separate the exosome and non-exosomal portion of follicular fluid. Following 
miRNA isolation from both fractions, the human miRCURY LNA
TM
 Universal RT miRNA 
PCR array system was used to profile miRNA expression. Western blot analysis against specific 
protein and electron microscopy imaging confirms the efficient separation of exosomal and non-
exosomal fraction of follicular fluid. The real time qPCR array analysis revealed that a handful 
number of miRNAs are present in both exosomal and non-exosomal portion of bovine follicular 
fluid. Results revealed 25 miRNAs differentially expressed (16 up and 9 down) in exosomes 
and 30 miRNAs differentially expressed (21 up and 9 down) in non-exosomal portion of 
follicular fluid in comparison of BCB- versus BCB+ oocyte groups. Expression of selected 
miRNAs was detected in theca, granulosa and cumulus cells that may indicate the origin of 
extra-cellular miRNAs in follicular fluid. To further explore the potential roles of these extra-
cellular miRNAs in follicular fluid, the potential targets were predicted using in silico based 
analysis, and functional annotation and pathway analysis revealed most of these pathways are 
known regulators of follicular development and oocyte growth. In order to validate exosome 
mediated cell-cell communication within follicular microenvironment, we demonstrated uptake 
of exosomes and resulting increase of endogenous miRNA level and subsequent alteration of 
mRNA levels in follicular cells in vitro. The present study demonstrates for the first time, the 
presence of exosome or non-exosome mediated transfer of miRNA in the bovine follicular fluid, 
and oocyte growth dependent variation in extra-cellular miRNA signatures in the follicular 
environment. 
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Exosomale und non-exosomale zirkulierende miRNAs in der Follikelflüssigkeit beim Rind: Die 
Rolle von exosomalen miRNAs in der Oozytenentwicklung 
Wachstum und Entwicklung der Rinder Follikel und Eizellen ist das Ergebnis einer Reihe von 
komplexen und koordinierten Prozessen, die umfangreiche Zell-Zell-Kommunikation innerhalb der 
Follikel beinhaltet. Diese Interaktion beruht auf komplexen und heterogenen biochemischen Stoffen 
sowohl in den Eizellen, den benachbarten Zellen als auch in der Follikelflüssigkeit. Die Zell-Zell-
Kommunikation innerhalb der Follikel ist geprägt durch viele Signalmoleküle. Dieser Prozess kann 
durch Sekretion und Aufnahme von Exosomen die mehrere bioaktive Moleküle einschließlich 
extrazellulärer miRNAs enthalten, vermittelt werden. Bisher jedoch, sind die molekularen 
Mechanismen der Eizellenentwicklung und der Interaktion zwischen Eizellen und Follikelzellen in 
der follikulären Umgebung noch nicht voll aufgeklärt. Follikelflüssigkeit und Zellen aus einzelnen 
Rinder Follikeln wurden auf der Grundlage einer Vitalfärbung der entsprechenden Eizellen mittels 
Brillant Cresyl blau Pro gruppiert. Sowohl eine Exoquick-Präzipitation als auch differentielle 
Ultrazentrifugation wurde verwendet, um die exosomalen und non-exosomalen Bestandteile der 
Follikelflüssigkeit zu trennen. Nach miRNA Isolation von beiden Fraktionen wurde mittels des 
humanen miRCURY LNA™ Universal RT miRNA PCR-Array-System, ein miRNA 
Expressionsprofil erstellt. Durch Western-Blot-Analysen und Elektronen-Mikroskopie konnte die 
effiziente Trennung von exosomalen und non-exosomalen Bestandteilen in der Follikelflüssigkeit 
bestätigt werden. Mittels Echtzeit-qPCR-Array-Analysen konnte einige miRNAs im exosomalen 
und non-exosomalen Teil der Rinder Follikelflüssigkeit nachgewiesen werden. Von diesen waren 25 
miRNAs im exosomalen Teil differentiell exprimiert (16 rauf- und 9 runter reguliert) und 30 
miRNAs waren im non-exosomalen Teil der Follikelflüssigkeit differentiell exprimiert (21 rauf- und 
9 runter reguliert) im Vergleich zu den BCB- versus BCB+ Oozyten Gruppen. Im Anschluss daran, 
wurde die Expression ausgewählter miRNAs in Thecazellen, Granulosa- und Kumuluszellen 
ermittelt. Das Ergebnis könnte ein Hinweis auf die Herkunft der extrazellulären miRNAs in der 
Follikelflüssigkeit sein. Für eine genauere Erklärung der möglichen Funktion dieser extrazellulären 
miRNAs in der Follikelflüssigkeit wurden potenziellen Zielgene mit in silico Analyse, funktioneller 
Annotation und Pathway-Analysen untersucht. Dies ergab, dass die miRNAs überwiegend an 
Signalwegen der Regulation der follikulären Entwicklung und des Eizellen Wachstums beteiligt 
sind. Um die Ergebnisse in Bezug auf die exosomal vermittelte Zell-Zell-Kommunikation in der 
follikulären Mikroumgebung zu überprüfen, konnten wir nachweisen, dass aus der Aufnahme des 
Exosoms in die Zelle eine Erhöhung des miRNA-Levels mit nachträglicher Veränderung des 
mRNA-Niveaus von Targetgenen in Follikel-Zellen in vitro resultiert. Die vorliegende Studie zeigt 
zum ersten Mal, den von exosomalen oder non-exosomalen Bestandteilen vermittelten Transfer von 
miRNA in die bovine Follikelflüssigkeit. Weiterhin ist das Wachstum der Eizellen von den 
Variationen der extrazellulären miRNA Signaturen in der follikulären Umgebung abhängig. 
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Introduction 1 
1 Introduction 
Growth and development of bovine follicle and subsequent maturation of oocyte is the 
result of series of complex and coordinated processes that involves functional and 
morphological changes in different types of follicular cells and extensive cell-to-cell 
communication within follicular micro-environment (Eppig 2001). The close physical 
association of two cell types in follicular microenvironment, namely somatic cells and 
gonadal cells, indicated this to early biologists, however, physiological evidence was 
first presented by Pincus and Enzmann (1935). The authors found that fully grown 
oocytes removed from antral follicles underwent a spontaneous, gonadotrophin-
independent resumption of meiosis in culture, and concluded that follicular somatic 
cells maintain oocytes in meiotic arrest. Subsequent studies demonstrated that follicular 
somatic cells promote the reinitiation of meiosis and its progression to metaphase II 
(nuclear maturation). Follicular somatic cells also promote oocyte competence to 
undergo fertilization and pre-implantation embryogenesis (cytoplasmic maturation) 
(Buccione et al. 1990) and granulosa cells participate in the global suppression of 
transcription in oocytes that occurs before nuclear maturation (De La Fuente and Eppig 
2001). Efficient delivery of factors to and from oocyte at critical stages of development 
is essential for coordination of folliculogenesis and triggering of different signaling 
molecules: Kit ligand, members of TGFB, insulin & WNT signaling family (Harwood 
et al. 2008; Luo et al. 2010), growth factors: GDF9, BMP15 (Su et al. 2004), hormonal 
regulation FSH, LH (Patsoula et al. 2001) are also crucial for oocyte growth and 
developmental competence. A fully grown oocyte shows better competency than a 
growing oocyte in terms of in-vitro maturation and fertilization (Alm et al. 2005; Wang 
et al. 2012). Oocyte competence is acquired during folliculogenesis, and ultimately the 
coordinated communication and signaling between the different follicular cells and 
follicular cells-oocyte as well which is critical for the growth, maturation and release of 
an oocyte that can be fertilized and develop into an embryo. Oocyte developmental 
competence is defined as the ability of an oocyte to resume meiosis, to cleave following 
fertilization, to develop to the blastocyst stage, to induce a pregnancy and bring 
offspring to term with a good health (Krisher 2004; Sirard et al. 2006). This ability of 
oocytes to develop is possible to asses by measuring the activity of glucose-6-phosphate 
dehydrogenase (G6PDH) enzyme in response to Brilliant Cresyl Blue (BCB) stain 
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(Ericsson et al. 1993). Many factors including follicular fluid (FF) are involved in 
follicle development and subsequent oocyte developmental competence (Armstrong and 
Webb 1997). 
Follicular fluid is a product of both the transfer of blood plasma constituents that cross 
the ‘blood-follicle barrier’ and of the secretory activity of granulosa and thecal cells 
(Gosden et al. 1988). Follicular fluid has been recognized as a reservoir of biochemical 
factors and theoretically represent an optimal source on non-invasive biochemical 
predictors of oocyte quality (Revelli et al. 2009). Follicular fluid provides an important 
microenvironment for oocyte maturation and contains hormones such as FSH, LH, GH, 
inhibin, activin, estrogens and androgens, pro-apoptotic factors including TNF and Fas-
ligand, proteins, peptides, amino acids, and nucleotides (Revelli et al. 2009). Follicular 
fluid is at least partly responsible for subsequent embryo quality and development and 
has some important oocyte-related functions: maintenance of meiotic arrest (McNatty 
and Baird 1978), protection against proteolysis, extrusion during ovulation (Espey 
1994) and acts as a buffer against adverse haematic influences (Gosden et al. 1988). As 
follicular fluids are derived from plasma and secretory results of granulosa and theca 
cells, thus, it is logical to think that products contained within follicular fluid may play a 
role in follicle growth and oocyte developmental competence. However, it is unclear if 
or how surrounding different follicular cells respond to these factors during follicular 
development and oocyte maturation. 
Exosomes have been postulated to play an important role in cell–cell communication, 
other physiological and pathological processed and appear to affect target cells either by 
stimulating them directly by surface expressed ligands or by transferring molecules 
between cells (Valadi et al. 2007). However, the exosomes-cell interaction mode and 
the intracellular trafficking pathway of exosomes in their recipient cells remain unclear. 
Exosomes are small membrane vesicles that are released into the extra-cellular milieu 
upon the fusion of multivesicular bodies with the plasma membrane. Unlike other cell 
secreted vesicle, exosomes are more homogenous and smaller in size ranges from 40-
100 nm in diameter. Exosomes contain a characteristic composition of proteins, and 
express cell recognition molecules on their surface that facilitates their selective 
targeting of and uptake by recipient cells (Mittelbrunn et al. 2011). Recent reports 
indicate that exosomes also harbor a variety of mRNAs and microRNAs (miRNA)  
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(Valadi et al. 2007), which can be transported over large distances through blood to 
recipient cells and modulate their function (da Silveira et al. 2011; Pegtel et al. 2010; 
Taylor and Gercel-Taylor 2008; Valadi et al. 2007). These findings have increased 
interest in the role of exosomes in cell-to-cell communication, and support the idea that 
exosomes might constitute an exquisite mechanism for local and systemic intercellular 
transfer not only of proteins but also of genetic information in the form of RNA (mRNA 
and miRNA). Currently a role of bovine follicular fluid exosomes and/or miRNAs in 
follicular growth and oocyte maturation is unknown.  
During the dynamic phase of follicular development and oocyte maturation miRNAs 
plays an important role by coordinating the expression of genes in a spatial and 
temporal specific manner (Baley and Li 2012; Hossain et al. 2012). However, miRNAs 
are not only present in cells but also a considerable proportion of miRNAs are present in 
body fluids including plasma, serum, urine, saliva, milk and semen (Mitchell et al. 
2008; Park et al. 2009; Weber et al. 2010) commonly termed as circulating or extra-
cellular miRNA. Recent findings have shown that these extra-cellular miRNAs are 
remarkably stable in plasma despite high RNase activity in extra-cellular environment 
(Mitchell et al. 2008), suggesting circulating miRNAs may be wrapped with some 
protective manner to bypass this extra-cellular harsh conditions. Currently, the 
dominant model for circulating miRNA stability is that miRNAs are released from cells 
in membrane-bound vesicles, which protect them from high RNase activity in 
circulation (Simons and Raposo 2009; Valadi et al. 2007; Weber et al. 2010). In 
particular, a significant portion of circulating miRNA is also associated with Argonaute 
2 (Ago2), the effector component of the miRNA-induced silencing complex that 
directly binds miRNAs and mediates messenger RNA repression in cells (Arroyo et al. 
2011). 
Therefore, the present study was conducted to investigate 1) the presence of extra-
cellular miRNAs in exosomal and non-exosomal portion of follicular fluid, 2) 
differential expression of extra-cellular miRNAs follicular fluid derived from follicle 
containing growing and fully grown oocyte sources and finally 3) exosome mediated 
transfer of miRNAs in follicular microenvironment. In this study, we showed that 
microRNAs are present in bovine follicular fluid and most of the extra-cellular miRNAs 
are associated with exosomes and a significant portion of extra-cellular miRNAs are 
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also present in non exosomal fraction of follicular fluid being coupled with Ago2 
protein, which is a part of RNA-induced silencing complex. Furthermore, fluorescent 
microscopy demonstrated that exosomes are taken up by surrounding follicular cells and 
exosomes mediated transfection of miRNAs can elevate the endogenous level of 
miRNA in cellular level. 
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2. Literature review 
 
2.1 Ovarian follicle 
The ovary, the primary organ in female reproductive system, is only the source of 
female germ cells called oocyte which is pre-requisite for sexual reproduction. The 
ovarian follicle is the fundamental unit of the ovary which contains the oocyte that may 
eventually ovulate, undergo fertilization and sustain embryo development. It also 
provides the essential steroids and protein hormones that is crucial for maintenance of 
the ovarian cycle, follicular development, the secondary sex characteristics and 
preparation of the uterus for implantation, and after ovulation, the corpus luteum 
provides the hormones essential for establishment and maintenance of pregnancy 
(Pohler et al. 2012). Follicle formation and folliculogenesis have been well documented 
for many mammalian species including cattle (Adams et al. 2008; van Wezel and 
Rodgers 1996), sheep (Evans et al. 2000; Seekallu et al. 2010), pig (Schwarz et al. 
2008) and human (Gougeon 2010; van Dessel et al. 1996). However, the control of 
follicular reserves (Tilly and Rueda 2008) and entry of follicles into the growth path 
towards atresia or ovulation (Findlay et al. 2002) are not well understood. The adult 
ovary contains a reserve of inactive primordial follicles. Each contains a small non 
growing oocyte and a layer of non-dividing pre-granulosa cells encapsulated by the 
follicular basal lamina (Rodgers and Irving-Rodgers 2010b). Number of primordial 
follicles are selected and become active every day, and the oocyte commences growing 
while the granulosa cells start to divide. As the granulosa cells divide, the number of 
layers of cells (called the membrana granulosa or follicular epithelium) around the 
oocyte increases, and the follicular basal lamina expands (Cox 1997). Later in 
development, a fluid filled cavity or antrum forms and specialized stromal layers, the 
theca interna and externa, develop. Only follicles that reach the stage of having a large 
antrum, and in the follicular wave following regression of corpora lutea, can ovulate an 
oocyte in response to the surge release of LH (Rodgers and Irving-Rodgers 2010b). 
Following ovulation, the granulosa cells and thecal cells differentiate into the large and 
small luteal cells of the corpus luteum, and the vascular supply of the corpus luteum is 
derived from the capillaries of the theca interna. All non-ovulating follicles undergo 
atresia and regression (Rodgers and Irving-Rodgers 2010b).  
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Ideally a fully grown follicle (graafian follicle) is a three-dimensional structure with an 
antrum in centre and surrounded by a variety of different cell types. There are at least 
six distinct histologic components in the mature follicle, including the theca externa, 
theca interna, basal lamina, granulosa cells, oocyte, and follicular fluid (O'Shea 1981). 
Following paragraphs highlight the different components of a follicle and their 
functions. 
 
 
Figure 2.1: Schematic presentation of a fully grown follicle indicating different 
components 
The remarkable characteristics of theca externa is the presence of smooth muscle cells 
(Amsterdam et al. 1977), which are innervated by autonomic nerves (Erickson et al. 
1985). Although the physiologic significance of the theca externa remains unclear, there 
is evidence that it has certain function during ovulation and atresia (Moley and 
Schreiber 1995). The theca interna is composed of differentiated TICs located within a 
matrix of loose connective tissue and blood vessels. In all graafian follicle, LH is a key 
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regulatory hormone for TIC function, and its importance in regulating TIC androgen 
production in vivo and in vitro has been established (Erickson et al. 1985). Beginning at 
the very early stages of graafian follicle development, the TICs express their 
differentiated state as androgen (i.e. androstenedione-producing cells) (Erickson et al. 
1985). The theca interna is richly vascularized and serves to deliver hormones (e.g. 
FSH, LH), nutrient molecules, vitamins, and cofactors required for the growth and 
differentiation of the oocyte and granulosa cells. The theca compartments (i.e. theca 
externa and interna) express their differentiated functions at the beginning of graafian 
follicle development (at cavitation) and appear to constitutively express a mature 
phenotype throughout the life and death of the graafian follicle. 
Basal lamina is a specialized extracellular matrix sheets that provide mechanical support 
and important signals for growth and differentiation to cells with which they are 
associated (Yurchenco and Schittny 1990). It separates the granulosa cells from the 
surrounding stromal elements in primordial and pre-antral follicles, or from the 
specialized stromal theca layers in antral follicles (Irving-Rodgers and Rodgers 2006). 
Basal laminas are generally observed as a single layer aligned to the cell surface. 
However, a number of physiological and pathological conditions lead to different 
morphological appearances of basal laminas (Irving-Rodgers et al. 2009). The follicular 
basal lamina is believed to play a role in influencing granulosa cell proliferation and 
differentiation (Irving-Rodgers and Rodgers 2006). Additionally, it has been well 
documented that the components of basal lamina/basement membrane obtained from 
non-ovarian sources regulated the morphology and steroidogenesis in granulosa cells 
from rat (Furman et al. 1986b) and human (Furman et al. 1986a) ovaries. 
In the antral follicle, granulosa cells represent the major category of follicular cells. The 
granulosa cells and oocyte exist as a mass of perfectly shaped and precisely positioned 
cells. The positional variation of granulosa cells creates at least four different cell layers 
or domains. These are the outermost domain is known as membrana granulosa, the inner 
most domain is the periantral, the intermediate domain is the cumulus oophorus, and the 
domain close together to the oocyte is the corona radiata (Amsterdam and Rotmensch 
1987). A characteristic histologic property of the membrana domain is that it is 
composed of a pseudostratified epithelium of tall columnar granulosa cells, all of which 
are anchored to the basal lamina (Irving-Rodgers and Rodgers 2000). The 
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differentiation of a granulosa cell can be traced to its position within the cellular mass. 
For example, cells in the membrana domain stop proliferating before those in central 
domain (Hirshfield 1989). The ability of the granulosa cells to continue dividing in the 
inner domains of a follicle throughout graafian follicle development leads to conclude 
that they might be precursor cells (Hirshfield 1989). Cumulus oophorus may be defined 
as those granulose cells which are closely associated with oocyte (Tanghe et al. 2002). 
The fully developed cumulus oophorus perform three important biological functions- 
firstly, before ovulation it supports during oocyte maturation (Tanghe et al. 2002), 
secondly during ovulation it conducts the oocyte in to the oviduct (Mahi-Brown and 
Yanagimachi 1983) and finally shortly after ovulation it participate in the complex 
mechanisms that controlling the access of spermatozoa in to the oocyte (Tanghe et al. 
2002).  
In mammals, several studies have demonstrated that steroidal and nonsteroidal factors 
produced by granulosa and theca cells together influence proliferation and 
differentiation of both cell types on opposite sides of a basal membrane during 
folliculogenesis (Driancourt et al. 2000; Gougeon 1996; Monget et al. 2002). During 
preantral follicle development, LH receptors are found exclusively on theca cells and 
FSH receptors exclusively on granulosa cells. It has been well documented that LH 
stimulates theca cell androgen and growth factor production, while FSH induces 
aromatase expression and increases the conversion of theca cell androgen to estrogen, 
which is commonly known as two-cell two-gonadotropin theory (Hillier et al. 1980). 
Androgens also enhance FSH action in the follicles by increasing FSH receptor 
expression, FSH-induced granulosa cell aromatase activity and proliferation, and 
follicular growth (Pakarainen et al. 2005). 
 
2.2 Follicular development 
In present most widely accepted hypothesis of follicular reserve is “at birth the ovaries 
of primates and most domesticated animal species contain a finite number of primordial 
follicles whereas in rodents this ovarian reserve develops in the first few days 
postpartum” (Fortune 2003). In contrast, Johnaon et al. demonstrated the existence of 
mitotically active germ cells in juvenile and adult mouse ovaries, and claim stem cell-
based renewal of follicle reserve in postnatal mammalian ovaries (Johnson et al. 2004). 
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Although some studies reported the presence of mitotically active germ cells in ovaries 
of some species of prosimian primate adults (Loris tardigradus lydekkerianus and 
Nycticebus coucang) (David et al. 1974; Duke 1967), to date the presence of germline 
stem cells in other mammalian species remains to be proven (Telfer 2004).  
Follicular development within the ovary is a dynamic process which occurs throughout 
the estrous cycle and involves recruitment of follicles into the growing pool, 
physiological and morphological changes in the follicular cells, physiologic selection of 
an ovulatory follicle and ovulation or regression (Araki et al. 1996). Since it is a 
continuous process, therefore throughout the reproductive life, the mammalian ovary 
contains a mixed population of follicles in different stages of development. There is a 
large pool of primordial follicles in the bovine ovary (~150,000) in a resting phase, 
some of them are released in each estrous cycle and this process continues throughout 
the reproductive life and the number of follicles decrease to about 3,000 by the age of 
15-20 years (Webb et al. 1992). Sequential recruitment, selection and growth of the 
follicles, atresia, ovulation and luteolysis these processes are repeated on a cyclical 
order within the ovary and resulting in the development of a number of ovulatory 
follicles (Hunter et al. 2004).  All follicles start as a primordial follicle, among them 
some will eventually develop to the preovulatory stage. Morphologic studies of ovaries 
have shown that during ovarian follicular developmental process a primordial follicle 
continuously grow into primary follicles, preantral and antral follicles (van Wezel and 
Rodgers 1996). Only antral follicles are capable of releasing oocytes at a stage when the 
oocyte can be fertilized (Tomic et al. 2004). Thus, the continuous growth of primordial 
follicles to the antral stage is essential for female fertility. The development of a follicle 
begins with the transformation of the flattened pre-granulosa cells of the primordial 
follicle to cuboidal granulosa (follicular) cells, after which a follicle with a single layer 
of granulosa cells is termed a primary follicle (Eppig 2001). The granulosa cells in 
primary follicles undergo continuous proliferation, the oocyte enlarges and becomes 
surrounded by a zona pellucida. Gradually the follicles changes to secondary follicles 
and, when fibroblast cells in the inner thecal layer differentiate, the secondary follicle is 
defined as a preantral follicle (Nussey and Whitehead 2001). The early growth phase of 
a follicle is considered to be independent of gonadotropin stimulation (Braw-Tal and 
Roth 2005; Palma et al. 2012), nevertheless some studies has reported that the presence 
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of FSH receptors in these immature follicles (Ranta et al. 1984). It is poorly understood, 
why a few primordial follicles start to grow and how they are selected, but paracrine 
factors within the ovary such as cytokines and epidermal growth factor has shown to be 
involved in this process. In the early luteal phase of each menstrual cycle, cohorts of 
preantral follicles undergo further growth into antral follicles (Nussey and Whitehead 
2001). At this time, the follicles enlarge, the thecal cells become richly supplied with 
blood vessels and a fluid-filled cavity (the antrum) forms (Fraser 2006). The oocyte 
itself becomes surrounded by several layers of granulosa cells known as the cumulus 
oophorus (Khamsi and Roberge 2001). 
In bovine and several other mammalian species, the pattern of follicular development 
during the terminal stages of folliculogenesis (follicles ≥4 mm) has been characterized 
as wave-like pattern that include 2 or 3 consecutive waves, which refers to the periodic 
and synchronous growth of a group of follicles (Adams 1999; Webb et al. 1992). The 
wave-like pattern of follicular development in heifers was first proposed more than 50 
years ago by Rajakoski using the histological data of ovaries collected from different 
heifers on different days of the estrous cycle (Rajakoski 1960). However, the proposed 
wave-like developmental pattern of follicles was validated using ultrasonographic real-
time follicular images, collected over a time-period on the same follicles from the same 
set of animals (Pierson and Ginther 1984; Pierson and Ginther 1986; Savio et al. 1988; 
Sirois and Fortune 1988). During each wave of follicular growth, a group (normally 1 to 
6) of follicles (primordial) 4 to 5 mm in diameter emerge and begin to grow, this phase 
is termed as recruitment. Initiation of each wave of follicular growth is preceded by a 
transient increase in FSH that begins about 2.5 day before initiation of the new wave of 
follicular growth and starts to decline about the time of appearance of the group of 
follicles in the wave. This subsequent decrease of circulating FSH is temporally 
associated with the selection of the dominant follicle (Adams et al. 1992). The group of 
recruited follicles grow over the next 36 to 48 h, after which one follicle (8 to 9 mm in 
diameter) is selected (selection) for further growth to become larger than the others, 
where as others stop growing and undergo atresia (Adams et al. 1992). The selected 
follicle achieves dominance over the other follicles in the cohort, which regress while 
the dominant follicle continues to increase in size. 
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Figure 2.2: Schematic depiction of follicular wave dynamics in cattle in relation to 
hormones. In this figure the pattern of secretion of follicle-stimulating hormone 
(FSH; blue line), luteinizing hormone (LH; green lines), and progesterone (P4; 
orange line); and the pattern of growth of ovarian follicles during the estrous 
cycle in cattle was demonstrated (Mark and Michael 2013).   
 
During this stage of follicular development, granulosa cells of large healthy, estrogen-
secreting follicles also acquire LH receptors (Ireland and Roche 1983; Xu et al. 1995). 
It has been shown that the granulosa cells of large healthy antral follicles possess more 
LH receptors than smaller atretic follicles (Ireland and Roche 1983; Spicer et al. 1986) 
and the levels of mRNA for LH receptor in granulosa cells of a dominant follicles 
increase as follicular development advances. When the dominant follicle reaches its 
maximum size, it maintains that size for 3 to 6 day before regressing if the animal is in 
the luteal phase of the estrous cycle (Ginther et al. 1996). The fate of the dominant 
follicle that reaches maximum size during the luteal phase of the estrous cycle and of 
subordinate follicles that enter as cohorts during the initiation of each wave of follicular 
growth is atresia. If luteal regression occurs during the growing phase of the dominant 
follicle, the fate of dominant follicle follicle is ovulation (Kastelic et al. 1990). 
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2.3 Cell-cell communication during follicular development 
Oocyte growth and follicular development occurs in an ovarian follicular 
microenvironment characterized by extensive cell-cell interaction mediated by gap 
junctional communication, as well as autocrine, paracrine and endocrine signaling. Gap 
junctions coupling between surface membranes of oocytes and their surrounding 
granulosa cells has been reported from the primordial stage in mice (Mitchell and 
Burghardt 1986) and secondary follicle stage in cattle (Fair et al. 1997). Gap junctions 
are specialized structures occurring between very close cell-cell contact; facilitate the 
transfer of amino acids, glucose metabolites and nucleotides to the growing oocyte 
(Eppig 1991). The proteins connexins is the principle component of gap junction. It has 
been demonstrated that connexins 32, 37, 43, 45 and 57 have been detected within 
growing and mature mouse follicles (Wright et al. 2001). However, in cattle, connexin 
expression shows in a stage specific manner; for instance, Cx26 is expressed in oocytes 
of primordial, primary and secondary follicles and in the granulosa of healthy antral 
follicles (Johnson et al. 1999). Furthermore, expression of Cx37 in preantral follicles is 
high, but expression decreases significantly at the onset of antral formation (Nuttinck et 
al. 2000). However, the reverse is true of Cx43, which is weakly expressed, in preantral 
follicles but increased significantly at the onset of antral cavity formation and become 
more intense with increase in follicular size in healthy antral follicle (Nuttinck et al. 
2000). These collective data provides a plausible suggestion of differential regulation of 
Cx37 and Cx43 throughout folliculogenesis. Studies in mice (Wright et al. 2001), and 
pig (Itahana et al. 1996) indicating the expression of connexins is associated with 
granulosa cell proliferation. Connexin KO mice exhibit infertility due to failure of 
follicle growth past the late preantral stage. Furthermore, gonadotropin stimulation 
could not induce ovulation in these mice (Carabatsos et al. 2000). Studies has revealed 
that smaller gonads appear on Cx43 deficient mice in the neonates and impaired post 
natal folliclulogenesis; indicating the importance of requirement of Cx43 for both germ 
line development and early folliculogenesis (Juneja et al. 1999).  
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Figure 2.3: Proposed schematic of thecal cell - granulosa cell interactions during 
follicular development. Mesenchyme-derived thecal cells produce KGF and 
HGF that regulate epithelial-derived granulosa cell functions. Granulosa cell 
expression of KL is stimulated (+) by KGF and HGF. Granulosa cell-derived KL 
feedback on thecal cells to regulate thecal cell growth and differentiated 
functions. Thecal cell expression of KGF and HGF is stimulated (+) by KL. 
Also illustrated is the previously established positive effect (+) of KL on oocyte 
development. Adopted from Parrott and Skinner (1998c). 
 
During follicular development, mesenchymal-derived thecal cells produce a number of 
growth factors that include KGF (keratinocyte growth factor) and HGF (hepatocyte 
growth factor) (Parrott and Skinner 1998c). Both KGF and HGF are mesenchymal-
derived growth factors that act on adjacent epithelial cells in a number of tissues 
(Parrott and Skinner 1998c). During follicular development gene expression of KGF 
and HGF is developmentally and hormonally regulated in thecal cells (Parrott and 
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Skinner 1998a; Parrott and Skinner 1998b). Thecal cells have been shown to produce 
and secrete these growth factors (Parrott et al. 1994), furthermore, granulosa cells have 
also been shown to proliferate in response to KGF and HGF in vitro (Parrott et al. 
1994). These observations strongly suggest that KGF and HGF may be important 
mediators of ovarian mesenchymal-epithelial cell interactions that promote 
folliculogenesis. Moreover, later investigations demonstrate that thecal cell-derived 
KGF and HGF also stimulate KL expression in granulosa cells (Parrott and Skinner 
1998c). The actions of KGF and HGF on granulosa cell KL expression indicate that 
these growth factors also alter cellular parameters other than cell growth (Parrott and 
Skinner 1998c). As granulosa cell-derived KL is important for oocyte maturation, thecal 
cells may indirectly regulate oocyte function by influencing granulosa cell production of 
KL (Parrott and Skinner 1998c).  
 
 
Figure 2.4: Members of the TGF-β super family feature prominently amongst the 
growing list of extra-cellular ligands implicated in the bi-directional 
communication between theca and granulosa cells, and granulosa cells and 
oocyte. Both autocrine (thick grey arrows) and paracrine (thick black arrows) 
signaling events are likely, depending on the expression of appropriate 
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combinations of type-I and type-II receptors on the cell surface (Knight and 
Glister 2006). 
 
Several studies have demonstrated the importance of the gap junction network during 
oocyte growth, development and meiotic maturation (Simon et al. 1997; Vozzi et al. 
2001). Denudation of preantral mouse oocytes prior to in vitro culture inhibits their 
growth, alone or in co-culture with granulosa cells (Eppig 1979). In addition, the growth 
rate of oocyte is directly correlated to the number of granulosa cells coupled to the 
oocyte (Herlands and Schultz 1984). It has been well documented that granulosa cells 
play a crucial role in oocyte development (Buccione et al. 1987), affecting the pattern of 
protein phosphorylation in oocytes in a stage specific manner (Cecconi et al. 1991). In 
mice, the network facilitates the transport of a paracrine factor which is commonly 
known as ‘Cumulus expansion enabling factor’ (Eppig et al. 1993). In addition, this 
paracrine factor appears to be essential for bringing about gonadotropin induced 
production of hyaluronic acid and cumulus expansion just before ovulation (Salustri et 
al. 1990; Vanderhyden et al. 1990). Gene targeting ablation of Cx37 resulted in the 
removal of all gap junctions from the mouse oocyte surface and compromised oocyte 
meiotic maturation (Simon et al. 1997). Similarly, exposition of bovine COCs to gap 
junction uncoupling agents during routine in vitro maturation reversibly blocked the 
resumption of meiotic maturation and anti-sense silencing of Cx43 expression in COCs 
with a recombinant adenovirus resulted in the inhibition of GVBD in 50% of the COCs 
(Vozzi et al. 2001). 
 
2.4 Oocyte competence 
Female fertility is determined to a large extent by the developmental competence of the 
oocyte.  Oocyte competence is acquired gradually over a prolonged period of oocyte 
growth (i.e., oogenesis) and follicular development (i.e., folliculogenesis), and is reliant 
on complex bi-directional interactions between germ and follicular somatic cells 
beginning in the fetus and extending into adult life (Eppig 2001). A good quality oocyte 
or a competent oocyte is the prerequisite for high blastocyst rates. A good-quality 
oocyte is an oocyte at metaphase I (MI) or metaphase II (MII) with a clear zona 
pellucida, clear or moderately granular cytoplasm and a small perivitelline space, on the 
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other hand a poor-quality oocyte is at the germinal stage, is post-mature or has a 
fractured zona pellucida (Balaban and Urman 2006; Robker et al. 2009). Oocyte 
competence also refers to the completion of the first meiotic division and 
complementary processes essential for subsequent fertilization and embryo 
development. This process consists of two general components, cytoplasmic maturation 
and nuclear maturation; both must take place to achieve healthy and competent oocytes 
(Swain and Pool 2008). Many important factors play a crucial role in determining the 
final intrinsic developmental capacity and quality of the oocytes obtained. Most of these 
are donor-related, stage of the estrous cycle at the time of retrieval, follicular status 
related to oocyte growth and final maturation, donor condition and breed, hormonal 
stimulation prior to OPU and the number of oocyte collections within a specific time 
span. All of these can be considered as ‘biological factors’, acting separately or in 
combination for a specific donor (Bols 2005). In parallel, there is a group of more 
‘technical factors’, intrinsically related to the retrieval procedure: follicle visualization, 
needles and aspiration vacuum used and cumulus oocyte complex (COC) processing 
immediately before IVP (Bols 2005). 
Since the primary goal for a commercial IVP set up is to select oocytes with the highest 
developmental potential, preferentially before in vitro maturation process, oocytes with 
lower developmental competence should be discarded from the production system in the 
mean time. This will be undoubtedly beneficial for the development of the remaining 
oocytes as well for the efficiency of the production system. Non-invasive oocyte quality 
assessment techniques need to meet several specific criteria to be applicable in routine 
IVP systems. The ideal technique to assess quality parameters should be easy to 
perform, economically sound, quick, allow a high throughput of COCs, have an 
acceptable reliability and above all, be non-invasive, so that the oocyte’s developmental 
capacity is not hampered by quality assessment (Bols 2005). When cumulus investment 
morphology and homogeneity of the cytoplasm is used as criteria to assess oocyte 
quality only 35-45% blastocyst can be produced (Bols 2005), which strongly suggests a 
need for additional oocyte quality parameters.  The use of brilliant cresyl blue (BCB), to 
select competent oocytes for IVP, is substantially documented in several studies. One of 
the earliest reports demonstrates the use of BCB for the selection of pig oocytes for 
IVM and IVF (Ericsson et al. 1993). The basic idea behind using BCB staining is a 
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measure for the intracellular activity of glucose-6-phosphate dehydrogenase (G6PDH), 
an enzyme that is synthesized by the oocyte during oogenesis as part of the pentose 
phosphate cycle (Alm et al. 2005). This enzyme is particularly active in growing 
oocytes with a clear decrease in its activity when the oocyte finishes its growth phase 
(Mangia and Epstein 1975). Brilliant cresyl blue is a blue dye that is converted to a 
colorless substance through the action of G6PDH. As fully-grown oocyte show a 
decreased or no G6PDH activity, their cytoplasm will remain blue following exposing 
and subsequent uptake of BCB. This specific characteristic makes BCB an indicator for 
G6PDH activity and therefore indirectly indicates the growth stage of the oocyte. 
Rodríguez-González et al. used BCB stain to assess more competent pre-pubertal goat 
oocytes for in vitro embryo production (Rodriguez-Gonzalez et al. 2002). After 
exposing the oocytes to BCB, they categorized them according to the color of their 
cytoplasm: oocyte with a blue cytoplasm or fully grown oocytes (BCB+) and oocyte 
with a colorless cytoplasm or growing oocytes (BCB-). Importantly, they showed that 
BCB+ oocytes were significantly larger than BCB- ones and there was a higher 
proportion of BCB+ oocytes reached the MII stages compared to their BCB- 
counterparts (Rodriguez-Gonzalez et al. 2002). Similar results were demonstrated by 
Pujol et al. in a study where they used the BCB test to assess the developmental 
competence of heifer oocytes. While a slightly modified oocyte quality grading system 
was employed, they showed that nearly 79% of the morphologically classified grade 1 
oocytes were BCB+ and confirmed that BCB+ oocytes were larger and more competent 
for IVP than control heifer oocytes (Pujol et al. 2004). 
 
2.5 Follicular fluid 
Follicular fluid is composed partially of locally produced substances, which are related 
to the metabolic activity of the follicular cells and partly from the peripheral plasma by 
transudation across the follicular basal lamina and accumulates in the antrum formed by 
the coalescence of small pocket of fluid. Its composition reflects changes in the 
secretory processes of the granulosa layer and theca interna, and alterations in the 
components of plasma due to physiological or pathological processes (Ben-Rafael et al. 
1987). The fluid can be collected easily, especially as the follicle enlarges, and there has 
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been prolonged interest in its composition and functions (Edwards 1974). The following 
sub-sections describe in brief the formation and function of follicular fluid. 
 
2.5.1 Formation of follicular fluid 
It was originally proposed in 1948 that follicular fluid was merely a simple transudate 
of blood that accumulated between the layers of the granulosa cells in growing follicles 
(Harter, 1948). It is now well established that follicular fluid contains a large variety of 
components of serum along with an array of secretions, which may be released by the 
specialized cells in the follicular microenvironment. As a result, the components of 
follicular fluid changes depending on the  growth and expansion status of each follicle 
(Wise 1987). Follicular fluid is a slightly viscous solution with a pH reported to be 7.4, 
similar to that of plasma. Investigators have reported various elements of follicular fluid 
to be similar to those found in serum, with only a few differences (Edwards 1974; 
Greve et al. 1989; Grinsted et al. 1980; Luck et al. 2001). For instance, in case of 
bovine, while sodium and potassium were found to be higher in follicular fluid than 
serum, no differences were found in the concentration of zinc, magnesium, chloride, 
copper and inorganic phosphate (Menezo et al. 2011; Silberstein et al. 2009). To be 
transported into the follicular antrum fluid from the thecal capillaries obviously needs to 
cross the endothelium and sub-endothelial basal lamina before traversing the thecal 
interstitium, the follicular basal lamina, and the membrana granulosa. Changes in 
permeability of the thecal capillaries will lead to edema of the thecal tissue, as observed 
following the luteinizing hormone (LH) surge (Cavender and Murdoch 1988; Espey 
1980), but additional mechanisms are needed for fluid to accumulate in the follicular 
antrum. In earlier literature, both a sodium pump and cleavage of glycosaminoglycans 
to raise pressure in the preovulatory follicle were considered as such mechanisms 
(Gosden et al. 1988). Even if the cells of the membrana granulosa constitute a stratified 
epithelium and can directionally secrete osmotically active molecules toward the center 
of the follicle, because these cells lack a network of tight junctions, it would not be 
possible to establish an osmotic gradient across the membrana granulosa with small 
molecules like sodium (Rodgers and Irving-Rodgers 2010a). In addition, an early 
review found the evidence for a role for sodium to be “inconclusive”  (Gosden et al. 
1988). In fact, the composition of follicular fluid is similar to serum with respect to low-
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molecular weight components, with most electrolytes being at the same concentrations 
in fluid and serum (Shalgi et al. 1972). However, for increasing sizes above 100 kDa, 
plasma proteins are found at progressively lower concentrations than in plasma 
(Andersen et al. 1976), suggesting that there is a nominal “blood-follicle barrier” at 
sizes above 100 kDa. This barrier probably exists at the level of the follicular basal 
lamina and additionally at the level of the thecal capillaries, especially for the larger 
molecules (Zhou et al. 2007). However, such a barrier may also exist in reverse in that 
large molecules produced by oocytes or granulosa cells cannot cross the membrana 
granulosa or follicular basal lamina, thereby establishing a potential osmotic gradient. 
This osmotic gradient could then be responsible for recruiting fluid to the center of the 
follicle.  
 
2.5.2 Function of follicular fluid 
Follicular fluid is an avascular compartment within the mammalian ovary, separated 
from the perifollicular stroma by the follicular wall that  constitutes a ‘blood-follicle 
barrier (Bagavandoss et al. 1983). Besides a contribution of serum, follicular fluid is 
partially composed of locally produced substances, which might be related to the 
metabolic activity of follicular cells  (Gerard et al. 2002). Within the ovarian follicle, 
developing oocyte is surrounded by the follicular fluid. Besides meeting nutritional 
requirement of the growing oocyte, follicular fluid also maintains proper environment 
for growth and maturation of the oocyte (Romero-Arredondo and Seidel 1996). 
Follicular fluid contains numerous biochemical components that are essential for 
ovarian physiology, including steroidogenesis, follicular growth and maturation of 
oocytes, ovulation and transportation of oocyte to the oviduct for fertilization (Choi et 
al. 1998). In addition, it has been suggested that progesterone in follicular fluid could 
possibly play a role in the induction of the acrosome reaction in spermatozoa of 
stallions (Cheng et al. 1998; Rathi et al. 2003) and bulls (Lenz et al. 1982). However, 
follicular fluid does not play a major role in inducing the acrosome reaction in human 
sperm cells (Mortimer and Camenzind 1989). Another important function of follicular 
fluid is to inhibit the production of both progesterone and PGF2α (Shemesh 1979). 
Bovine follicular fluid from mid-cycle follicles inhibited prostaglandin synthetase as 
well as luteinization of follicles (Tsai and Wiltbank 2001). However, this inhibition was 
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not noted when follicular fluid from preovulatory follicles was used (Tsai and Wiltbank 
2001). Follicular fluid also functions to provide nourishment to the oocyte and 
granulosa cells by facilitating transport of specialized nutrients from plasma (Lange-
Consiglio et al. 2012). The dynamic constituents of this fluid reflect both biochemical 
and endocrinological activity of the follicle, thereby facilitating its role as a conductor 
of growth and development through the reproductive cycle (Edwards 1974). Like any 
other biological fluid, the physical characteristics and chemical composition of 
follicular fluid reflect physiological and/or pathological events that take place outside its 
environment. In a follicle, physiologic factors are influenced principally by the 
properties of the tissues, which separate follicular fluid from circulation. The 
permeability of the “blood-follicle barrier” to different biochemical components and 
water originating from blood can markedly alter the composition of follicular fluid 
(Fisch et al. 1990). In addition, the ability of granulosa cells to secrete both stimulatory 
and inhibitory factors as a result of metabolic processes can modify the composition of 
follicular fluid. These factors influence physical parameters such as osmolality, color, 
pH, viscosity and volume of the fluid originating within the developing follicle (Fisch et 
al. 1990). 
 
2.6 Involvement of miRNAs in follicular development 
The mammalian ovary is an extremely dynamic organ within which sequential waves of 
follicular growth and regression, rupture of mature follicles and the adjacent ovarian 
wall during ovulation, repair of the ovulation wound and the formation of fully 
functional corpora lutea followed by its demise a few days later occur within relatively 
short cycles and under tight transcriptional regulation throughout a female's 
reproductive life (Hawkins and Matzuk 2010). Cyclic ovarian activity is key to 
reproductive success and the profound changes in tissue composition and function 
involved require exquisite spatio-temporal co-ordination of proliferation, apoptosis and 
differentiation of many different cell types within follicles (Donadeu et al. 2012). 
Recruitment of growing follicles, atresia, ovulation, and luteal tissue formation and 
regression are dynamically regulated events that regenerate on a cyclical basis in the 
ovary. These events involve dynamic changes in cellular growth, angiogenesis, 
steroidogenesis, cell cycle, and apoptosis and are accurately regulated at the endocrine 
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and tissue levels (Carletti and Christenson 2009). Deregulation in the regulatory 
network results in ovarian failure such as premature ovarian failure (POF) due to 
disruption of folliculogenesis, blockage of ovulation, and loss of oocytes via apoptosis 
(Yang et al. 2012). Small RNA populations have been identified by cloning-based or 
next-generation sequencing of normal ovarian tissues from human (Landgraf et al. 
2007), cattle (Hossain et al. 2009; Huang et al. 2011; Tripurani et al. 2010), mice (Ahn 
et al. 2010; Mishima et al. 2008), pigs (Li et al. 2011), and sheep (McBride et al. 2012). 
Most of those studies involved analyses on whole ovaries rather than on specific ovarian 
tissue components, an approach that, although very useful for comprehensive 
identification of miRNA sequences, provides very limited insight into their functional 
relevance (McBride et al. 2012). For many miRNAs, cloning frequencies changed 
across developmental stages, and some miRNAs were clearly expressed differentially 
between follicular and luteal stages, this data suggests the involvement of miRNAs in 
the follicular–luteal transition period (McBride et al. 2012). Several studies have been 
precisely examined the involvement of specific miRNAs in different aspects of follicle 
development. Dynamic changes in the levels of different miRNAs have been reported 
during follicle development in mice (Lei et al. 2010; Yao et al. 2009), pigs (Xu et al. 
2011) and sheep (McBride et al. 2012) and also in response to stimulation of murine 
follicular cells with gonadotropins (Yin et al. 2012) or growth factors (Yao et al. 2010). 
Treatment of granulosa cells from mouse pre-antral follicles with TGFβ1 in culture 
resulted in the upregulation of three miRNAs and downregulation of 13 miRNAs (Yao 
et al. 2010). A subsequent study (Yin et al. 2012) showed that miR-383, a miRNA 
downregulated by TGFβ1, positively regulated aromatase expression and oestradiol 
production by mouse granulosa cells in culture. These observations, together with the 
finding that miR-383 levels increased in vivo during equine chorionic gonadotropin 
(eCG)-induced follicle growth and decreased following administration of hCG, provide 
strong support for a role for miR-383 in physiologically regulating changes in oestradiol 
production during follicle development. Three recent in vitro studies have also proposed 
roles of miRNAs in regulating granulosa cell proliferation and apoptosis. First Yan et 
al. reported attenuation of activin-induced proliferation of mouse granulosa cells by 
miR-145 targeting of both activin receptor 1B and cyclin D2 (Yan et al. 2012). In 
another study, showed that miR-23a was pro-apoptotic in cultured human luteinised 
granulosa cells presumably by decreasing the levels of X-linked inhibitor of apoptosis 
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protein (XIAP) and increasing caspase-3 cleavage, although it was not clarified whether 
these were actually direct targets of miR-23a in granulosa cells (Yang et al. 2012). 
Using a microarray approach in porcine ovarian follicles, another study demonstrated 
that miR-26b expression increased during follicular atresia and further showed that this 
miRNA could induce granulosa cell death by directly targeting ataxia telangiectasia 
mutated (ATM), a gene involved in DNA repair (Lin et al. 2012). Overall, these studies 
illustrate how a key follicular function, oestradiol production, can be distinctly 
regulated, directly or indirectly, by different miRNAs. 
 
2.7 Extra-cellular miRNAs 
While the majority of miRNAs detected intracellularly, a considerable number of 
miRNAs, commonly known as circulating miRNA or extra-cellular miRNA, have been 
also detected outside cells, mainly in various bio-fluids (Gilad et al. 2008; Hunter et al. 
2008; Mitchell et al. 2008; Weber et al. 2010). Recent studies have shown that miRNAs 
are not only present in serum (Chen et al. 2008; Chin and Slack 2008; Mitchell et al. 
2008) or plasma (Arroyo et al. 2011; Chim et al. 2008; Shen et al. 2010) but also 
different extra-cellular body fluids including saliva urine, tears, seminal fluid, breast 
milk, colostrum, peritoneal fluid, bronchial lavage and cerebrospinal fluid (Weber et al. 
2010). Moreover, the expression profile of extra-cellular miRNAs from different types 
of body fluids in relation to different physiological / pathological conditions shows a 
specific pattern which indicating that extra-cellular miRNAs are not only passively 
released from the necrotic or injured cells but also selectively released from the cells 
(Pigati et al. 2010). 
 
2.7.1 Characteristics of extra-cellular miRNAs 
In contrast to circulating miRNAs, when synthetic miRNAs spiked into human plasma, 
it shows rapid degradation (within few minutes). While denaturing solution inactivated 
RNase activity in plasma, the exogenous miRNAs get released from degradation 
(Mitchell et al. 2008). Thus, synthetic miRNA species are vulnerable and susceptible to 
quick degradation in plasma, where as circulating miRNAs are protected and more 
resistant to high endogenous RNase activity, indicating that circulating miRNAs are 
likely wrapped with some protective manner to bypass high RNase activity in the extra-
Literature review 23 
cellular environment. Moreover, studies have been demonstrated that circulating 
miRNAs in body fluid remain stable even they subjected to harsh conditions like 
boiling, high or low pH, prolonged storage time and multiple freeze-thaw cycles while 
most of cellular RNAs were degraded quickly (Gilad et al. 2008; Taylor and Gercel-
Taylor 2008). In addition, recent studies have been demonstrated that miRNAs in serum 
gives specific expression pattern in quantitative PCR (qPCR) after being subjected to 
incubation at room temperature for 24 h (Mitchell et al. 2008) and maximum 10 freeze-
thaw cycle (Chen et al. 2008). Chen et al. found that isolated serum miRNAs can 
survive the treatment of RNase A, compared to other endogenous RNAs such as 18s 
rRNA, 28s rRNA, GAPDH, β-actin and U6 (Chen et al. 2008). Most serum miRNAs 
maintain considerable expression levels after 3 hours or overnight RNase A treatment; 
however large RNAs were degraded following 3 hours of RNase A treatment (Chen et 
al. 2008). 
The mechanism underlying the remarkable stability of circulating miRNAs in the 
RNase-rich environment of blood is not well understood. Many hypotheses have been 
proposed to explain the possible mechanisms through which RNAs and miRNAs are 
released and protected from endogenous RNase activity in circulation. One of the 
earliest theory suggested that RNAs might conjugated with protein which would later 
protected them from both DNase and RNase activity (Sisco 2001). However, later on it 
has been showed that RNA species present in plasma are protected from degradation 
probably due to inclusion in lipid or lipoprotein complexes, not by binding with DNA 
(El-Hefnawy et al. 2004). Another hypotheses is that miRNAs are wrapped with 
microvesicles (exosomes, microparticles and apoptotic bodies), which shaded miRNAs 
in circulation and protect from RNase activity (Valadi et al. 2007). On the other hand 
some other studies have shown that, after isolation of microvesicles using high-speed 
ultra centrifugation from culture media (Turchinovich et al. 2011; Wang et al. 2010c) or 
plasma, a handful miRNAs are still detectable in the microvesicles free fraction, 
suggested that the presence of non-vesicle associated miRNA (might be miRNA-protein 
or miRNA-lipid/lipoprotein complexes) in extra-cellular fluid .  
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2.7.2 Pathways to release circulatory miRNAs 
There are arguments regarding how these miRNAs are released in extracellular body 
fluids, stability and serves cell-cell communications. Numbers of studies have been 
demonstrated that the transfer of protein, mRNA and miRNA in different body fluids 
can be mediated via exosomes, microvesicles apoptotic bodies and RNA-protein or 
RNA-lipoprotein complexes that are released from a variety of cell types to modulate 
angiogenesis, cell proliferation/ apoptosis, tumor cell invasion and cell-cell 
communication. 
 
2.7.2.1 Transport of circulating miRNA through exosomes 
Exosomes are homologous small vesicles (50-90 nm) and have an endosomal origin 
(Camussi et al. 2010; Heijnen et al. 1999; Thery et al. 2002). Exosomes are formed by 
invagination of the membrane of endosomes to produce intraluminal vesicles, thus 
rendering these organelles multivesicular bodies (Urbe et al. 2003). In response to cell 
stimulation, budding of endosomes occurs, a process dependent on calcium influx, 
calpain and cytoskeleton reorganization (Johnstone 2006).  Currently, accumulating 
evidences suggest that these secretory vesicles can function as intercellular transmitters 
to convey their contents, in particular, miRNA (Rechavi et al. 2009; Skog et al. 2008; 
Valadi et al. 2007). A total of 121 miRNAs were identified in exosomes from mast cells 
and the expression pattern of certain miRNAs was higher in microvesicles than in the 
donor cells (Valadi et al. 2007). Valadi and colleague reported that exosomes that are 
released from human and murine bone marrow-derived mast cells contain mRNA and 
miRNA, which are transferable to other human or mouse mast cells. When exosomes 
from mouse mast cells transferred to human mast cells, they produce new mouse protein 
in recipient cells, indicating that the exosomal mRNAs are functional and they can be 
translated after entering into another cell (Valadi et al. 2007). Furthermore, it has been 
shown that embryonic stem cell derived microvesicles are miRNA enriched and they 
can transfer a subset of miRNAs to mouse embryonic fibroblasts in culture, suggesting 
that gene expression of neighboring cells might be affected by exosomal miRNA that 
released by embryonic stem cells (Yuan et al. 2009). It has been demonstrated that 
miRNA released in exosomes by Epstein-Barr virus (EBV)-infected cells can be taken 
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up by peripheral blood mononuclear cells and these EBV-miRNAs repressed confirmed 
EBV target genes (Pegtel et al. 2010). 
 
2.7.2.2 Transport of circulating miRNA through microparticles 
Microparticles are lipid vesicles that are more than 1 μm in diameter and are secreted 
into extracellula environment by different type of cells and platelets (Aharon et al. 
2009; Chironi et al. 2009; Ratajczak et al. 2006b). Many cell types are known to secrete 
microparticles and these include some cancer cells (Castellana et al. 2009), neurons 
(Marzesco et al. 2005) and many of the vascular and hematopoietic cell types such as 
endothelial cells, dendritic cells and B cells (Shet 2008). Microparticles are larger than 
exosomes and form through plasma membrane budding and also contain miRNA (Yuan 
et al. 2009). Initially microparticles were considered as cell debris but experimental 
evidence suggests that microparticles influences diverse biological functions for 
example cardiovascular disorders, including atherogogenesis and thrombosis (Mack et 
al. 2000; Mause and Weber 2010; Shantsila et al. 2010). The presence of miRNAs in 
microvesicles has now been reported from different cells including mesenchymal stem 
cell (Chen et al. 2009), mast cells (Shefler et al. 2010; Valadi et al. 2007), cancer cells 
(Jaiswal et al. 2011; Taylor and Gercel-Taylor 2008), platelets (Hunter et al. 2008) and 
endothelial cells (Skog et al. 2008). Recently it has been shown that chemically 
modified miR-143 entrapped by microvesicles was significantly secreted from miR-
143-transfected human monocytic leukemia THP-1 cells during incubation in serum-
free media (Akao et al. 2011). These findings highly support that at least some 
extracellular miRNAs are used for cell-cell communication via microparticles but still 
thorough investigation need to understand the mechanisms how miRNAs are selected 
for secretion, recognized for uptake, and what information can be transmitted. 
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Figure 2.5: Extracellular transportation systems of miRNAs (Creemers et al. 2012).  
  
 
2.7.2.3 Transport of Circulatory miRNA through apoptotic bodies 
Apoptotic bodies (Abs) are small membranous particles released during programmed 
cell death (Hasselmann et al. 2001). The formation of ABs is a final outcome of 
apoptotic cell death. Budding of microparticles occurs mainly during early apoptosis, 
whereas ABs are formed in the late stages of this death process. Abs are larger than 
MPs and represent the compacted or condensed remnants of the shrinking apoptotic 
cells (Belting and Wittrup 2008; Beyer and Pisetsky 2009; Hristov et al. 2004). 
Recently it has been reported that ABs plays an important role in the repair of injured 
cells. In vitro experiment shows that endothelial progenitor cells (EPCs) engulf ABs 
released from endothelial cells (ECs) which trigger the secretion of cytokines and/or 
growth factors indicating that it may facilitate the repair of injured endothelial cells or 
somatic cells (Hristov et al. 2004). A microarray result shows that the presence of a 
panel of miRNAs in ABs derived from ECs where mir-126 is the most abundant one 
(Zernecke et al. 2009). Sprouty-related protein, SPRED1, and phosphoinositol-3 kinase 
regulatory subunit 2 (PIK3R2) are the negative regulators/ intracellular inhibitors of the 
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vascular endothelial growth factor (VEGF) signaling pathway. Through repressing the 
expression of these negative regulators in ECs, mir-126 facilitates the pro-angiogenic 
actions of VEGF and fibroblast growth factor (FGF) and promotes blood vessel 
formation (Fish et al. 2008; Wang et al. 2008). Moreover, mir-126 knockout in mice 
resulted leaky vessels, and partial embryonic lethality, because of a loss of vascular 
integrity, defects in endothelial cell proliferation and angiogenesis (Wang et al. 2008). 
In damaged tissue, the CXC chemokine CXCL12 and its receptor CXCR4 counteract 
apoptosis and recruit progenitor cells. In case of atherosclerosis, endothelial cell-derived 
ABs are generated and convey paracrine signals to recipient vascular cells that trigger 
the production of CXCL12 in a miR-126 dependent manner (Zernecke et al. 2009). 
Though, these observations confirms that ABs may serve as a carrier of circulating 
miRNA, more studies need to determine how specific miRNA secreted, recognized for 
up-take via this process. 
 
2.7.2.4 Transport of circulating miRNA through protein complex 
One of the major components of miRNA silencing complex is Argonaut 2 protein 
(Ago2). Ago2-miRNA complexes were detected in different cell culture media and 
western blot immunoassay shows that extracellular miRNA ultrafiltrated together with 
the Ago2 protein, a part of RNA-induced silencing complex, not associated with 
microvesicles or exosomes (Turchinovich et al. 2011). Furthermore, it has been 
demonstrated that only 10% cell-free miRNAs released in plasma through micro 
vesicles whereas potentially 90% of the miRNAs in the circulation co-fractionated with 
ribonucleo-protein complexes (Arroyo et al. 2011). Size-exclusion chromatography has 
been used to exclude the microvesicle or exosome contamination from protein 
complexes and shows that most of the miRNA co-purified with non-vesicle-associated 
ribonucleo-protein complexes, only few miRNA, such as miR-16 and miR-92a 
associated predominantly with microvesicles (Arroyo et al. 2011). However, Ago2-
miRNA is not only the protein complex that released in cell culture supernatant, mass 
spectrometry results revealed that a total of 197 proteins present in human fibroblast 
conditioned medium 2 h after serum starvation, of which 12 were known RNA-binding 
proteins (Wang et al. 2010b). Although, the role of other RNA-binding protein 
complexes, except Ago2, is presently unclear. Collectively these results indicate that 
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Ago2-protein complexes might be involved with the delivery of miRNA from donor 
cell to recipient cells and facilitate cell-cell communications. 
 
2.7.2.5 Transport of circulatory miRNA through high density lipoprotein 
Recently, Vickers et al. reported that purified fractions of HDL from healthy human 
plasma contain a number of miRNAs (Vickers et al. 2011). Highly purified HDL that is 
negative for exosomal marker proteins is rich in small RNA molecules that are 15 to 30 
nucleotides in length but devoid of long mRNAs (Vickers et al. 2011). Total RNA 
extracted from HDL and exosomes isolated from the plasma of healthy individuals 
revealed that their miRNA profile is distinct (Vickers et al. 2011). A specific miRNA 
signature of HDL-miRNA complexes was identified in patients with familial 
hypercholesterolemia, including miR-22, miR-105, and miR-106a (Vickers et al. 2011). 
The authors further showed that direct delivery of miRNAs to recipient cells can also 
occur by HDL in a ceramide signaling pathway dependent manner (Vickers et al. 2011). 
Thus, native HDL is associated with miRNAs in a way that resembles artificial gene 
delivery vehicles, acting as a carrier or depot for circulating miRNAs in plasma and 
facilitating their transport and delivery to recipient cells. Finally, the study by Vickers et 
al. provides evidence that the miRNAs within HDL alter the cellular miRNA pool and 
functionally downregulate corresponding miRNA targets (Vickers et al. 2011), 
suggesting that the miRNA content of HDL is biologically relevant. Collectively, these 
results indicate that besides its classical role as a delivery vehicle for excess cellular 
cholesterol, HDL may also function as a transporter of endogenous miRNAs. 
 
2.7.3 Potential role of extra-cellular miRNAs 
Whether the extra-cellular forms of miRNAs are simply waste products from cells or 
have a biological function, such as participating in intercellular communication is not 
yet clear. There are reports showing increased level of miRNAs in blood upon organ 
toxicity (Laterza et al. 2009; Zhang et al. 2010), and this could of course represent 
waste products. Nevertheless, since the various forms of extracellular miRNAs are 
probably products of distinct cellular processes, they might play different roles, and 
therefore it is important to distinguish between them. Apoptotic bodies are by definition 
formed during apoptosis. miRNA bound to Ago2 may be released from cells upon 
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apoptosis or necrosis (Turchinovich et al. 2011), but it is not known if miRNA-Ago2 
complexes also can be transported out of viable cells. This means that miRNAs bound 
to Ago2 proteins and miRNAs incorporated into apoptotic bodies might solely be by-
products from dying cells or represent a way for dying cells to communicate with 
neighboring cells. They could represent a signal warning the organism about cellular 
dysfunction. 
Shedding vesicles and exosomes are thought to be released by viable cells, though it is 
not ruled out whether these vesicles also are released by dying cells. Therefore, these 
vesicles have to a greater extent been suggested to play a role in intercellular signaling 
(Hunter et al. 2008; Valadi et al. 2007). Indeed, it has been shown that miRNAs can be 
transferred by exosomes from one cell to another in vitro and result in downregulation 
of target genes in the recipient cell (Kogure et al. 2011; Montecalvo et al. 2012). These 
findings indicate a role in intercellular communication which could have a huge impact. 
However, this remains to be shown in vivo conditions. Interestingly, it has been reported 
that injection of exosomes loaded with siRNA into mice can result in specific gene 
knockdown in certain cells (Alvarez-Erviti et al. 2011). It has been questioned whether 
the concentration of exosomes in biological fluids is high enough to play a role in 
intercellular communication, but this does not exclude a role in autocrine or paracrine 
signaling (Turchinovich et al. 2011). Exosomes probably exert their effect on 
neighboring cells, and thereby participate in creating a specific microenvironment. In 
this scenario, the exosomes found in body fluids would only be residual amounts, 
representing a secondary effect. 
In addition to their conventional role in post-transcriptional gene regulation, a new role 
for miRNAs as signaling molecules has recently been described by two independent 
groups. Interestingly, extra-cellular let-7 was shown to activate Toll-like receptor 7 in 
neurons and induce neurodegeneration (Lehmann et al. 2012). By another group, 
exosomal miR-21 and miR-29a was shown to activate TLR 7 and 8 in immune cells, 
triggering a prometastatic inflammatory response that may lead to tumor growth and 
metastasis (Fabbri et al. 2012). Thus, extra-cellular miRNAs could be important 
regulators of tumor microenvironment as well as exacerbate CNS damage, through 
agonistic effect on TLR 7 and 8. 
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Another possible role for miRNAs in exosomes and microvesicles is that they might 
function together with the RNAi machinery. RISC proteins have been shown to be 
associated with MVBs and exosomes (Gibbings et al. 2009). Moreover, blocking MVB 
formation by depletion of ESCRT (endosomal sorting complex required for transport) 
components has been reported to result in impaired miRNA silencing, indicating a role 
in RNAi dynamics (Gibbings et al. 2009; Lee et al. 2009). 
 
2.7.4 Potential application of extra-cellular miRNAs 
Utility of minimally invasive serum biomarkers in the form of DNA and RNA 
fragments in serum for altered physiological conditions were well documented 
(Fleischhacker and Schmidt 2010). In 1977, Leon et al. first observed that 
concentrations of cell-free circulating DNA (cirDNA) in blood of cancer patients is 
higher as compared to normal subjects (Leon et al. 1977). Since then, various studies 
have demonstrated elevated level of cell-free DNA concentration in plasma/serum in 
various pathological conditions, including cancer, autoimmune disorders, pregnancy 
and trauma (Mitchell et al. 2008). Recent discoveries on miRNAs in serum have stirred 
the demanding biomarker discovery field to identify reliable markers for early disease 
detection and classification. 
In general, the blood based biomarkers, including antigens, enzymes, and lipid 
components are very useful for prognosis, monitoring the effectiveness of treatments, 
prediction of recurrence risk, and also to monitor the recurrence of the disease. 
Currently there are very few blood-based biomarkers with respect to tumors and 
cancers. Some of the currently available serum/plasma biomarkers, such as 
carcinoembryonic antigen (CEA), cytokeratin 19 fragment (CYFRA21-1) and 
alphafetoprotein (AFP) offer some promise to analyze tumors systematically without 
involving the tissue biopsies or surgery (Dbouk et al. 2007). However, clinical 
implementation of these biomarkers at a broader level faces some major challenges 
specially their low sensitivity and specificity. 
The stability of miRNAs in plasma and the easier detection of these miRNAs in a 
quantitative manner by methods such as real-time PCR and microarrays have sparked 
great interest in the use of circulating miRNAs as clinical biomarkers for altered 
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physiological conditions. However, an ideal biomarker should satisfy a number of 
criteria, such as accessibility through noninvasive methods, a high degree of specificity 
and sensitivity, the ability to differentiate pathologies, allowing early detection, 
sensitivity to relevant changes in the disease, a long half-life within the sample, and the 
capability for rapid and accurate detection (Etheridge et al. 2011). Because of 
circulating miRNAs are able to fulfill a number of those criteria, since 2009, several 
groups have reported on the use of miRNAs as circulating biomarkers for diagnosis or 
prognosis of cardiovascular diseases such as myocardial infarction, HF, atherosclerosis 
and hypertension (Chen et al. 2008; Heneghan et al. 2010; Laterza et al. 2009; Wang et 
al. 2009a). Although many of those studies still require replication in multiple 
independent study populations, the picture emerges that some plasma miRNAs are quite 
specific for cardiovascular pathologies and not only may be useful for diagnostic and 
monitoring purposes but also may provide much needed intermediate end points for 
clinical trials (Creemers et al. 2012). 
Several groups have studied the hypothesis regarding heart-specific miRNAs that leak 
into the circulation during an acute myocardial infarction (AMI) and can be used to 
detect and monitor myocardial injury (Corsten et al. 2010). MicroRNAs such as miR-
208a, miR-499, miR-1 and miR-133 are found to be consistently highly abundant in 
plasma of AMI patients within hours after the onset of infarction (Cheng et al. 2010; 
Corsten et al. 2010; Wang et al. 2010b). Of these 4 miRNAs, miR-208a, which is 
encoded by an intron of the αMHC gene, is to the best of our knowledge the only heart-
specific miRNA. The other 3 miRNAs (miR-499, miR-1, and miR-133), besides being 
highly expressed in the heart, are also expressed in skeletal muscle (Chen et al. 2006; 
van Rooij et al. 2009).  
In the early phase after AMI (<3 hours), miR-1, miR-133a, and more particularly miR-
208a may even be more sensitive than the classic biomarker cTnI, because these 
miRNAs achieve their peak before cTnI (Creemers et al. 2012). The miRNA elevated 
level of these miRNAs in this earlier stage of infection suggests a faster release of 
miRNAs in circulation than cTnI from damaged cardiomyocytes because of differential 
release kinetics (Creemers et al. 2012). In this regard, cTnI is mainly bound to 
myofibrils (Ng et al. 2009), whereas miRNAs are believed to be bound to protein 
complexes in the cytosol or wrapped by vesicles, latter facilitate a faster release from 
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damaged cells (Wang et al. 2010b). Interestingly, not all myocardial miRNAs leak into 
the circulation with the same kinetics (Tijsen et al. 2012). The slower release of miR-
499 into the bloodstream compared with several other myocardial miRNAs may suggest 
the preferential release of miRNAs in the circulation (Creemers et al. 2012). Strikingly, 
miR-30c and miR-24 are strongly expressed in the heart, even more strongly than miR-
208, but their levels in the bloodstream still failed to increase after AMI (D'Alessandra 
et al. 2010). 
A significant reduction or elevation of specific miRNA level in serum/plasma of cancer 
patients as compared to healthy controls and their correlation with the surgical treatment 
of the tumor signifies the potential link between miRNA expression levels and primary 
tumors (Srivastava et al. 2011). Systematically analyzing the expression pattern of 
various miRNAs in human cancers can also provide significant understanding of origin 
of an unknown primary carcinoma (Barker et al. 2009). In one of the pioneer studies 
dealing with miRNA levels in serum samples, Lawrie et al. suggested that serum miR-
21 levels are associated with relapse-free survival in patients with diffuse large B-cell 
lymphoma and therefore holds potential to be a diagnostic biomarker for the disease 
(Lawrie et al. 2008). Heneghan et al. showed that cancer-specific miRNAs are 
detectable and significantly altered (miR-195 and let-7a) in the circulation of breast 
cancer patients, and that increased systemic miR-195 levels in breast cancer patients 
were also reflected in breast tumors (Heneghan et al. 2010). Following that, they also 
correlate specific circulating miRNAs with various pathological variables such as nodal 
status, estrogen receptor status etc (Heneghan et al. 2010). Altered expression of let-7, 
miR-25 and miR-223 miRNAs in serum has been observed in lung cancer patients while 
miR-15/16 were found to be down regulated in leukemia patients (Calin et al. 2002; 
Carlsen et al. 2013). Furthermore, some miRNAs like miR-210, miR-200a and miR-
200b have been shown to be overexpressed in patients with pancreatic cancer (Ho et al. 
2010; Wang et al. 2009a). In the case of pancreatic ductal adenocarcinoma, a collective 
analysis of four differentially expressed miRNAs (miR-21, miR-210, miR-155, and 
miR-196a) in plasma has been suggested to discriminate patients from healthy 
individuals (Wang et al. 2009a). In tongue squamous cell carcinoma miR-184 has been 
shown to be upregulated in plasma of patients (Wong et al. 2008). Moreover, let-7a 
miR-21 and miR-195 were observed to be upregulated in the breast cancer (Wang et al. 
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2010a). In gastric cancer miR-17-5p, miR-21, miR-106a, miR-106b are known to be 
upregulated (Wang et al. 2009a) while let-7a expression was down regulated (Tsujiura 
et al. 2010). miR-155 was differentially expressed in the serum of women with 
hormone-sensitive as compared to hormone-insensitive breast cancer patients (Zhu et al. 
2009). The level of miR-500 in the sera of the hepatocellular carcinoma (HCC) patients 
was highly elevated pre-surgery and which returned to normal level after the surgery, 
whereas lowered expression of miR-92a to miR-638 in plasma of HCC subjects was 
observed as compared to controls (Shigoka et al. 2010; Yamamoto et al. 2009). In 
colorectal cancer, miR-17-3p and miR-92 levels were elevated significantly in plasma 
of matched patient samples prior to surgery compared to post surgery (Ng et al. 2009). 
Decreased expression of miR-92a in plasma was also observed in acute leukemia 
patients (Tanaka et al. 2009). In ovarian cancer miR-21, -29a, -92, -93, and -126 were 
significantly overexpressed in serum from cancer patients as compared to healthy 
controls (Hausler et al. 2010; Taylor and Gercel-Taylor 2008). Also, miR-155, miR-
210, and miR-21 were found to be elevated in the patients’ serum of diffuse large B-cell 
lymphoma (DLBCL) as compared to healthy controls (Lawrie et al. 2008). In several 
studies, miRNA expression profiles have been shown to have signatures related to 
tumor classification, diagnosis, and disease progression. The realisation that miRNAs 
are deregulated in human cancers has generated considerable interest with regard to 
their potential as biomarkers. miRNAs have a number of desirable characteristics for 
such an application. Perhaps most importantly, miRNA expression profiles are often 
tissue, developmental, and disease specific. 
 
2.7.5 Challenges in extra-cellular miRNA study 
MicroRNAs have only been discovered within the last two decades. Although the 
assessment of the miRNA expression pattern in various cancers has revealed a plethora 
of potential miRNA biomarker candidates for cancer risk, diagnosis, prognosis and/or 
prediction and therapy, development of a reliable and reproducible miRNA clinical test 
still in infancy (Srivastava et al. 2011). In that respect, circulating miRNAs offer many 
features to make them an attractive class of biomarkers. They are stable; their sequences 
are evolutionarily conserved; miRNA expression is often tissue or pathology specific; 
and because they are detected by real-time PCR, assays can be highly sensitive and 
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specific. However, there are also challenges associated with the detection of circulating 
miRNAs that still need to be addressed. One of the challenges relates to the low amount 
of total RNA in blood, which makes it virtually impossible to measure the concentration 
and quality of the isolated RNA. As a consequence, it is of crucial importance to 
precisely normalize detected miRNA values for variances based on the amount of 
starting material and miRNA extraction. This has been tried by seeking a 
“housekeeping” circulating RNA. Some reports use U6 or other miRNAs (eg, miR-16) 
as a housekeeping RNA; however, the levels of these RNAs often change under 
pathological conditions. Mitchell et al. reported a spiked-in normalization approach in 
which 3 synthetic Caenorhabditis elegans miRNAs (without homology to human 
miRNAs) were added during the purification procedure and used for data normalization 
(Mitchell et al. 2008). This worked well in their hands; however, these synthetic 
miRNAs may be less stable than endogenous miRNAs when added to plasma. Cheng et 
al. (2010) reported that plasma volume is the best factor with which to standardize the 
amount of input miRNA. The amount of molecules per volume of plasma or serum is 
also used as the standard to evaluate blood levels of other molecules. Future studies are 
warranted to systematically characterize the different normalization methods to find the 
best way to reproducibly measure miRNAs in plasma. In this regard, it is very possible 
that plasma miRNAs from microparticles, HDL, or unbound miRNA require a different 
normalization procedure.  
 
2.8 Exosomes 
Exosomes are small nano sized (30–90 nm) extracellular vesicles and they correspond to 
the internal vesicles of multivesicular bodies (MVBs) and are released in the 
extracellular environment upon fusion of MVBs with the plasma membrane (Thery et 
al. 2002). Exosomes were first discovered in the process of eliminating transferrin 
receptors during reticulocyte (immature red blood cells) maturation, and thought to 
function as cellular waste products, thus received little attention and remained little 
studied. This “cellular waste” hypothesis was challenged in the 90’s, when exosomes 
were shown to have an immunoregulatory effect, with the demonstration that B cell-
derived exosomes could stimulate T cells (Raposo et al. 1996). The authors demonstrate 
that Epstein–Barr virus (EBV)-transformed B-lymphocytes secreted exosomes that bore 
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molecules essential for the adaptive immune response namely major histocompatibility 
class (MHC) II dimers bound to antigenic peptides. These exosomes were also shown to 
present the MHC-peptide complexes to specific T cells, suggesting that they could play 
a role in adaptive immune responses (Raposo et al. 1996). Two years later, the groups 
of Raposo, Amigorena, and Zitvogel demonstrated that dendritic cells (the immune cells 
that initiate adaptive immune responses by presenting MHC–peptide complexes to 
naïve T cells) also secrete exosomes bearing functional MHC–peptide complexes, 
which could promote induction of antitumor immune responses in mice in vivo 
(Zitvogel et al. 1998). These results provided the basis for the hypothesis that exosomes 
could play an active role in intercellular communication, at least in the immune system, 
and prompted the very first attempt at using them in the clinic, as a new type of 
anticancer therapy in humans (Thery 2011). This greatly increased the interest in the 
field. Today, exosomes have been found in a number of human body fluids. 
Exosomes can be distinguished from other classes of cell-secreted vesicles such as 
microvesicles (MVs) and apoptotic bodies by several classification features including 
size, biological content, and most markedly, by biogenesis and mode of release from the 
cell. Exosomes range in size from 100 nm or less while MVs are typically larger at 100 
to 1000 nm in diameter (Thery 2011). The secretion of exosomes can be spontaneous or 
induced depending on the cell type. Following the activation of a cell surface receptor, 
reticulocytes (Pan et al. 1985), T cells (Blanchard et al. 2002), mastocytes (Raposo et al. 
1997) and resting B cells (Arita et al. 2008; Muntasell et al. 2007; Saunderson et al. 
2008) secrete detectable levels of exosomes in the extra cellular milieu. In contrast, 
Epstein-Barr virus (EBV)-transformed B cells (Raposo et al. 1996), dendritic cells 
(Zitvogel et al. 1998) and macrophage (Bhatnagar et al. 2007) constitutively secrete 
exosomes in vitro, as do most tumor cell lines. Exosomes have also been purified in the 
absence of any mechanical dissociation from several body fluids, such as human plasma 
(Caby et al. 2005), serum (Taylor et al. 2006; Taylor and Gercel-Taylor 2008), broncho-
alveolar fluid (Prado et al. 2008), urine (Pisitkun et al. 2004), tumoral effusions (Andre 
et al. 2002), epididymal fluid (Gatti et al. 2005), amniotic fluid (Asea et al. 2008) and 
milk (Admyre et al. 2007). These exosomes contain proteins that are expressed by 
epithelial, tumor and haematopoietic cells, which suggest that exosomes could be 
released from several cell types and tissues in vivo. 
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2.8.1 Biogenesis of exosomes 
Exosome formation begins with initiation of the endocytotic pathway as material, such 
as protein, is engulfed by the cell at its surface. This process may be clathrin dependent, 
as is true in the case of the transferrin receptor, or may be clathrin-independent, as is the 
case with glycosylphosphatidylinositol (GPI)-anchored proteins, caveolae, or lipid raft 
mechanisms (Mayor and Riezman 2004). Once internalized, the endocytotic vesicles are 
delivered to early endosomes in which the mildly acidic pH (~6.2) causes an un-
coupling of housekeeping receptors from their ligands, and then recycled back to the 
plasma membrane or transported to late endosomes together with other proteins and 
lipids (Maxfield and McGraw 2004). In late endosomes, which is spherical in shape and 
acidic in nature (pH 5.0 to 5.5), two sequential steps have been recognized for sorting of 
protein during MVBs formation. The first step include the lateral sorting or selection of 
proteins at the limiting membrane of endosomal lumen and the second step is the 
formation of inwardly budding vesicles, commonly known as intraluminal vesicles 
(ILV), with the concomitant incorporation of selected proteins, lipids, mRNAs and 
miRNAs. Once MVBs formed they can either fuse with lysosomes for degradation of 
proteins or direct interaction with the plasma membrane, resulting in the release of the 
ILVs as exosomes. Since two membrane inversion occur during the formation of an 
exosome from a membrane patch on the plasma membrane, it allow exosomes to 
present trans membrane cargo in the same orientation relative to the cell cytoplasm and 
with the same membrane protein on the outside as at the plasma membrane (Lakkaraju 
and Rodriguez-Boulan 2008). 
The mechanisms underlying the formation of ILVs and the sorting of proteins and lipids 
into these vesicles, as well as docking and fusion of the MVBs with the plasma 
membrane are poorly understood, although the ESCRT have been shown to be involved 
in this process. However, it has been shown that protein can also be sorted 
independently of ESCRT (de Gassart et al. 2003). There are five distinct protein 
complexes, ESCRT-0, ESCRT-I, ESCRT-II, ESCRT-III and Vps4, found to be involved 
in ESCRT machinery protein complexes, including which direct ubiquitin tagged cargo 
to endosomes where they are sorted into ILVs (Gould and Lippincott-Schwartz 2009; 
Henne et al. 2011). The process is started by ESCRT-0 which is made up of HRS 
(hepatocyte growth factor- regulated Tyr-kinase substrate) or Vps27 in the case of yeast, 
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and STAM (signal transducing adaptor molecule) that binds to ubiquitinated proteins 
(Katzmann et al. 2003). ESCRT-0 then binds with the ubiquitin binding protein Tsg101 
(tumor susceptibility gene-101) via its N-terminal UEV domain, which is a component 
of ESCRT-I. Importantly, ESCRT-I also composed of Vps28 and one of four isotypes 
of Vps37 (Vps37A-D) (Teo et al. 2004). ESCRT-I recruits the next pathway complex, 
ESCRT-II, with the help of ESCRT adaptor protein Alix (ALG-2 interacting protein X), 
leads to the recruitment of ESCRT-III. ESCRT-III is composed of the most constituents 
and associated proteins, more than the other ESCRT complexes, including Vps2A,B, 
CHMP3 (charged MVB proteins or chromatin modifying protein-3), SNF7-1,-2,-3, and 
CHMP7, among others (Williams and Urbe 2007). The final step of ILVs formation 
also requires Vps4, which binds to ESCRT-III and also induces the ESCRT machinery’s 
release from the endosomal membrane, thus enabling it to be recycled (Babst 2011; 
Hanson et al. 2009). Another theory for the underlying mechanism behind sorting of 
content into ILVs involves a ubiquitin-independent pathway while utilizing the ESCRT 
machinery, most likely by direct interference with ESCRT-I and –III (Babst 2005; de 
Gassart et al. 2004; van Niel et al. 2006). 
 
Figure 2.6: Exosome biogenesis. Membrane proteins (shown in purple and green) are 
internalized and delivered to early endosomes (EE). In early endosomes, the 
proteins can be recycled to the plasma membrane or delivered to late endosomes. 
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Intraluminal vesicles are formed by budding of the endosomal limiting 
membrane into the endosomal lumen, forming multivesicular bodies (MVB). 
MVBs either can fuse with lysosomes for protein degradation or they can also 
dock to and fuse with the plasma membrane. This results in the release of the 
intraluminal vesicles to the extracellular compartment. The vesicles are now 
called exosomes. Exospores display the same topology as the plasma membrane, 
with extracellular domains exposed on the outside and cytoplasm on the inside 
enclosed by a lipid membrane. Modified from (Bellingham et al. 2012). 
In the absence of the ESCRT machinery, proteins can also be sorted independently of 
ESCRT. Under this circumstances cells may employ different mechanisms for the 
formation and protein sorting of MVBs, and consequently ILVs. These ESCRT-
independent pathways seem to be driven by cholesterol, tetraspanins and lipids, such as 
sphingomyelin, that form specialised microdomains in the endosomal limiting 
membrane, called lipid rafts, which can bend inwards and consequently form ILVs (de 
Gassart et al. 2003; Wubbolts et al. 2003). Proteins can also be co-sorted into ILVs, by 
binding to membrane proteins or lipids (de Gassart et al. 2003). Additionally, 
engulfment of the cells cytoplasm during the vesicle formation can lead to random 
packaging of cytosolic proteins. Proteins and lipids are not the only content that is 
sorted into ILVs, as exosomes have been shown to also contain different RNA species 
(Valadi et al. 2007). The sorting of RNA into ILVs is an even a greater enigma, 
however the poor correlation between the mRNA content of exosomes and their donor 
cells (Mittelbrunn et al. 2011) suggests that the RNA is specifically packed into the 
vesicles, rather than randomly engulfed from the cells cytoplasm (Nazarenko et al. 
2010; Valadi et al. 2007). Some studies have suggested that MVBs are the location of 
the assembly and loading of RISC and therefore miRNA (Gibbings et al. 2009). 
In addition to an incomplete understanding of biogenesis and sorting, the mechanisms 
underlying the secretion of exosomes is also poorly understood. Secretion involves the 
docking and fusion of MVBs with the plasma membrane, with several different factors 
involved in the regulation of this process. Several members of the GTPase family Rab, 
regulators of membrane trafficking, have been shown to be involved in the docking and 
fusion of MVBs with the plasma membrane, and thus the release of exosomes. One 
member of the family, Rab11, has been shown to be involved in this process in a 
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calcium (Ca2+)-dependent manner (Savina et al. 2003). It was first suggested that an 
intracellular increase of Ca2+ stimulate exosome secretion (Savina et al. 2003). Later, it 
was shown that Rab11, together with Ca2+, are involved in the secretion of exosomes. 
An overexpression of Rab11, together with an increased intracellular Ca2+ 
concentration, promotes MVBs docking and fusion with the plasma membrane, and thus 
increases the secretion of exosomes (Savina et al. 2005). The regulation of exosome 
secretion is not only controlled by Rab proteins. Other proteins such as the p53 protein 
and the transmembrane protein TSAP6 have been shown to be involved in the secretion 
process (Amzallag et al. 2004; Yu et al. 2006). In addition, factors such as stress and pH 
are also involved in the secretion of exosomes (King et al. 2012). The release and the 
uptake of exosomes by recipient cells have been shown to increase at low pH (Parolini 
et al. 2009). Furthermore, stress such as hypoxia has also been shown to increase 
exosome secretion (King et al. 2012). 
 
2.8.2 Isolation methods of exosomes 
The accepted protocol for isolation of exosomes includes ultracentrifugation, often in 
combination with sucrose density gradients or sucrose cushions to float the relatively 
low-density exosomes (Thery et al. 2006). Isolation of membrane vesicles by sequential 
differential centrifugations is complicated by the possibility of overlapping size 
distributions with other microvesicles or macromolecular complexes. Furthermore, 
centrifugation to pelleting may prove insufficient means to separate vesicles based on 
their sizes. However, sequential centrifugations, when combined with sucrose gradient 
ultracentrifugation, can provide a high enrichment of exosomes. 
Isolation of exosomes based on size, using alternatives to the ultracentrifugation routes, 
is an obvious option. Cheruvanky et al. reported successfully purifying exosomes using 
ultrafiltration procedures that are less time consuming than ultracentrifugation, and do 
not require use of special equipment (Cheruvanky et al. 2007). Similarly, Bioo 
Scientific launched a kit (ExomiR) that essentially removes all cells, platelets and 
cellular debris on one microfilter and captures all vesicles bigger than 30 nm on a 
second microfilter using positive pressure to drive the fluid. For this process, the 
exosomes are not reclaimed - their RNA content is directly extracted off the material 
caught on the second microfilter, which can then be used for PCR analysis. HPLC-
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based protocols could potentially allow one to obtain highly pure exosomes, though 
these processes require dedicated equipment and are not trivial to scale up (Lai et al. 
2010). The complication is, both blood and cell culture media contain a large number of 
nanoparticles (some non-vesicular) in the same size range as exosomes. For example, 
Wang et al. found that large number of miRNAs are contained within extracellular 
protein complexes rather than exosomes (biological roles for these are yet to be 
understood). As a consequence, the above methods are best described as allowing one to 
obtain exosome-enriched samples, rather than pure exosomes (Wang et al. 2010c). 
Volume-excluding polymers such as PEGs are routinely used for precipitation of 
viruses and other small particles (Lewis and Metcalf 1988). This principle, or perhaps 
differential solubility in alternative solvents, could be used to precipitate exosomes 
(quite probably along with other macromolecular particles) from experimental samples. 
The precipitate can be isolated using either low-speed centrifugation or filtration. 
Recently, System Biosciences released a proprietary reagent named ExoQuick that can 
be added to serum, conditioned cell media or urine, and is claimed to precipitate the 
exosomes (Vlassov et al. 2012). However, although the process is very fast and 
straightforward, there is the inevitable lack of specificity toward exosomes, and the 
pellet from serum is rather difficult to resuspend (Vlassov et al. 2012). 
In theory, a superior alternative for specific isolation of exosomes should be affinity 
purification with antibodies to CD63, CD81, CD82, CD9, EpCAM, and Rab5. These 
could be used by themselves or potentially in combination. For this application, the 
antibodies could be immobilized on a variety of media, including magnetic beads, 
chromatography matrices, plates and microfluidic devices (Chen et al. 2010; Thery et al. 
2006). HansaBioMed is offering an array of products called ExoTest kits – featuring 
anti-CD63, -CD81 or -CD9 antibodies immobilized on 96 well plates – for exosome 
capturing and characterization (Vlassov et al. 2012). As with any young field, it has to 
be confirmed how well these systems work, and for researchers wanting a diverse 
exosome population, which of these proteins is (are) the best and most robust exosomal 
tag(s) for their needs. 
In the same vein as antibodies, other affinity-capture methods could be used, such as 
lectins, which will bind to specific saccharide residues on the exosome surface. This 
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strategy has been proposed by Aethlon Medical (Vlassov et al. 2012) using a 
proprietary lectin that targets mannose residues. The convenient feature of this 
procedure is easy elution/release of the captured exosomes by free alpha-methyl-
mannoside. However this approach is not specific to exosomes as a number of cells 
contain mannose on their surface; and it has yet to be proven if all exosome types can be 
captured this way. Multiple types of lectins are available, and these can be carefully 
investigated to select the best options.  
 
2.8.3 Characteristics and composition of exosomes 
Besides a characteristic morphology, exosomes are thought to be somewhat unique in 
their protein and lipid composition, providing additional traits for their identification. 
Due to their endosomal origin, all exosomes contain membrane transport and fusion 
proteins (GTPases, Annexins, flotillin), tetraspannins (CD9, CD63, CD81, CD82), heat 
shock proteins (Hsc70, Hsp 90), proteins involved in multivesicular body biogenesis 
(Alix, TSG101), as well as lipid-related proteins and phospholipases (Conde-Vancells et 
al. 2008). Although these proteins are routinely used as positive markers, there is wide 
variation across exosomes from different sources. Beyond these membrane-associated 
proteins, over 4400 different proteins have been identified in association with 
exosomes, usually by mass spectrometry, presumably serving as cargo for inter-cell 
communication (Mathivanan and Simpson 2009). Although much of this variation has 
to do with the cells of origin, Carayon et al. reported that the protein repertoire in 
secreted exosomes also changed during erythrocyte maturation. The most widely used 
“markers” include tetraspannins, Alix, flotillin, TSG101, and Rab5b. Antibody-based 
techniques to detect these targets, such as Western or ELISA, are becoming popular for 
rapid confirmation of exosome presence (Carayon et al. 2011). 
Besides proteins, exosomes are enriched in certain raft-associated lipids such as 
cholesterol (primarily B lymphocytes), ceramide (implicated in the differentiation of 
exosomes from lysosomes) other sphingolipids, and phospoglycerides with long and 
saturated fatty-acyl chains (Subra et al. 2007). Laulagnier et al. also found that, at least 
for mast and dendritic cells, there was an increase in phosphatidylethanolamines and 
that the rate of flipping between the two leaflets of the bilayer was higher than in 
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cellular membranes (Laulagnier et al. 2004). There are also indications that exosomes 
could serve to deliver prostaglandins to target cells (Subra et al. 2010). 
 
Figure 2.7: Composition of exosomes. Exosome contain mRNA and miRNA, and a vast 
array of different proteins depending on their host cell. In addition to generic 
proteins, proteins associated with neurodegenerative diseases such as 
Alzheimer’s, Prion disease, and Parkinson’s disease have been identified in 
exosomes. Adopted from Bellingham et al. (2012) 
 
Exosomes also bear saccharide groups on their outer surface. This was investigated 
recently by Batista et al. and they found that these were enriched in mannose, 
polylactosamine, α-2, 6 sialic acid, and complex N-linked glycans (Batista et al. 2011). 
Exosomes have been reported to contain significant amounts of miRNA, other non-
coding RNAs, as well as mRNA. Valadi et al. reported that, although the RNA 
appeared to be mostly degraded to less than 200 nt fragments, some full-length 
Literature review 43 
molecules must also be present, since the extracted RNA could be used to generate 
identifiable full-length proteins using an in vitro translation system (Valadi et al. 2007).  
Table 2.1: Molecular composition of exosomes, adopted from Denzer et al. (2000) 
 Functions Reference for exosomal 
localization 
TfR Iron transport Davis et al., 1986; Johnstone 
et al., 1987 
Integrin a4b1 Adhesion/co-stimulation Rieu et al., 2000 
Mac-1/integrin a chain  Adhesion to target cells Théry et al., 1999 
MFG-E8/lactadherin " Théry et al., 1999 
   
GPI-anchored proteins   
AchE  
 
 Johnstone et al., 1987 
DAF/CD55 Regulation of complement 
activation 
Rabesandratana et al., 1998 
MIRL/CD59 Protection from complement 
mediated lysis/signaling 
Rabesandratana et al., 1998 
 
LFA-3/CD58 (GPI-
isoform) 
Adhesion/co-stimulation Rabesandratana et al., 1998 
   
Immunoglobulin-
supergene family 
  
MHC class II molecule  
 
Antigen presentation Raposo et al., 1996, 1997a; 
Zitvogel et al., 1998 
MHC class I molecule " Zitvogel et al., 1998; 
Kleijmeer et al., 1998 
CD86/B7.2 Co-stimulation Escola et al., 1998 
CD54/ICAM-1 Adhesion to target cells Théry et al., 1999 
   
Tetraspan protein family   
CD9  Signal 
transduction/adhesion/complex 
formation with MHC and 
integrins 
Théry et al., 1999 
CD37 " Escola et al., 1998 
CD53 " Escola et al., 1998 
CD63/Lamp-3 " Escola et al., 1998; Heijnen 
et al., 1999 
CD81 " Escola et al., 1998 
CD82 "+HLA-DM/DO Escola et al., 1998 
   
Cytosolic proteins   
Hsp70  Protein folding Mathew et al., 1995 
Hsc73 Uncoating ATPase/peptide 
transfer to MHC 
Théry et al., 1999 
Gi2 a subunit Fusion Théry et al., 1999 
Annexin II MVB formation Théry et al., 1999 
   
Lipids   
LBPA  Cholesterol transport Denzer et al., 2000 
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Several papers indicate that the RNA “cargo” of exosomes is significantly different 
from the parental cell content, i.e. certain RNAs are present at significantly different 
levels compared to the total cell lysate from the originating cells (Mittelbrunn et al. 
2011; Zomer et al. 2010). This runs counter to several authors working with cancer 
cells, who have noted that the miRNA content for their originating cancer cells is 
similar to that found in circulating exosomes, and they have postulated the feasibility of 
using this as a basis for diagnostic markers (Rabinowits et al. 2009). Since the primary 
current procedure to verify the presence of exosomes is through EM, a costly and time-
consuming process, there is clearly an urgent need to develop simpler, more molecule-
based tools and protocols for confirmation of exosomal presence. MicroRNA (miRNA) 
may provide this marker, although it has yet to be determined if any RNA molecules 
can serve as reliable generic exosomal markers. 
 
2.8.4 Functions of exosomes 
The function of exosomes most probably depends on the cells from and conditions 
under which they are produced, as this provides them with their characteristic 
composition. When exosomes were first discovered from reticulocytes, they were 
shown to function as a way to discard proteins, such as the transferrin receptor during 
the maturation process of reticulocytes into erythrocytes (Johnstone et al. 1987). 
Reticulocytes lack lysosomes, and it seems as if exosome release is an alternative to 
lysosome degradation. Another function of exosomes that was later described is as cell 
free messengers, which can be released from one cell and have an effect on another. 
This communication with other cells may occur either in the microenvironment, or over 
a distance (Fevrier and Raposo 2004). Since exosomes have been found in blood plasma 
(Caby et al. 2005), they may be transported between organs via the systemic circulation.  
How this interaction occurs between exosomes and cells is not fully known.  However, 
several mechanisms describing the interactions of exosomes and cells have been 
hypothesized. Exosomes can bind to cells through receptor-ligand interactions, similar 
to cell to cell communication, mediating for example antigen presentation (Admyre et 
al. 2006). Clayton et al. showed that B cell exosomes express functional integrines, 
which are capable of mediating adhesion to extra-cellular matrix components and 
activated fibroblasts. This adhesion was strong and resulted in an increase in 
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intracellular calcium (Clayton et al. 2004). Alternatively, exosomes can attach to or fuse 
with the target cell membrane, thus delivering exosomal surface proteins and perhaps 
cytoplasm to the recipient cell (Denzer et al. 2000). MHCII positive exosomes have 
been shown to be attached to follicular DCs. These cells do not express MHCII 
themselves, and the exosomes provide them with new properties (Denzer et al. 2000). 
Finally, exosomes may be internalized by the recipient cells due to mechanisms such as 
endocytosis. Immature DCs have been shown to internalize and process exosomes for 
antigen presentation to CD4+ T cells (Morelli et al. 2004). 
 
2.8.5 Functional delivery of miRNAs via exosomes 
A recent breakthrough in exosome biology is that RNA molecules, in particular, 
miRNAs, are present in these vesicles. To date, studies have demonstrated that miRNAs 
in exosomes can influence target cell function (Kosaka et al. 2010). The transport of 
nucleic acids inside the exosomes can play an important role in functioning of a 
multicellular organism; moreover, the supposed specificity of this process can, on 
necessity, contribute to the directed transfection of an exogenous material (Mittelbrunn 
et al. 2011). In early 2008, Hunter et al. identified miRNAs that differentially expressed 
in circulating plasma microvesicles from diseased and normal subjects, creating the 
platform for future work for examination of the predictive role of peripheral blood 
miRNA signatures in human disease, as well as defining the biological processes 
regulated by particular miRNAs (Hunter et al. 2008). Advances in miRNA array 
techniques have provided significant advances in miRNA profiling of exosomes. Koh et 
al. demonstrated that miRNAs are also found in the extracellular environment of human 
embryonic stem cell-derived mesenchymal stem cells (hES-MSC). Significant 
differences in expression profile of miRNAs in the intracellular and extracellular 
environment of hES-MSC cultures were identified. Interestingly, the let-7 miRNA 
family is highly expressed in both intra- and extra-cellular samples of hES-MSC (Koh 
et al. 2010). It has been well documented that exosomes contain a substantial amount of 
small RNAs, but little or no ribosomal RNA compared to the levels observed in the 
donor cells (Valadi et al. 2007). Moreover, selective packaging of miRNAs into 
exosomes appears to occur, as the miRNA profiles in exosomes do not reflect the 
miRNA profiles observed in the parental cells (Mittelbrunn et al. 2011; Rabinowits et 
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al. 2009; Valadi et al. 2007). T cells, B cells, and dendritic cells derived exosomes had 
miRNA expression profiles unique from their donor cells. Furthermore, the authors also 
showed that there was antigen-driven unidirectional transfer of miRNAs from the T cell 
to the APC mediated by CD63
+
 exosomes (Mittelbrunn et al. 2011). The mechanism for 
the selective packaging of RNAs into exosomes is still illusive. Alvares-Erviti et al. 
used exosomes of mice dendritic cells as a transfection vector for short interfering 
RNAs (Alvarez-Erviti et al. 2011). It was supposed that the use of exosomes produced 
by animal’s own cells will lead to the decreased immunogenicity of this vector, here as 
inclusion into exosomes of a hybrid protein consisting of Lamp2b (a membrane protein 
of the exosomal fraction) and a neuron specific peptide RVG should result in a directed 
delivery of RNA into the cells of nervous tissue. The intravenous injection of exosomes 
electroporated with delivered RNAs resulted in a specific delivery of biologically active 
RNAs into neurons, microglia cells, and brain oligodendrocytes, but not into other 
tissues (liver, spleen, kidneys, etc.). The exosome mediated transfection allowed the 
authors to obtain significant decrease of the levels of the target mRNA and of the 
protein encoded by it (by 60 and 62%, respectively). In this case the authors showed not 
only the possibility of using short RNAs inside exosomes as a transfecting system 
capable of inhibiting the target gene expression in brain tissues (i.e. of penetrating 
across the blood–brain barrier), but the principle of in vivo functioning of exosomes was 
demonstrated, which is of no less importance (Alvarez-Erviti et al. 2011).  
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Figure 2.8: Scheme of microRNA transfer by exosomes. (1) microRNAs are selectively 
incorporated into the intraluminal vesicles of a multivesicular body. (2) 
Multivesicular bodies fuse with the plasma membrane, therewith secreting their 
intraluminal vesicles into the extracellular milieu. (3) Exosomes may bind to the 
plasma membrane of a target cell. Recruited exosomes may either fuse directly 
with the plasma membrane (4) or first be endocytosed and then fuse with the 
delimiting membrane of an endocytic compartment. (5) Both pathways result in 
the delivery of the exosomal microRNA to the cytosol of the target cell where it 
may associate with and silence corresponding mRNA (Stoorvogel 2012). 
 
Regulation of the immune system can be an important function of released miRNAs. 
Both T and B lymphocytes and also dendritic cells of the immune system are known to 
secrete miRNAs as components of exosomes (Mittelbrunn et al. 2011; Naslund et al. 
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2013). It has also been demonstrated that the interaction of T-lymphocytes with antigen 
presenting cells may be associated with antigen-induced directed transfer of miRNAs. 
Exosomal miRNAs are transferred into antigen-presenting cells during formation of the 
immune synapse with T-lymphocyte, and they can modulate the transcriptional function 
of the recipient cell (Mittelbrunn et al. 2011). The involvement of exosomes in the 
transfer of biologically active RNAs from mother to child during pregnancy and breast 
feeding might represent a unique example of immunological functions of exosomes. By 
using real time PCR and in situ hybridization the authors demonstrated that specific 
placental miRNAs were also in exosomes of the villiferous trophoblast (Luo et al. 
2009). The exchange of exosomal contents between the fetus and mother’s tissues is 
supposed to provide adaptation of the two organisms to one another during the 
progression of pregnancy. Breast milk also contains a significant amount of immuno-
relevant miRNAs, and at least some of them are inside the exosomes (Luo et al. 2009). 
These miRNAs might play an important role in development of the child’s immune 
system.  
 
2.8.6 Transfer of infectious agents via exosomes 
Exosomes have not only been shown to be involved in the metastasis of cancers but 
have also been implicated in the spread of infectious agents. Prior to the knowledge 
about exosomes, HIV particles were demonstrated to accumulate in late endosomes of 
macrophages (Pelchen-Matthews et al. 2003) and the fact that retroviruses and 
exosomes had biochemical similarities (Nguyen et al. 2003) led to the “The Trojan 
exosome hypothesis” (Gould et al. 2003). “The Trojan exosome hypothesis” proposes 
that retroviruses can hi-jack the exosomal biogenesis pathway for their replication and 
release, and consequently escape the host’s immune system (Gould et al. 2003). 
Contentiously, despite the similarities between retroviruses and exosomes, differences 
between the two have been demonstrated that argue against the “The Trojan exosome 
hypothesis” (Gould et al. 2003). Furthermore, exosomes have been suggested to transfer 
the infectious prion proteins and β-amyloid peptides between cells (Fevrier et al. 2004; 
Wakim and Bevan 2011). 
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2.8.7 Role of exosomal RNA in cell-cell communication 
Exosomes have many different functions, which depend on both their cellular origin as 
well as the current state of that cell, as it influences the cargo of the released exosomes. 
However, these functions have primarily been associated with the exosomal proteins. 
The novel finding that exosomes contain RNA (Valadi et al. 2007) has prompted many 
researchers to address the biological role of exosomal RNA, which further increases the 
complexity of the understanding of cell-to-cell communication. Valadi et al. did not 
only demonstrate the presence of RNA in exosomes, but also demonstrated that the 
exosomal RNA could be transferred to recipient cells. This was demonstrated by 
culturing mouse mast cells with radioactive uridine prior to exosome isolation, thus 
incorporating radioactive RNA into the exosomes released by these cells. Radioactive 
RNA could be measured in recipient cells following co-culture with the exosomes, 
demonstrating RNA transfer from exosome to cell. Since exosomes themselves do not 
contain the complete machinery to produce proteins, the functionality of the RNA 
content was shown by using an in vitro translation assay, where mouse mast cell-
derived exosomes were used as templates. Subsequently, after adding mouse mast cell-
derived exosomes to human mast cells, newly produced mouse proteins could be 
identified in the human cells. These proteins were shown to be present only as mRNA, 
not as proteins, in the mouse mast cell-derived exosomes. Thus, this translation 
demonstrated the functionality of the exosomal mRNA (Valadi et al. 2007). 
The fact that exosomal mRNA can travel a long distance to recipient cells, subsequently 
affect the protein production of recipient cells (Valadi et al. 2007), and that it has been 
well documented that a single miRNA can interfere with 100-200 mRNA (Lim et al. 
2005), suggests a potential biological role for exosomal RNA. Keeping this fact in 
mind, numerous studies have been conducted and published describing RNAs in 
exosomes from different cellular origin (Gibbings et al. 2009; Kogure et al. 2011; 
Mittelbrunn et al. 2011; Montecalvo et al. 2012; Palanisamy et al. 2010) and functional 
delivery of exosomal RNAs from donor cells to recipient cells (Kosaka et al. 2010; 
Montecalvo et al. 2012; Palanisamy et al. 2010; Pan et al. 2012; Tomasoni et al. 2012) 
in various research fields including cell biology, reproduction, immunology and cancer. 
In order to demonstrate that the exosomal RNAs to be functional, exosomes must not 
only be internalized by the recipient cell, but it is important that the exosomal RNA 
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must also be transported to the cytosol where the mRNA can be translated and miRNA 
function as an inhibitor of translation. The functionality of mRNA has been further 
shown in other studies by the use of luciferase reporter genes. One study conducted by 
Skog et al. revealed that the exosomal mRNA derived from glioblastoma cells could be 
transferred and subsequently expressed in recipient cells (Skog et al. 2008). The authors 
demonstrated this by transducing glioblastoma cells with a lentivirus vector encoding a 
luciferase reporter gene. The resulting exosomes from donor cells contain luciferase 
activity. These exosomes were then added to endothelial recipient cells, where they can 
measure the luciferase activity. Furthermore, they also showed that this activity 
increased over time, indicating an ongoing translation (Skog et al. 2008). A similar 
study confirmed that exosomes could transfer mRNA coding for a luciferase reporter 
gene, leading to a luciferase activity in recipient cells. Furthermore, they conclude that 
this activity was dose dependent (Kogure et al. 2011). Montecalvo et al. demonstrated 
that exosomes can interact with recipient cells by fusion with the cells plasma 
membrane rather than endocytosis, thus releasing the exosomal material in terms of 
nucleotide into the cytosol of the recipient cell (Montecalvo et al. 2012). This was 
demonstrated by capturing luciferin inside the exosomes and co-culturing these with 
transgenic luciferase recipient cells. As luciferin is not able to cross lipid membranes, 
the measurement of luciferase activity in recipient cells, only 8 minutes after the cells 
received exosomes, indicates the delivery of the exosomal luminal cargo, including 
miRNA and mRNA (Montecalvo et al. 2012). 
 
Messenger RNAs are not the only RNA species that transported via exosomes from 
donor to recipient cells. Moreover, several studies have demonstrated that microRNAs 
are not only transported by exosomes to recipient cells, but also they are potentially 
functional (Montecalvo et al. 2012; Pan et al. 2012; Pegtel et al. 2010). Pegtel et al. 
showed that Epstein-Barr virus (EBV)-transformed B cells release exosomes that 
contain mature EBV-miRNAs, which can be transferred to recipient cells (Pegtel et al. 
2010). They also showed that when incubated with EVB-miRNA containing B cell-
derived exosomes, there was an 80% reduction in luciferase activity in recipient cells 
transfected with a luciferase vector carrying an EBV-miRNA-regulated sequence. 
However, cells expressing disrupted EBV-miRNA binding sites were shown to have 
significantly less reduction in luciferase activity. This study suggested that exosomes 
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can regulate functional gene repression of specificmRNAs targets in recipient cells by 
the transfer of functional miRNAs (Pegtel et al. 2010). Montecalvo et al. also 
demonstrated the delivery of functional miRNA via exosomes, by transfecting recipient 
cells with a luciferase reporter gene containing copies of the complementary target 
sequence for a specific miRNA. When exosomes containing the specific miRNA were 
incubated with these cells, the result was inhibited luciferase activity in these cells 
(Montecalvo et al. 2012). The functionality of exosomal miRNA has also been 
demonstrated with the transfection of cells with lentiviral vector short hairpin RNA 
(LVsh). Exosomes released from cells transfected with LV-shCD81 resulted in the 
downregulation of CD81 surface expression in the recipient cells (Pan et al. 2012). 
 
2.8.8 Exosomes in physiological processes 
Exosomes can be secreted from different cell types in the extracellular environment 
where they can interact with other cells resulting in physiological changes (Thery et al. 
2001). The entire mechanisms underlying how exosomes interact with the recipient 
cells have not been properly understood. While some studies showed that exosomes can 
fuse with the plasma membrane of the target cells leading to the release of the exosome 
content into the target cell (Parolini et al. 2009; Skog et al. 2008), other studies 
proposed a binding at the cell surface of the recipient cell via specific receptors (Segura 
et al. 2007) or the internalization by endocytosis or macropinocytosis following fusion 
with internal compartments (Fitzner et al. 2011; Morelli et al. 2004). Because exosomes 
are readily released by different cell types, they are likely involved in many 
physiological processes such as antigen presentation (Thery et al. 2001), tissue repair 
(Lai et al. 2010) or transfer of RNAs (Valadi et al. 2007). Later Lai et al. demonstrated 
that exosomes are the active components of conditioned medium from human 
embryonic stem cell-derived mesenchymal stem cells and the injection of these 
exosomes into swine and murine models of ischemia/reperfusion injury reduced the 
infarct size (Lai et al. 2010).  Because most of the exosome studies were performed in 
vitro culture conditions or from different biological fluids, therefore, it is not perfectly 
assessed if the quantities of exosomes used to see effects in vitro are comparable to 
physiological amounts of exosomes secreted in vivo. Moreover, recently one study 
demonstrated that there are differences between exosomes derived from in vitro tumor 
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cells and tumor cells grown in vivo (Xiang et al. 2010). The remarkable finding of the 
presence of exosomes in biological fluids and their purification from these body fluids 
emphasizes their in vivo secretion and their physiological relevance. A study in human 
tonsils provides more compelling evidence for the in vivo existence of exosomes 
(Denzer et al. 2000). Using electron microscopy, exosomes bearing MHC class II 
antigen and tetraspan molecules were identified in tonsil germinal centers where they 
attach to the surface of follicular dendritic cells (Denzer et al. 2000). Thus, if exosomes 
have a physiological function in vivo remains to be answered. 
 
2.8.9 Exosomes in pathological processes 
Exosomes have been associated with the progression of disease conditions including 
neurodegenerative disease, cardiovascular diseases and cancer (Thery 2011). It was in 
1983 when Tailor revealed for the first time the secretion of tumor-derived 
microvesicles in ovarian cancer patients (Taylor et al. 1983). Exosomes from cancer 
cells can transfer tumor antigens to dendritic cells and present tumor antigens, which 
induce immune responses (Thery 2011). In contrast, tumor exosomes can also suppress 
the function of immune cells by inducing apoptosis of activated cytotoxic T cells or 
promoting differentiation of regulatory T lymphocytes (Clayton et al. 2007). Other 
reports suggest that tumor exosomes can promote tumor growth by suppressing 
antitumor immune responses or by promoting neoangiogenesis or migration to other 
cells resulting in metastasis (Valadi et al. 2007). A recent study revealed that 
exosomes/microvesicles secreted from tumor-associated macrophages can transport 
miRNAs into breast cancer cells promoting the invasiveness of breast cancer cells 
(Yang et al. 2011). Further, exosomes were found in the serum of cancer patients 
displaying the characteristic surface molecules of tumors (Huber et al. 2005). Increased 
amount of exosomes correlates with advanced disease conditions (Bergmann et al. 
2009). Consistently, studies in patients with ovarian cancer and lung cancer revealed 
that the plasma-exosome levels were increased in patients with advanced disease 
(2.85 mg/ml exosomes for lung cancer patients vs. 0.77 mg/ml exosomes for healthy 
patients) (Simpson et al. 2009). This suggests that tumor-derived exosomes can be used 
as diagnostic biomarkers of a disease. However, if this increase in exosomes is the 
cause of tumor size or the promotion of tumor growth is not clear. 
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Another report published by Stefanie Dimmler's lab revealed a new role of 
microvesicles/exosomes in cell–cell communication during atherosclerotic protection 
(Hergenreider et al. 2012). Smooth muscle cells (SMCs) are the key players of 
atherosclerosis, which is caused by the formation of a plaque within an artery leading to 
myocardial infarction. The study demonstrated that endothelial and smooth muscle cells 
communicate to each other via microvesicles/exosomes (Hergenreider et al. 2012). 
Endothelial cells release microvesicles enriched with miR-143/145, which are 
transferred to smooth muscle cells and regulate gene expression of miRNA target genes. 
The injection of miR-143/145 containing microvesicles in a mouse model of 
atherosclerosis resulted in a reduction of atherosclerotic lesion formation (Hergenreider 
et al. 2012). This further suggests a potential use of exosomes containing miRNAs as 
therapeutic tool to treat diverse pathological conditions. 
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3. Material and methods 
 
3.1 Materials 
 
3.1.1 List of chemicals and kits  
 
During this experiment, various chemicals, kits and culture media purchased from 
different manufacturers were used. Besides, during data analysis multifarious software 
packages, tools and databases were utilized. 
 
Chemicals  Manufacturer/Supplier 
10x PCR buffer                                       Promega, WI, USA 
2x SYBR Green master mix, Universal RT Exiqon, Vedbaek, Denmark 
2-Mercaptoethanol Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
5x First-Strand buffer Invitrogen Life Technologies, 
Karlsruhe, Germany 
Acetic acid Roth, Karlsruhe, Germany 
Agarose                                                         Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Ammonium acetate Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
BME (essential amino acids) Gibco BRL, life technologies, 
Karlsruhe, Germany 
Bovine serum ablbumin (BSA) Promega, Mannheim, Germany 
Brilliant cresyl blue stain (BCB) Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Calcium chloride dihydrate Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Chloroform Roth , Karlsruhe, Germany 
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Citric acid Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Coomassie Brilliant Blue  
Diethylpyrocarbonate (DEPC)  Roth, Karlsruhe, Germany 
Dimethyl sulfoxide (DMSO) Roth , Karlsruhe, Germany 
dNTPs Roth , Karlsruhe, Germany 
Dithiothreitol (DTT) 
Invitrogen Life Technologies, 
Karlsruhe, Germany 
Ethanol Roth, Karlsruhe, Germany 
Ethidium bromide Roth, Karlsruhe, Germany 
Ethylenediaminetetra acetic acid (EDTA) Roth , Karlsruhe, Germany 
ExoSAP-IT USB, Ohio, USA 
Fetal Bovine Serum (FBS) Gibco, Karlsruhe, Germany 
Gentamycin sulphate Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Hemi-calcium lactate Promega, WI, USA 
HEPES Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Hyaluronidase Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Hydrochloric acid Roth, Karlsruhe, Germany 
Hydroxylamine Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Igepal Roth, Karlsruhe, Germany 
Ionomycin Sigma-Aldrich, Chemie GmbH, 
Munich, Germany 
Isopropyl -D-thiogalactoside (IPTG) Roth, Karlsruhe, Germany 
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L-Glutamine Sigma-Aldrich, Germany 
Magnesium chloride Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Medium 199 Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Methanol Roth, Karlsruhe, Germany 
MicroRNA LNA
TM
 PCR primer set Exiqon, Vedbaek, Denmark 
MicroRNA Ready-to-Use PCR Panels Exiqon, Vedbaek, Denmark 
Mineral oil 
Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
MiRNA PCR array Exiqon, Vedbaek, Denmark 
MiRNeasy® mini kit QIAGEN, Hilden, Germany 
Nuclease free water Exiqon, Vedbaek, Denmark 
Oligonucleotide primers MWG Biotech, Eberberg, Germany 
Oligo (dT) 23 Promega, WI, USA 
Penicillin G Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Peptone Roth, Karlsruhe, Germany 
Phenol red solution (5% in D-PBS) Sigma-Aldrich Chemie GmbH , 
Munich, Germany 
PKH67 Green Fluorescent Cell Linker mini kit Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Potassium chloride 
Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Proteinase K Roth, Karlsruhe, Germany 
QIAquick PCR Purification Kit QIAGEN, Hilden, Germany 
Random primer Promega, WI, USA 
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Ribo-nuclease inhibitor (RNasin) Promega, WI, USA 
RNA later Sigma-Aldrich, MI, USA 
Ribo-nuclease inhibitor (Rnasin) Promega, WI, USA 
RNA 6000 Nano LabChip® kit Agilent Technologies Inc, CA, USA 
Roti PAGE gradient (4-20%) 
Carl Roth GmbH, Karlsruhe, 
Germany 
Rotiphorese Gel 30 (37, 5:1) 
Carl Roth GmbH, Karlsruhe, 
Germany 
RQ1 Rnase-free Dnase Promega, WI, USA 
Sample Loading Solution (SLS) Beckman Coulter, Krefeld, 
Germany 
Sequagel XR sequencing gel Beckman Coulter, Krefeld, 
Germany 
Sodium acetate Roth , Karlsruhe, Germany 
Sodium bicarbonate Sigma-Aldrich Chemie, Steinheim, 
Germany 
Sodium chloride Roth , Karlsruhe, Germany 
Sodium citrate Roth, Karlsruhe, Germany 
Sodium hydrogen carbonate Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Sodium dihydrogen phosphate Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Sodium hydrogen sulphate Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Sodium pyruvate Sigma-Aldrich Inc, MO, USA 
Streptomycin Sigma-Aldrich, Deisenhofen, 
Germany 
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Streptomycin sulphate Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Superscript II reverse transcriptase Invitrogen,  CA, USA 
SuperSignal West Pico Chemiluminescent Substrate Thermo Scientific, Rockford, 
U.S.A. 
Taq DNA polymerase Sigma-Aldrich Inc, MO, USA 
TCM-199 Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
TEMED Roth, Karlsruhe, Germany 
Tris Roth, Karlsruhe, Germany 
Trypsin-EDTA Sigma-Aldrich, Chemie GmbH, 
Munich, Germany 
Tween-20 Roth, Karlsruhe, Germany 
Universal cDNA synthesis kit  Exiqon, Vedbaek, Denmark 
   
3.1.2 Reagents and media preparation 
During this experiment, the following reagents and media formulation were used. All 
solutions used in this study were prepared with deionised and demineralised Millipore 
water (ddH2O) and when necessary, the pH was adjusted with sodium hydroxide 
(NaOH) or hydrochloric acid (HCl). In addition, the solutions or buffers were 
subsequently filtered through 0.2 μ filter and autoclaved at 120°C for 20 minutes when 
it is recommended. 
 
Name of the buffer/media Constituents  Volume / 
amount 
Physiological saline solution Sodium chloride 9.0 g 
( NaCl 9%) added to water 1000.0 ml 
   
Manipulation medium TCM-199  1500.0 g 
 Gentamycine sulfate  0.050 g 
 Sodium pyruvate  0.022 g 
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 NaHCO3  0.350 g 
 BSA  
 
1.00 g 
 Water up to 1000.0 ml 
70% Ethanol Ethanol (100%) 700 ml 
 Water 300 ml 
   
10x CMF (Calcium manesium free  Sodium chloride (NaCl) 8 g 
PBS) Potasium chloride (KCl) 0.2 g 
 Sodium hydrogen phosphate 
(Na2HPO4) 
1.15 
 Potasium hydrogen phosphate 
(KH2PO4) 
0.2 g 
 Water up to 1000 ml 
   
10x PBS NaCl  8.77 g 
 Na2HPO4  1.50 g 
 NaH2PO4  2.04 g 
 Water up to 1000.0 ml 
   
1x PBS 10x PBS  100 ml 
 DEPC-treated water upto 1000 ml 
   
3% BSA in PBS BSA 30g 
 10x PBS : added to 1,000.0 ml 
   
3M Sodium acetate, pH 5.2 Sodium acetate  123.1 g 
 ddH2O added to 500 ml 
 ddH2O added to 1000 ml 
   
Agarose loading buffer Bromophenol blue 0.0625 g 
 Xylencyanol 0.0625 g 
 Glycerol 7.5 ml 
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 ddH2O added to 25 ml 
   
BCB stock solution BSA 0.2 g 
 BCB  0.005 g 
 PBS Up to 50 ml 
   
BCB working solution BCB stock solution 1 ml 
 3% BSA in PBS 14 ml 
   
DEPC-treated water (1000 ml) DEPC 1 ml 
 added to water  1000 ml 
   
dNTP solution dATP (100 mM) 10 l 
 dGTP (100 mM) 10 l 
 dTTP (100 mM) 10 l 
 ddH2O added to 400 l 
   
EDTA 100 Mm (pH 2.0)  EDTA 37.224 g 
 Water up to  1000.0 ml 
   
3M Sodium acetate (pH 5.2)  Sodium Acetate 123.1 g 
 Water added to 500.0 ml 
   
4 % paraformaldehyde  Paraformaldehyde  4.0 g 
 1X PBS 100.0 ml 
   
Guanidin-ethanol solution (50 ml) Guanidin 1.43 g 
 95% Ethanol up to 50 ml 
   
Proteinase K solution  Proteinase K 20 mg 
 DEPC-treated H2O 1 ml 
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Modified parker medium HEPES 0.140 g 
 Sodium pyruvate 0.025 g 
 L-Glutamin 0.010 g 
 Gentamicin 500 μl 
 Medium 199 99 ml 
 Hemi calcium lactate 0.06 g 
 added to water 110 ml 
   
Lysis buffer Igepal (0.8%)  0.8 μl 
 40U RNasin  5.0 μl 
 DTT  5.0 μl 
 ddH2O added to 100.0 μl 
   
Resolving solution Rotiphorese gel 2 ml 
 Trenngel buffer  1.25 ml 
 dd water 1.65 ml 
 APS (10%) 25 μl 
 TEMED 5 μl 
   
1x Blotting buffer (500 ml) 10x blotting buffer 50 ml 
 Methanol 100 ml 
 dd Water 350 ml 
   
Fixation solution Methanol 500 ml 
 Glacial acetic acid 100 ml 
 Water up to 1000 ml 
   
Coomassie staining solution Coomassie Blue R-250 2 ml 
 Methanol 500 ml 
 Glacial acetic acid 100 ml 
 Water up to 1000 ml 
   
Stacking solution Rotephorese gel 0.725 ml 
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 Sammel gel buffer 0.5 ml 
 dd water 2.825 ml 
 APS (10%) 20 μl 
 TEMED 5 μl 
   
Stripping solution Glycin 15 g 
 SDS 1 g 
 Tween 20 10 ml 
 dd water up to 1000 ml 
   
Urea-DTT solution Urea 3 g 
 Water  3 ml 
 Stock DTT 250 μl 
 
 
3.1.3 Equipments  
 
Equipment Manufacturer 
ABI PRISM® 7000 SDS  Applied Bio Systems, CA, U.S.A. 
ABI StepOnePlus
TM
 PCR system Applied Bio Systems, CA, U.S.A. 
ABI 7900 HT real time PCR system Applied Bio Systems, CA, U.S.A. 
Agilent 2100 Bioanalyzer Agilent Technologies , CA, USA 
ApoTome microscope  Carl Zeiss Microlmaging, Germany 
Centrifuge Hermel, Wehingen, Germany 
CEQ
TM
 8000 Genetic Analysis Beckman Coulter, Krefeld, Germany 
Confocal laser scanning microscope-510 Carl Zeiss, Germany 
CO2-incubator (MCO-17AI) Sanyo, Japan 
ECL plus western blotting detection system GE Healthcare, Freiburg, Germany 
Eight well chamber slide Lab-Tek
TM
, Thermo Scientific, US 
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Electrofusion machine CFA 400 Kruess Hamburg, Germany 
Electrophoresis unit BioRad, Munich, Germany 
Four well culture dishes Thermo Fisher Scientific, Nunc, 
Denmark 
Inverted fluorescence microscope DM IRB Leica, Germany 
Nanodrop 8000 spectrophotometer  Thermo Fisher Scientific, DE, USA 
Millipore apparatus Millipore Corporation, USA 
MyCycler thermal cycler  Bio-Rad Laboratories, CA, USA 
MicroAmp® optical 96-well reaction plate 
with barcode  
Applied Bio Systems 
Stereomicroscope SMZ 645 Nikon, Japan 
StepOnePlus real-time PCR system Applied Bio Systems 
Tweenty four well culture dishes Thermo Fisher Scientific, Nunc, 
Denmark 
Ultra centrifugation machine Beckman Coulter, Krefeld, Germany 
Ultra-low freezer (-80
o
C) Labotect GmbH, Göttingen, Germany 
UV Transilluminator (Uvi-tec)  Uni Equip, Martinsried, Germany 
 
3.1.4 List of software programs and statistical packages  
 
Programs (soft wares) 
 and statistical packages 
Source  
BLAST program  http://www.ncbi.nlm.nih.gov/Blast/ 
DAVID Bioinformatic Resource 6.7 http://david.abcc.ncifcrf.gov/ 
EndNote X1 Thomoson 
ENSEMBL genome browser  http://www.ensembl.org/ 
Entrez Gene http://www.ncbi.nlm.nih.gov/ 
GraphPad prism v.5  GraphPad software, Inc. 
Ingenuity's pathway analysis Ingenuity® Systems, www.ingenuity.com 
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MiRBase v.16  http://www.mibase.org/ 
miRDB  
 
http://www.mirdb.org/ 
MicroRNA.org-Target and 
Expression 
http://www.microrna.org/ 
miRecords http://mirecords.biolead.org/ 
PicTar  http://www.pictar.org/ 
Primer Express® software v.2.0 Applied Biosystems, Foster City, CA, USA 
RT
2
 PCR Array Data Analysis Version 3.5 
http://pcrdataanalysis.sabiosciences.com/pcr
/arrayanalysis.php 
Primer 3 (version 4) http://frodo.wi.mit.edu/primer3/ 
Prism for windows (ver.5.0) GraphPad software, Inc. 
TargetScan 5.1 http://www.targetscan.org/ 
Weight to molar quantity  
(for nucleic acids) converter 
http://www.molbiol.ru/eng/scripts/01_07.ht
ml 
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3.2 Methods 
 
3.2.1 Experimental layout 
 
Figure 3.1 Brief overview of the present study 
 
Brilliant cresyl blue (BCB), growing oocyte (BCB-), fully grown oocyte (BCB+), 
follicular fluid (FF), number of follicle (n), theca cells (TC), granulosa cells (GC) and 
cumulus oocyte complex (COCs). 
 
3.2.2 Collection of follicular fluid and follicular cells 
Ovaries were obtained from local slaughterhouse (Bernhard Frenken GmbH Vieh- und 
Fleischhandle Schlachthof Düren, Paradiesstrasse 19, 52349 Düren, Germany) after 
official permission by the slaughterhouse management to use ovaries for research 
purpose. Ovaries were transported in 0.9% saline solution at a temperature of 38°C in 
thermo flask within 2 hours after collection. Following washing with new saline 
solution, antral follicles of 4-8 mm in diameter were blunt-dissected from the ovaries 
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with scissors and forceps. A caliper was used to measure the diameter of the follicles. 
Follicular materials from 120 follicles were harvested individually by breaking onto the 
plastic sterile culture dish. The cumulus oocyte complex (COCs), retrieved from each 
follicle, were subjected to brilliant cresyl blue (BCB) to categorize as a fully grown 
oocyte (BCB+) or growing oocyte (BCB-) as described in next paragraph.  The 
corresponding follicular fluid, granulosa cells and theca cells were collected and stored 
separately for further analysis. Follicular fluid, containing granulosa cells, was placed in 
a sterile microcentrifuge tube and centrifuge at 500×g for 3 minutes. While follicular 
fluid was collected as supernatant, the granulosa cells were collected as pellet from the 
bottom of the tube. Follicular fluid was snap frozen and stored at -80°C for further use. 
After two additional washes in DPBS (Gibco, Life Technologies, UK) containing 
0.02% polyvinyl alcohol (PVA), granulosa cells were also stored at -80°C.  The theca 
cell layer of the follicles was peeled carefully and scraped off with a plastic inoculation 
loop, washed several times for complete removal of granulosa cells, and stored at -20ºC 
in RNA later (Sigma). Following BCB staining, the COCs were stored at -80°C 
separately for further use.  
 
3.2.3 Brilliant cresyl blue (BCB) staining of cumulus oocyte complexes 
To investigate the expression of miRNAs follicular fluid containing oocytes of different 
competence, the COCs were retrieved from individual follicles and washed in mDPBS. 
Following washing COCs subjected to stain with 26 μM BCB (Sigma- Aldrich Chemie 
GmbH, Munich, Germany) diluted in mDPBS for 90 min at 38.5°C in humidified air 
atmosphere (Alm et al. 2005). After washing, the stained COCs were examined under 
stereo microscope and categorized into two groups according to oocyte cytoplasm 
coloration, which is dependent on the glucose 6 phosphate dehydrogenase (G6PDH) 
activity of the oocytes. Fully grown oocytes (competent oocyte) are known to have 
lower G6PDH activity, this decreased activity indicated that the oocyte achieved 
developmental competence, thereby the oocyte cytoplasm remain stained blue (BCB+), 
while growing oocytes (non competent oocyte) have a higher G6PDH activity which 
changes the oocyte cytoplasm to colorless (BCB-). Following this, the COCs were 
washed two times in PBS and were snap-frozen separately in cryo-tubes containing 
lysis buffer and stored at -80°C until further analysis. 
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3.2.4 Isolation of exosomes and non-exososmal fractions of follicular fluid 
Exosomes were isolated from follicular fluid using two different methods: Exoquick 
precipitation and differential ultracentrifugation. 
 
3.2.4.1 Isolation of exosomes using Exoquick
TM
  
Exosomes were isolated using Exoquick kit (SBI System Biosciences, Inc.) according to 
the manufacture’s protocol with some modifications. Briefly, follicular fluids were 
subjected to differential centrifugation at 300xg and then 4000xg each for 10 min to 
remove cells and cellular debris. The follicular fluid samples were then filtered through 
0.22 µm screen to remove particles whose size is more than 200 nm (apoptotic bubbles 
and microvesicles portion). After that, samples were subjected to centrifugation at 
25,000×g for 30 minutes to remove further microparticles, and the microvesicles 
fraction remained in samples after filtration. All centrifugation steps were performed at 
4°C. Cell free and microvesicle depleted follicular fluid samples were used for exosome 
precipitation with Exoquick. Exoquick reagent (120 µl) was added to 500 µl of 
follicular fluid, incubated 12 h at 4°C, and centrifuged at 1500 × g for 30 min to obtain 
pelleted exosomes. The supernatant (non-exosomal portion) of the samples were 
collected without disturbing the exosome pellets, and exosome pellets were resuspended 
in 200 µl of DPBS. Both the exosomes and exosome-depleted supernatant were further 
used for total RNA isolation and miRNA profiling.  
 
3.2.4.2 Isolation of exosomes using ultracentrifugation 
Exosome isolation from independent follicular fluid samples was also performed by 
ultracentrifugation using previously described methods (Arroyo et al. 2011; Valadi et al. 
2007). Briefly, follicular fluids were subjected to differential centrifugation at 300xg 
and then 4000xg each for 10 min to remove cells and cellular debris. The follicular fluid 
samples were then filtered through 0.22 µm screen to remove particles whose size is 
more than 200 nm (apoptotic bubbles and microvesicles portion). After that, samples 
were subjected to centrifugation at 25,000×g for 30 minutes to remove further 
microparticles, and the microvesicles fraction remained in samples after filtration. 
Follicular fluids, obtained from 25,000×g centrifugation steps, were centrifuged at 
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120,000×g for 70 minutes at 4°C in a Beckman SWTi55 rotor. The resulting exosome 
pellet was resuspended in DPBS and re-centrifuged at 120,000×g for 70 min at 4°C and 
then resuspended in DPBS and stored until further use for exosome labeling and uptake 
experiment. 
 
3.2.5 Electron microscopy and visualization of exosomes 
Morphological evaluation of exosomes isolated using Exoquick kit and 
ultracentrifugation was performed by visualizing them using electron microscope (Leo 
922, Zeiss, Germany). For this, 15 μl drops of isolated exosomes in DPBS were placed 
on parafilm before the Formvar/carbon-coated grids were placed on top of exosome 
drops and allowed to stand for 5–10 min to absorb the exosomes. The grids with 
adherent exosomes were transferred to three 30 μl drops of DPBS for washing and 
subsequently fixed with 2% paraformaldehyde in DPBS for 7 min. Then the grids were 
incubated with 25 μl drops of 2% uranyl acetate followed by examination with electron 
microscope. 
 
3.2.6 Protein isolation and western blot analysis  
Exosomal and non exosomal proteins were isolated from organic phenol portion during 
total RNA isolation using Qiagen miRNeasy mini kit following optimized protocol and 
resuspended in 8M urea and used for protein detection and western blot analysis. 
 
3.2.6.1 Isolation of protein  
Briefly, after complete removal of aqueous phase 300 μl of 100% ethanol was added, 
mixed carefully and incubated at room temperature for 2-3 min. Following 
centrifugation at 2000 × g at 4°C, supernatant containing protein frection was transfered 
to a new cap lock tube and 1.5 ml of isopropanol was added and incubated for 10 min at 
room temperature. Samples were centrifuged at 12,000 × g for 10 min at 4°C, 
supernatant was removed and 2 ml of guanidin-ethanol solution was added and 
incubated for 20 min followed by centrifugation at 7500 × g at room temperature. After 
removing the supernatant 2 ml of 100% ethanol was added, vortexed and incubated at 
room temperature for 20 min. After that, samples were centrifuged at 7500 × g for 5 
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min. This washing step with 100% ethanol was repeated twice. Following final 
centrifugation and removal of supernatant the pellets were air dried for 5-10 min. Then 
first 50 μl of urea-DTT solution was added to break up the pellet using a needle. After 
that 450 μl of urea-DTT solution was added and incubated at room temperature for 1 h. 
Following this, the samples were incubated at 95°C for 3 min. and then placed on ice. 
During the incubation period on ice samples were sonicated 10 times using short bursts 
to allow all proteins mixed properly in the solution. The solution containing protein was 
transferred into new tube and centrifuged at 10,000 × g for 10 min at room temperature. 
Then 500 μl of urea-DTT solution was added and incubate at 95°C for 3 min. The 
solution containing protein was transferred into new tube and centrifuged at 10,000 × g 
for 10 min. The supernatant containing protein was then transferred into new tube and 
the quantity was measured using NanoDrop ND-1000 spectrophotometer. 
3.2.6.2 Coomassie blue staining 
Fifty µg of protein from each sample were loaded and resolved in 12% SDS-PAGE 
polyacrylamide gels (Bio-Rad, Corp., Hercules, CA, USA) at 120 V for 1 hr. Following 
this, the gel was incubated in fixation solution for over night with gentle agitation. After 
that the gel was stained with Comassie blue R-250 for 1 hr at room temperature. The gel 
was then washed with destaining solution several times until the background become 
clear and the stained proteins image were captured with a Chemidoc XRS (Bio-Rad) 
instrument. 
3.2.6.3 Western blot analysis 
Fifty µg of protein from each sample were loaded and resolved in 12% SDS-PAGE 
polyacrylamide gels (Bio-Rad, Corp., Hercules, CA, USA) and then  transferred to 
nitrocellulose membranes (Biotrace NT, Pall life Sciences, Pensacola, FL, USA). 
Membranes were blocked (5% non-fat dried milk in TBST) for 1 h at room temperature, 
and incubated separately with antibodies raised against CD63 (ExoAB Antibody, SBI, 
CA, USA), EIF2C2 (0.4 µg/ml; Santa Cruz Biotechnology Inc, USA) and cytochrome C 
(CYCS; 0.4 µg/ml; Santa Cruz Biotechnology Inc, Texas, USA)  overnight at 4°C. 
After subsequent washing, membranes preincubated with the respective primary 
antibody were further incubated with a horseradish peroxidase conjugated anti-goat, 
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anti-rabbit and anti-mouse secondary antibody (Santa Cruz Biotechnology Inc., USA), 
respectively.  After additional washes, membranes were incubated for 5 min in 
chemiluminescent substrate (Thermo Scientific, Waltham, USA), and immunoreactive 
proteins were visualized with a Chemidoc XRS (Bio-Rad) instrument. 
 
3.2.7 Total RNA isolation  
Total RNA (including miRNA) was isolated from exosome preparations, exosome-
depleted portion of follicular fluid and surrounding follicular cells using miRNeasy 
Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions with 
some modification adopted for liquid samples.  
 
3.2.7.1 Total RNA isolation from exosomes  
Briefly, exosome pellets obtained from Exoquick
TM
 precipitation or ultracentrifugation 
were diluted in 200 μl of RNase free water. 4 × volumes (800 μl) of Qiazol lysis buffer 
was added to diluted exosomes (200 μl) and exosomes depleted portion (200 μl) of 
follicular fluid. To ensure complete digestion vortexed for 2-3 min and incubated for 6-
7 min. After that, 200 μl of chloroform was added and shacked vigorously for 1 min and 
incubated for 5 min. The samples were then centrifuged at 12,000 × g for 15 min. This 
will allow the phase separation and after that clear aqueous phase containing total RNA 
was transferred to new 2 ml microcentrifuge tube. After retrieving the clear aqueous 
phase, 1.5 volume of 100% ethanol was added and mixed gently by pipetting. After 
mixing, 700 μl of sample were transferred to miRNeasy spin column and centrifuged at 
10,000 × g for 15 sec. The supernatant was discarded. Since the sample volume was 
exceeding 700 μl, remaining samples were centrifuged in the same column. Following 
this, 700 μl of RWT buffer was added to the spin column and centrifuged at 10,000 × g 
for 15 sec at room temperature. After removing the flow-through, 500 μl of buffer RPE 
was added to each spin column and centrifuged at 10,000 × g for 15 sec at room 
temperature. This step was repeated twice with the same centrifugation speed for 2 min. 
The spin column was transferred to a new 2 ml collection tube (supplied by company) 
and centrifuged at full speed for 2 min to eliminate any possible carryover of buffer 
RPE and residual flow-through that remained on the spin column. Following this, the 
spin column was transferred to a new 1.5 μl collection tube (supplied by company) and 
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open the lid for 1 min which allow the evaporation of residual ethanol portion from the 
spin column. Total RNA was eluted by adding 30 μl of RNase free water to the 
membrane of the spin column and incubated for 1 min before centrifugation at 12,000 × 
g for 1 min at room temperature. The RNA was stored at 80°C.  
 
3.2.7.2 Total RNA isolation from non-exosomal portion of follicular fluid 
Total RNA was isolated from exosome depleted follicular fluid using miRNeasy mini 
kit (Qiagen, Hilden, Germany) according to the protocol adopted for serum or plasma 
with some modification. Briefly, 5 volume of Qiazol lysis buffer was added to the 
follicular fluid, vortexed for 3-4 min and incubated for 8 min at room temperature. 
Following incubation, 200 μl of chloroform was added to the sample, vigorously 
shacked for 1 min and incubated for 5 min. After that, same protocol was followed 
which was used for total RNA isolation from exosomes, total RNA was eluted by 
adding 30 μl of RNase free water and stored at -80°C for further analysis. 
 
3.2.7.3 Total RNA isolation from surrounding follicular cells 
Total RNA (including miRNA) was isolated from theca cells, granulosa cells and 
cumulus oocyte complexes using the miRNeasy mini kit (Qiagen, Hilden, Germany) 
according to manufacturer’s instruction. Briefly, 700 μl of Qiazol lysis buffer was added 
to cells and vortex until complete digestion and incubate for 5 min. To ensure complete 
digestion vortexed for 2-3 min and incubated for 6-7 min. After that, 200 μl of 
chloroform was added and shacked vigorously for 1 min and incubated for 5 min. The 
samples were then centrifuged at 12,000 × g for 15 min. This will allow the phase 
separation and after that clear aqueous phase containing total RNA was transferred to 
new 2 ml microcentrifuge tube. After retrieving the clear aqueous phase, 1.5 volume of 
100% ethanol was added and mixed gently by pipetting. After mixing, 700 μl of sample 
were transferred to miRNeasy spin column and centrifuged at 8,000 × g for 15 sec. The 
supernatant was discarded. Since the sample volume was exceeding 700 μl, remaining 
samples were centrifuged in the same column. Following this, 350 μl of RWT buffer 
was added to the spin column and centrifuged at 8,000 × g for 15 sec at room 
temperature. After that 80 μl (10 μl of DNase I + 70 μl of buffer RDD) of diluted DNase 
I solution was added to the RNeasy mini spin column membrane and incubated for 15 
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sec at room temperature on the benchtop. Following incubation 350 μl of buffer RWT 
was added to the spin column and centrifuged at 8,000 × g for 15 sec at room 
temperature. After removing the flow-through, 500 μl of buffer RPE was added to each 
spin column and centrifuged at 8,000 × g for 15 sec at room temperature. This step was 
repeated a second time. The spin column was then transferred to a new 2 ml collection 
tube (supplied by company) and centrifuged at full speed for 1 min to eliminate any 
possible carryover of buffer RPE and residual flow-through that remained on the spin 
column. Following this the spin column was transferred to a new 1.5 μl collection tube 
(supplied by company) and open the lid for 1 min that allowed the evaporation of 
residual ethanol portion from the spin column. Total RNA was eluted by adding 50 μl of 
RNase free water to the membrane of the spin column and incubating for 1 min before 
centrifugation at 12,000 × g for 1 min at room temperature. Total RNA concentration 
and purity were determined using a NanoDrop ND-1000 spectrophotometer.   
 
3.2.8 Quality control of isolated RNA 
Before committing RNA samples to profiling on microRNA qPCR panels, it is very 
important to ascertaining the purification yield and absence of PCR inhibitors. This was 
done by testing different RNA sample input volumes in the cDNA synthesis reaction, 
for instance 0.5 μl, 1.0 μl, 2.0 μl, and 4.0 μl in a 10 μl reaction. Corresponding cDNA 
samples were analysed by qRT-PCR using miR-103 and miR-191. The relative 
quantification of miRNAs expression was calculated using a comparative threshold 
cycle (Ct) method. Samples containing PCR inhibitors will show dilution curves 
without the expected linear relationship between sample input and signal. Subsequently 
samples with low RNA quality were excluded from further studies.  
 
3.2.9 First strand cDNA synthesis 
A reverse transcription reaction was performed using the miRCURY LNA™ Universal 
RT microRNA PCR system (Exiqon, Denmark) according to the manufacturer’s 
instructions. In brief, approximately a total of 100 ng of total RNA, including small 
RNA, were anchor-tailed with a poly(A) sequence at their 3'end and then reverse 
transcribed into cDNA using a universal poly(T) primer with a 3'end degenerate anchor 
and a 5' end universal tag. For this 5x reaction buffer and nuclease free water was gently 
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thawed and immediately placed on ice. RNA spike-in was resuspended by adding 40 μl 
of nuclease free water and mixed by vortexing prior to use. The RT master mix was 
prepared by adding 5x reaction buffer, water, enzyme mix and spike-in RNA in the 
proportion iindicated in the Table 3.1. RT master mix was dispended into nuclease free 
tube and then total RNA template was added to each tube and mixed by gentle 
vortexing or pipetting to ensure all reagents were thoroughly mixed. The mix was 
incubated for 60 min at 42°C and 5 min at 95°C. After the incubation period samples 
were immediately cooled by placing in ice. The cDNA products were subsequently 
diluted 100 fold. 
 
 
Table 3.1: Reverse transcription reaction setup 
 
Reagent Volume (μl), 
RT reaction 
5x Reaction buffer        4 
Nuclease-free water        9 
Enzyme mix        2 
Synthetic RNA spike ins, optional replace  
with H2O if omitted 
       1 
Template total RNA        4 
Total volume       20 
 
 
 
3.2.10 miRNA profiling 
The expression of miRNAs in exosomal and non-exosomal portion of follicular fluid 
derived from follicles with growing (BCB-) or fully grown (BCB+) oocyte was 
examined using Exiqon microRNA PCR Human Panels (I + II) and quantified using 
SYBR green based real time PCR technology. Subsequently, the resulting cDNA 
products were mixed with nuclease free water and ready to use SYBR-green mix. 
Briefly, 2x SYBR Green master mix (Exiqon, Vedbaek, Denmark) was placed on ice 
for 15-20 min for melting and during that time the vial contining SYBR Green was 
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protected from light by wrapping with aluminum foil. After that SYBR Green master 
mix was pipetted up and down for proper mixing. Following this, 4000 μl of SYBR 
Green master mix was pipetted and 3960 μl of water was added and mixed by gentle 
vortexing. At this point, 40 μl of cDNA was added to the mixed cocktail, mixed 
properly by gentle vortexing and centrifuged at 1000 × g for 1min. Before removing the 
plate seal, the plates were briefly centrifuged in a plate centrifuge machine. Then a 
multichannel laboratory automation workstation was employed to distribute mixed 
cocktail (Biomek® NXP, Beckman Coulter, Krefeld, Germany) on 384 well PCR plate 
containing miRNA specific primers. The real time PCR was run on a 7900HT 
thermocycler (ABI) using the following thermal-cycling parameters: 95°C for 10 min, 
40 cycle of 95°C for 10 sec, 60°C for 1 min followed by a melting curve analysis.  
 
3.2.11 miRNA expression analysis 
Raw Ct values were calculated as recommended by Exiqon using the RQ manager 
software v1.2.1 (ABI) with manual settings for threshold and baseline, i.e. all 
miRCURY assays were analyzed using a ΔRn threshold of 60 and baseline subtraction 
using cycles 1-14. The PCR data were analyzed using web-based PCR array data 
analysis software (http://pcrdataanalysis.sabiosciences.com/pcr/arrayanalysis.php-). The 
raw miRNA data was first normalized using a global normalization method. To 
calculate the global normalization value, miRNAs with CT value range from 22-32 
were taken under consideration. To minimize the potential noise introduced by 
measurements below detection threshold, miRNAs with Ct value less than 35 in all 
groups were considered as undetected. Based on their enrichment in exosomal and non-
exosomal portion of follicular fluid from fully grown (BCB+) or growing (BCB-) 
oocytes, 8 candidate miRNAs were selected for further characterization of their 
expression in surrounding follicular cells. For this individual, miRNA specific LNA-
TM primer assays were used to investigate their expression in triplicate cDNA samples 
obtained from the surrounding follicular cells from the contemporary oocyte 
competence group. Relative expression of each miRNA was analyzed using a 
comparative CT (2−ΔΔCT) method and global normalization strategy was employed to 
normalize the data. 
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3.2.12 Quantitative real time PCR analysis of selected microRNAs 
The expression profiling of selected miRNAs in granulosa cells, theca cells and oocyte 
cumulus complexs have been examined using LNA
TM
 PCR miRNA qPCR Indivudual 
assay primer set for miR-654-5p, miR-640, miR-526b*, miR-373, miR-19b-1*, miR-
29c, miR-381, miR-30e* and U6 was used as endogenous control. Complementary 
DNA was synthesized from total RNA of granulosa cells, theca cells and COCs 
according to the previously mentioned protocol using Universal cDNA synthesis kit 
(Exiqon, Vedbaek, Denmark). The resulting cDNA was diluted 40x using nuclease free 
water. The qRT PCR master mix was prepared using the 4 μl of diluted cDNA template, 
1μl LNATM PCR miRNA qPCR assay primer set and 5 μl of 2x SYBR Green master 
mix (Exiqon, Vedbaek, Denmark). The reaction was done by using ABI prism 7000 real 
time PCR apparatus with a thermal program of initial heating at 95°C for 10 min 
followed by 40 cycles of 95°C for 10 sec and 60°C for 1 min. The stability of the U6 
expression was checked (Figure 3.2) before it was utilized for data normalization. The 
relative quantification of miRNAs expression was calculated using a comparative 
threshold cycle (Ct) method as described before in previous study (Tesfaye et al. 2009). 
Where, relative abundance (Fold change) = 2
-ΔΔCt
  
ΔCt = average Ct target miRNA - average Ct of normalizer  
ΔΔCt = ΔCt target miRNA - ΔCt of the calibrator 
Calibrator was the one with the highest ΔCt value among the groups 
Figure 3.2: The average threshold cycle (Ct) value of endogenous control U6 RNA in 
different cell samples. 
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3.2.13 miRNA target prediction 
To predict miRNA targets, we used miRecords at http://mirecords.biolead.org/, which 
contains animal miRNA targets according to combinations of the widely used target 
prediction programs DIANA MicroTest, Micro Inspector, mirTarget, miRDB, miRanda, 
TargetScanS, PicTar and experimentally supported targets from TarBase. For miRNAs 
annotated with *, as their target genes are not present in miRecords database, therefore 
we used miRDB to predict the target genes list for those miRNAs. To identify 
biological processes most involved in the biological phenomena under study we have 
performed a Gene Ontology (GO) analysis using the DAVID Bioinformatics Resource 
(http://david.abcc.ncifcrf.gov/). The predicted miRNA target genes were also analyzed 
by using the DAVID Bioinformatics Resource (http://david.abcc.ncifcrf.gov/) server for 
Annotation, Visualization, and Integrated Discovery to identify the pathway 
distribution. These pathways were presented according to the Kyoto Encyclopedia of 
Genes and Genomes (KEGG) database (http://www.genome.jp/ kegg/).  
 
3.2.14 Stability of exosomal miRNA under in vitro culture conditions  
To check the stability of exosomes under culture conditions, follicular fluid samples 
were collected from random slaughterhouse ovaries and exosomes were isolated by 
ultracentrifugation according to previously mentioned protocol (section 3.2.4.2). After 
two additional washes in DPBS exosomes were resuspended in 800 μl of F-12 media 
containing 10% exosomes-free fetal bovine serum (FBS, Invitrogen, South America 
origin). Exosomes were pre-cleared from the FBS via filtration using a 0.22 µm filter 
(Millipore) and ultracentrifugation at 120,000 g for 2 hours. The samples were 
incubated at 37ºC in humidified atmosphere of 5% CO2 for 0 hr, 6 hrs, 12 hrs and 24 
hrs. After incubation total RNA was isolated using miRNeasy mini kit (Qiagen, Hilden, 
Germany ) and individual miRNA expression was measured as described above and 
miRNAs used in this experiment were miR-654-5p, miR-640, miR-526b-1* & miR-
373. Exosomes at 0 hr time point was used as control group. 
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3.2.15 Exosome labeling 
Follicular fluid was collected from random slaughter house. Exosomes isolated from 
follicular fluid using ultracentrifugation were subjected to fluorescent labeling using 
PKH67 dye (Sigma-Aldrich), which is a green fluorescent dye that labels the lipid 
membranes, according to the manufacturer’s instructions.  Briefly, exosomes in DPBS 
were resuspended in 1 ml of Diluent C (Sigma-Aldrich, catalog number G8278) by 
gentle pipetting for complete dispersion to prepare “2x exosome suspension”. “2x dye 
solution” was prepared by adding 4 µl of PKH67 ethanolic dye solution (Sigma-
Aldrich, catalog number P7333) to 1 ml of Diluent C in a polypropylene centrifuge tube 
and mixed well by pipetting to disperse. To minimize the ethanol effects on exosomes, 
the volume of dye added in this step should not exceed 1-2% ethanol in the final mix. 
Following this, 1 ml of 2x exosome suspension was rapidly added to 1 ml of 2x Dye 
solution and immediately mixed by pipetting. This solution was incubated for 3-5 min 
with periodic mixing. Labeling was stopped by addition of an equal volume (2 ml) of 
exosome-free FBS and 1 min incubation, followed by the addition of F12 media with 
10% exosome-free FBS to fill up the centrifuge tube and subsequently 
ultracentrifugation for 30 min at 120,000×g was performed. After two additional washes 
in F12 media (with 10% exosome-free FBS) using ultracentrifugation, the exosomes 
were resuspended in 100 µl of F12 media with 10% exosome-free FBS. 
 
3.2.16 Co-incubation of bovine granulosa cells with labeled exosomes 
Primary cultures of bovine granulosa cells were established as previously described 
(Spanel-Borowski et al. 1994) to undertake labeled exosomes uptake experiment. 
Briefly, ovaries were collected from slaughter house randomly and transported to the 
laboratory within 2-3 hrs of collection in a thermoflask containing physiological 
solution at 38°C. In the laboratory ovaries were then washed two times in 0.9% NaCl 
solution. Following washing steps granulosa cells were isolated from bovine follicles 
(4-8 mm) by aspirating with 5 ml syringe attached to 18 gauge needle. The aspirated 
follicular fluid was collected in a 50 ml sterilized tube and allowed to precipitate for 15 
min. Following this, supernatant containing granulosa cells were transferred to new 
sterilized 50 ml tube and centrifuged at 500×g for 5 minutes. After that granulosa cell 
pellet were washed once in calcium-magnesium free PBS (CMF) followed by 
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centrifugation at 500×g for 5 minutes and resuspended in 2 ml of RBC lysis buffer for 
3-5 minutes to remove erythrocytes. Osmality was restored by adding 8 ml of F-12 
media containing 10% exosome free FBS. After two additional washes with media cell 
viability was determined by a trypan blue exclusion test. Granulosa cells (approximately 
45000 viable cells) were seeded on the chamber slide (Lab-Tek
TM
, Thermo Scientific, 
USA) and cultured for 24 hours in DMEM/F-12 media supplemented with 10% 
exosomes free FBS, penicillin (100 U/ml) and streptomycin (100 μg/ml) at 37°C in a 
humidified atmosphere of 5% CO2.  On the next day, the cells were washed two times 
with DMEM/F-12 media to remove dead cells and DMEM/F-12 medium+10% 
exosome-free FBS was supplemented with labeled exosomes and co-cultured with the 
cells for 24 hrs. After 24 hours of co-culture with labeled exosomes, granulosa cells 
were washed three times with DPBS and fixed with 4% paraformaldehyde and mounted 
in mounting medium containing DAPI and observed under a laser scanning confocal 
microscope (LSM710-Carl Zeiss). These experiments were performed three times, and 
a parallel negative control was run each time in which cells were co-incubated with 
sterile PBS labeled with fluorescent dye. 
 
3.2.17 Exosome mediated transportation of miRNAs in granulosa cells in vitro 
Once the uptake of labeled exosomes by granulosa cells was confirmed, exosomes were 
isolated from independent follicular fluid from follicle containing BCB+ or BCB- 
oocytes according to the previously mentioned protocol. After confirming the candidate 
miRNA enrichment in each group of exosomal samples, a portion of exosomes from 
each group was co-incubated with granulosa cells. For this granulosa cells were cultured 
in 24 well culture plate and 1 × 10
5
 viable cells were seeded to each well. After 24 hrs 
of co-culture with exosomes, the granulosa cells were washed three times in DPBS, 
collected using 200 μl of trypsin and snap frozen in lysis buffer before using for RNA 
isolation.  The same volume of DPBS added to culture media was used as negative 
control. 
 
3.2.18 Quantitative analysis of selected target genes after exosome transfection 
To end up with limited number candidate genes for our analysis, we have refined the 
selection criteria based on the sequence compelementarity between 5′ “seed” region of 
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miRNAs and the 3’UTR of mRNAs of the potential target genes(Wang et al. 2009b). , 
As in animals, as little as 6 bp match with the target mRNA can be sufficient to 
suppress gene expression (Brennecke et al. 2005; Lewis et al. 2003), we searched for 
target genes with 3’UTR target sites for a 7-mers seed match (position 2–8) with the 
seed region of the respective miRNA. Based on this criteria and their potential 
involvement in critical pathways for follicular development, a total of seven target 
genes (ITGA3, MAP3K1, SOCS4, BRMS1L, ZNFX1, CD44 and VEGFA) were 
selected for quantitative real time PCR analysis after exosome mediated transfer of 
miRNAs in cultured granulosa cells. The respective primers were designed by using 
FASTA product of the GenBank mRNA sequences for Bos taurus using Primer3 
program (Table 3.2). A portion of total RNA (used for miRNA abundance study) 
isolated from exosome transfected granulosa cells was used for cDNA synthesis 
performed as described elsewhere (Tesfaye et al. 2009).  The corresponding cDNA 
samples were used to quantify all the target genes and GAPDH as endogenous control 
(Gad et al. 2011) in ABI PRISM® 7000 sequence detection system instrument (Applied 
Biosystems, Foster City, CA, USA). The qRT-PCR was set up using a 2 µl first-strand 
cDNA template, 7.4 µl deionized H2O, 0.3 µM of forward and reverse gene specific 
primers and 10 µl 1× Power SYBR Green I (Bio-Rad) master mix with ROX as a 
reference dye. The thermal cycling conditions were 3 min at 95°C followed by 40 
cycles of 15 seconds at 95°C and 1 min at 60°C. Relative expression of each mRNA 
was analyzed using a comparative CT (2
-ΔΔCT
) method. 
 
 
Table 3.2: Details of primers used for quantitative real-time PCR analysis of selected 
target genes. 
Gene 
Accession number 
Primer sequences 
(5’ -> 3’) 
Annealing 
temperature (°C) 
Product size 
(bp) 
GAPDH NM_001034034             
F:CCAGGGCTGCTTTTAATTCT 
R:ATGGCCTTTCCATTGATGAC 
60 247 
CD44 NM_174013 
F: CTGAAATGAGGGCCCAGTTA 
R: CCAACCCCACTTGAAAGAAA 
57 236 
BRMS1L NM_001083428 F: GCCATCTCTCCAGTTCTGCT 59 211 
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R: AAGTGGGACCCAACTCAGTG 
ZNFX1 NM_001205716 
F: GTCAGCCAGGAGCGACTTAC 
R: GCTGAAGCTCAAACGCTTCT 
58 189 
ITGA3 XM_003587418 
F: CAAGTCTGAGGGCCAGAAAC 
R: CTCCTTCACCACCAGGAATC 
59 265 
MAP3K1 NM_001205906 
F: ACTGGCCAGCATTTCAGTAG 
R: TGTGTTTGAGGAGATGCAGA 
56 217 
SOCS4 NM_001076218 
F: CATTCTTCAGGGCTTCCATC 
R: TGGTTATGACACAGGGCTGA 
57 244 
 
 
3.2.19 Statistical analysis 
All graphs were made and statistical analyses performed using GraphPad Prism, or 
Microsoft Excel 2010. All experiments were performed with a minimum of three 
replicates. When two groups were compared (i.e., BCB- vs. BCB+) the Student’s t-test 
was used to detect differences between treatment groups. A P value of ≤ 0.05 was 
considered to be significant. Data are expressed as mean ± SD of three biological 
replicates. 
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4 Results 
 
4.1 Efficient recovery of exosomes from bovine follicular fluid 
Exosomes were isolated from follicular fluid using two different methods, namely 
chemical precipitation (using Exoquick
TM
 Exosome precipitation kit) and mechanical 
separation (using differential ultracentrifugation). In order to determine the specificity 
of exosome isolation procedures, it was characterized at the protein level by detecting 
the presence of CD63, a membrane protein, which is abundantly present in exosomes 
derived from variety of cellular origin and absent in non-exosomal fraction of follicular 
fluid. Furthermore, exosomes derived from follicular fluid were morphologically 
characterized by analyzing the size and shape using electron microscope. However, for 
the non-exosomal fraction of follicular fluid the presence of Ago2 protein, abundantly 
present in non-exosomal fraction, was used to characterize the isolation specificity. On 
the other hand, in order to demonstrate that the samples were free of contamination of 
protein from cellular origin we checked the absence of cellular cytochrome C (CYCS), 
which is exclucively present in mitochondria.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Coommassie blue staining of proteins from different fraction of follicular 
fluid. 
Exo-ultra = Exosomes derived 
from ultracentrifugation 
 
Exo-Exoq = Exosomes derived 
from Exoquick precipitation 
 
Non-exo ultra = Non-exosomal  
from ultracentrifugation 
 
Non-exo Exoq = Non-exosomal  
from Exoquick precipitation 
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In order to check the specificity of exosome isolation, first we confirmed the abundance 
of protein in isolated protein samples from both exosomes and non-exosomal fraction of 
follicular fluid. Coomassie brilliant blue staining of SDS-PAGE gel revealed the 
presence of wide range of detectable proteins in both fractions of the follicular fluid 
(Figure 4.1).  
 
 
Figure 4.2: (A) Proteins (50 µg) from exosomal fraction (lane 1 & 2) and non exosomal 
fraction (lane 3 & 4) of follicular fluid isolated either by ultracentrifugation (lane 
1 & 3) or Exoquick kit (lane 2 & 4) were resolved on a 12% SDS-PAGE gel to 
detect CD63 and Ago2 proteins. (B) Confirmation of absence of detection of 
CYCS (mitochondrial protein) in both exosomal and non exosomal proteins as 
isolated by ultracentrifugation (lane 1 & 3) and Exoquick kit (lane 2 & 4). A 
known cellular origin protein was used as a positive control (lane 5). 
Morphological characterization of exosomes isolated from bovine follicular fluid 
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using Exoquick kit (C) and ultracentrifugation (D) by transmission electron 
microscopy. The scale bar indicates 100 nm. 
 
As shown in Figure 4.2 A, CD63 protein was detected in the exosomal fraction of 
follicular fluid derived from both isolation procedures, either by ultracentrifugation 
(lane 1) or Exoquick precipitation (lane 2).  Efficient recovery of exosomes by both 
methods was also confirmed by the absence of Ago2 protein in the exosomal fraction of 
follicular fluid. Non-exosomal fraction of follicular fluid derived using the Exoquick 
isolations contained an ignorable amount of CD63 protein (Figure 4.2 A lane 4); 
however, both non-exosomal fractions (either from exoquick preparation or 
ultracentrifugation) contained Ago2 protein (Figure 4.2 A lanes 3 and 4). Furthermore, 
CYCS (mitochondrial protein) was not present in the exosomal or non-exosomal 
fraction of follicular fluid isolated by both methods, indicating that those protein 
samples are free of any protein of cellular origin (Figure 4.2B). 
 
To investigate the morphological characteristics of exosomes in follicular fluid, 
exosomes were isolated using Exoquick Kit and differential ultracentrifugation. The 
exosomes were absorbed on formwar carbon coated grids, fixed with PFA, contrasted 
using uranyl acetate and observed under electron microscope. Observation by electron 
microscope revealed that both preparations contained vesicles (Figure 4.2C & D) which 
were similar in size (40-100 nm) to the previously described exosomes. 
 
4.2 Quality control of total RNA  
Reliable results in real-time RT-PCR array and microarray analysis depend on the 
quality of the RNA sample. Standard methods for measurement of the RNA yield and 
quality are inappropriate for use with biofluid samples. The presence of carrier RNA in 
these samples makes measuring the low levels of endogenous RNA by OD260 
impossible. Even if carrier was not included during the isolation, the RNA 
concentration in the eluate would still be too low for reliable OD260 quantification on a 
NanoDrop or other spectrophotometers. Therefore, an extensive alternative quality 
control of total RNA has been implemented to secure technical soundness. For this total 
RNA from exosomes and non-exosomal fraction of follicular fluid was synthesized to 
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cDNA with different inpute volume (i.e. 0.5 μl, 1 μl, 2 μl and 4 μl) and subsequently 
examined by quantitative real time PCR using miR-103 and miR-109. Following this, a 
correlation analysis was performed between the input volume of total RNA and 
threshold cycle value (Ct) of specific miRNA. The results revealed that miR-103 
generated a linear curve for the total RNA samples from both exosome and non-
exosomal fraction of follicular fluid (Figure 4.3). On the other hand, the expression of 
miR-191 in exosome samples showed a linear pattern, for non-exosomal fraction the 
deviation from linearity was acceptable (Figure 4.4). 
 
Figure 4.3: Expression of miR-103 in exosomes and non-exosomal fraction of follicular 
fluid across the input volume (A) and amplification graph in qRT-PCR (B). Where Ct is 
the threshold cycle value and Rn is the fluorescence of the reporter dye divided by the 
fluorescence of a passive reference dye. In Figure 4.3B amplification plot shows the 
variation of log (ΔRn) with PCR cycle number.  
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Figure 4.4: Expression of miR-191 in exosomes and non-exosomal fraction of follicular 
fluid across the input volume (A) with amplification graph in qRT-PCR (B). Where Ct 
is the threshold cycle value and Rn is the fluorescence of the reporter dye divided by the 
fluorescence of a passive reference dye. In Figure 4.3B amplification plot shows the 
variation of log (ΔRn) with PCR cycle number. 
 
 
4.3 Detection of miRNAs in exosomal and non-exosomal fraction of bovine follicular 
fluid 
The presence of circulatory miRNAs in exosomal and non-exosomal fractions of bovine 
follicular fluid was examined by quantitative real time RT-PCR. The expression of 
mature miRNAs were examined in exosomal and non-exosomal fractions isolated from 
follicular fluid of each catagory (BCB+ or BCB-) using microRNA ready-to-use Human 
PCR Panels (I + II) (Exiqon, Denmark). After comparative analysis of these mature 
human miRNA sequences to the recent bovine mature miRNA sequences available in 
miRBase version 19 (http://www.mirbase.org/), we found 241 miRNAs to be 
completely identical with bovine sequence, 126 miRNAs showed differences in size due 
to addition or deletion of up to 5 nucleotides, 58 miRNA sequences contained 
mismatches within the mature sequences, out of which 27 miRNAs showed only single 
mismatch. But no bovine homologous sequences were found for the 323 miRNAs in the 
present miRBase databank.The miRNAs with Ct value (number of cycles required to 
get a fluorescence signal above background) less than 35 were considered to be present 
Results 86 
in bovine follicular fluid while those with Ct value of >35 were considered as 
undetected. This analysis revealed that both exosomal and non-exosomal fractions of 
follicular fluid contain a large array of miRNAs (detected miRNAs were listed in Table 
4.1). Among the 748 miRNAs profiled, 509 and 356 miRNAs were detected in 
exosomal and non-exosomal fraction, respectively. From the detected miRNAs, a total 
of 331 miRNAs were commonly detected in both exosomal and non-exosomal part of 
follicular fluid. However, 178 and 25 miRNAs were detected only in exosomal and non-
exosomal fractions, respectively (Figure 4.5).  
 
 
 
 
 
Figure 4.5 Venn diagram showing the number of detected miRNAs in exosomal and 
non exosomal fraction of follicular fluid. From a total of 748 miRNAs used in 
the PCR panel 509 and 356 miRNAs were detected (with threshold cycle value 
of ≤35 in real time PCR analysis) in exosomal fraction and   non-exosomal 
fraction of bovine follicular fluid respectively. 
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Table 4.1: List of miRNAs detected in exosomal and non-exosomal portion of follicular 
fluid derived from follicles containing a growing and fully grown oocyte 
Detected only in Exosomes Detected in both Exosomal and non exosomal  Detected only 
in non 
exosomal 
structures 
hsa-let-7c*, hsa-let-7f-2*, hsa-
let-7g*, hsa-let-7i, miR-105, 
miR-10a, miR-1183, miR-1185, 
miR-122, miR-1227, miR-1247, 
miR-1249, miR-1256, miR-
1272, miR-127-3p, miR-127-
5p, miR-128, miR-129*, miR-
129-5p, miR-130a*, miR-132*, 
miR-135a*, miR-135b, miR-
136, miR-137, miR-143*, miR-
146a, miR-147, miR-148b*, 
miR-153, miR-155*, miR-15a*, 
miR-17*, miR-181c, miR-
181c*, miR-181d, miR-182*, 
miR-187, miR-188-3p, miR-
190, miR-190b, miR-1911*, 
miR-192*, miR-193b*, miR-
196a, miR-196b, miR-196b*, 
miR-198, miR-200a, miR-200c, 
miR-200c*, miR-205, miR-206, 
miR-208b, miR-20a*, miR-
20b*, miR-21*, miR-2113, 
miR-214*, miR-216b, miR-22*, 
miR-223*, miR-23a*, miR-
23b*, iR-24-1*, miR-24-2*, 
miR-26a-1*, miR-27b*, miR-
28-3p, miR-296-3p, miR-296-
5p, miR-297, miR-299-3p, 
miR-299-5p, miR-29a*, miR-
29c*, miR-301b, miR-31, miR-
323-3p, miR-326, miR-33a*, 
miR-335*, miR-338-3p, miR-
338-5p, miR-33a*, miR-33b, 
miR-340, miR-342-5p, miR-
345, miR-34a, miR-34a*, miR-
34b, miR-361-3p, miR-362-3p, 
miR-365*, miR-370, miR-371-
5p, miR-372, miR-377, miR-
378, miR-379*, miR-383, miR-
384, miR-409-5p, miR-410, 
miR-411, miR-411*, miR-429, 
miR-431*, miR-450b-5p, miR-
451, miR-454, miR-487a, miR-
487b, miR-490-5p, miR-492, 
miR-493*, miR-494, miR-502-
3p, miR-504, miR-514, miR-
517a, miR-518f, miR-520a-5p, 
miR-520d-3p, miR-520d-5p, 
miR-520h, miR-524-3p, miR-
525-3p, miR-526a, miR-541, 
miR-544, miR-548c-3p, miR-
551b*, miR-556-5p, miR-566, 
hsa-let-7a, hsa-let-7a*, hsa-let-7b, hsa-let-7b*, hsa-let-
7c, hsa-let-7d, hsa-let-7d, hsa-let-7d*, has, let-7e, hsa-
let-7f, hsa-let-7f-1*, hsa-let-7g, hsa-let-7i*,  miR-1, 
miR-100, miR-101, miR-103, miR-103-2*, miR-103-
as, miR-105*, miR-106a, miR-106b, miR-106b*, miR-
107, miR-10a*, miR-10b, miR-10b*, miR-1179, miR-
1181, miR-1207-5p, miR-1224-3p, miR-1237, miR-
124, miR-1254, miR-125a-3p, miR-125a-5p, miR-
125b, miR-125b-1*, miR-125b-2*, miR-126, miR-
126*, miR-1260, miR-1266, miR-1272, miR-129-3p, 
miR-1296, miR-130a, miR-130b, miR-130b*, miR-
132, miR-133a, miR-133b, miR-134, miR-135a, miR-
138, miR-138-2*, miR-139-5p, miR-140-3p, miR-140-
5p, miR-141, miR-141*, miR-142-3p, miR-142-5p, 
miR-143, miR-145, miR-1468, miR-146b-5p, miR-
1471, miR-147b, miR-148a, miR-148a*, miR-148b, 
miR-149, miR-149*, miR-150, miR-151-3p, miR-151-
5p, miR-152, miR-1538, miR-1539, miR-155, miR-
15a, miR-15b, miR-15b*, miR-16. miR-17, miR-181a, 
miR-181a*, miR-181a-2*, miR-181b, miR-183, miR-
184, miR-185, miR-186, miR-187*, miR-188-5p, miR-
18a, miR-18a*, miR-18b, miR-1909, miR-191, miR-
191*, miR-1913, miR-1914, miR-192, miR-193a-3p, 
miR-193a-5p, miR-193b, miR-194, miR-194*, miR-
195, miR-195*, miR-197, miR-1972, miR-1979, miR-
199a-3p, miR-199a-5p, miR-199b-5p, miR-19a, miR-
19b, miR-19b-1*, miR-200b, miR-200b*, miR-202, 
miR-202*, miR-203, miR-204, miR-20a, miR-21, mir-
210,, miR-2110, miR-212, miR-214, miR-215, miR-
218, miR-218-1*, miR-219-5p, miR-22, miR-221, 
miR-221*, miR-222, miR-224, miR-224*, miR-23a, 
miR-23b, miR-24, miR-25, miR-25*, miR-26a, miR-
26a-2*, miR-26b, miR-26b*, miR-27a, miR-27b, miR-
28-5p, miR-29a, miR-29b, miR-29b-1*, miR-29c, 
miR-300, miR-301a, miR-302c, miR-302d*, miR-30a, 
miR-30a*, miR-30b, miR-30b*, miR-30c, miR-30c-
1*, miR-30c-2*, miR-30d, miR-30d*, miR-30e, miR-
30e*, miR-31*, miR-320a, miR-320b, miR-324-3p, 
miR-324-5p, miR-328, miR-329, miR-330-3p, miR-
330-5p, miR-331-3p, miR-331-5p, miR-335, miR-339-
5p, miR-33a, miR-33b*, miR-342-3p, miR-346, miR-
34c-3p, miR-34c-5p, miR-361-5p, miR-362-5p, miR-
363, miR-365, miR-369-5p, miR-373, miR-373*, 
miR-374a, miR-374b, miR-375, miR-376a, miR-
376a*, miR-376b, miR-376c, miR-378*, miR-379, 
miR-381, miR-382, miR-409-3p, miR-421, miR-422a, 
miR-423-3p, miR-423-5p, miR-423-5p, miR-424, 
miR-424*, miR-425, miR-425*, miR-432, miR-433, 
miR-449a, miR-449b, miR-450am, miR-450b-3p, 
miR-452, miR-454*, miR-455-3p, miR-455-5p, miR-
483-3p, miR-484, miR-485-3p, miR-486-3p, miR-486-
5p, miR-490-3p, miR-491-3p, miR-491-5p, miR-493, 
hsa-let-7a-2*, 
miR-101*, 
miR-1244, 
miR-1267, 
miR-145*, 
miR-185*, 
miR-216a, 
miR-223, 
miR-302a, 
miR-367, miR-
431, miR-498, 
miR-501-5p, 
miR-518b, 
miR-518c*, 
miR-548j, 
miR-549, miR-
572, miR-576-
5p, miR-584, 
miR-622, miR-
629, miR-646, 
miR-654-3p, 
miR-802, miR-
887 
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4.4 Differential expression of miRNAs in exosomal and non-exosomal of follicular 
fluid based on oocyte competence 
 Next step is to test the hypothesis that miRNAs are present as circulatory molecules in 
follicular fluid and have different expression patterns depending on the stage of oocyte 
growth.  The miRNAs were profiled in both exosomes and non-exosomal of follicular 
fluid of BCB+ & BCB- oocyte origin.  Since global normalization showed better results 
within groups compared to spiked-in miRNA or mammalian U6 (Cui et al. 2011), we 
chose the same normalization procedure (correction with the sum of the expression 
levels of detected miRNAs) to normalize the expression in array data analysis. 
Comparisons were made for expression analysis of miRNA in follicular fluids of 
follicles containing growing oocyte (BCB-) versus a fully grown oocyte (BCB+) in 
exosomal and non-exosomal separately. The number of differentially expressed 
miRNAs (P<0.05) restricted by fold change (1.5- and 2-fold) for each comparison is 
summarized in Table 4.2. Accordingly, 25 and 30 miRNAs in the exosomal and non-
exosomal, respectively, were differentially regulated (≥2 fold change, P< 0.05) between 
follicular fluids from BCB+ & BCB- groups (Table 4.3). 
 
miR-590-5p, miR-596, miR-
600, miR-601, miR-605, miR-
608, miR-615-5p, miR-616, 
miR-620, miR-627, miR-629*, 
miR-631, miR-649, miR-652, 
miR-660, miR-663b, miR-671-
3p, miR-671-5p, miR-675*, 
miR-708, miR-7-1*, miR-767-
5p, miR-769-5p, miR-876-5p, 
miR-877*, miR-885-5p, miR-
886-3p, miR-888*, miR-891a, 
miR-9, miR-9*, miR-924, miR-
92b*, miR-93*, miR-937, miR-
941, miR-942, miR-95, 
miRPlus-C1076, miRPlus-
C1089, miRPlus-D1061 
miR-495, miR-496, miR-497, miR-499-5p, miR-500a, 
miR-502-5p, miR-503, miR-505, miR-505*, miR-509-
3p, miR-510, miR-518c, miR-518f*, miR-519d, miR-
521, miR-526b, miR-526b*, miR-532-3p, miR-532-5p, 
miR-542-5p, miR-543, miR-545, miR-550a*, miR-
551b, miR-552, miR-555, miR-558, miR-562, miR-
564, miR-571, miR-573, miR-574-3p, miR-577, miR-
582-5p, miR-589, miR-592, miR-593, miR-595, miR-
598, miR-615-3p, miR-617, miR-624*, miR-628-3p, 
miR-628-5p, miR-638, miR-639, miR-640, miR-643, 
miR-654-5p, miR-659, miR-661, miR-662, miR-663, 
miR-664, miR-665, miR-668, miR-675b, miR-7, miR-
708*, miR-720, miR-744, miR-744*, miR-758, miR-
760, miR-765, miR-766, miR-873, miR-876-3p, miR-
877, miR-885-3p, miR-886-5p, miR-888, miR-92a, 
miR-92a-1*, miR-92b, miR-93, miR-933, miR-934, 
miR-936, miR-940, miR-943, miR-98, miR-99a, miR-
99a*, miR-99b, miR-99b*, miRPlus-A1027, miRPlus-
A1031, miRPlus-C1066 
miRNAs were considered as detected only when the threshold cycle (Ct) value is less than 35. 
Differentially expressed miRNAs (P<0.05 & 2 fold change) are bold and underlined 
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Table 4.2: Summary of the number of differentially expressed miRNAs obtained from 
comparisons (growing vs. fully grown) in exosomal and non exosomal of follicular 
fluid. 
 
 
 
Of the 25 exosomal miRNAs that were differentially expressed, 16 and 9 miRNAs were 
up- and down-regulated, respectively in the growing oocyte (BCB-) group. Among the 
up-regulated miRNAs, miR-654-5p & miR-640, and down-regulated miRNAs, miR-373 
& miR-526b*, displayed the greatest fold change difference in the exosomal of 
follicular fluid. Among the 30 non-exosomal differentially expressed miRNAs, 21 and 9 
miRNAs were found to be up- and down-regulated, respectively, in the growing oocyte 
group (BCB-). However, from the up-regulated miRNAs, miR-19b-1* and miR-29c, 
and from down-regulated miRNAs, miR-381 and miR-30e*, had the highest fold 
change in the non-exosomal of follicular fluid. Importantly, there was no overlap 
observed between the differentially expressed miRNAs identified from exosomal and 
non-exosomal, suggesting that each  of follicular fluid transport a distinct subset of 
differentially regulated miRNAs. 
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Table 4.3. List of differentially expressed microRNAs in exosomal and non-exosomal 
fraction of bovine follicular fluid obtained from growing vs. fully grown oocyte 
comparison. 
 
 
 
4.5 Target prediction, biological functions and canonical pathways identified for 
differentially expressed miRNAs 
To understand the biological relevance of the miRNA signature in follicular fluid (both 
exosomal and non-exosomal) we have performed in silico analysis in order to identify 
the potential target genes of the differentially expressed (≥2-fold change, P<0.05) up-
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regulated miRNAs of growing oocyte (BCB-) group. As the number of experimentally 
validated miRNA targets is limited, we used miRecords at http://mirecords.biolead.org/, 
which contains animal miRNA potential targets according to combinations of the 
widely used target prediction programs DIANA, MicroTest, Micro Inspector, 
mirTarget, miRBD, miRanda, TargetScanS, and PicTar. We considered a gene as a 
potential target of a specific miRNA when it was predicted by at least 4 target 
prediction programs.  
 
 
Figure 4.6: Venn diagram showing the overlap at gene and pathway levels targeted by 
differentially expressed miRNAs. (A)The targeted genes predicted (predicted by at least 
4 target prediction tools) to be regulated by differentially expressed miRNAs. (B) The 
enriched pathways (P<0.01) in targeted genes predicted to be regulated by differentially 
expressed miRNAs. 
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A total of 7,960 and 4,948 potential targets were identified through this process for 
differentially expressed exosomal and non-exosomal miRNAs respectively (Figure 4.6 
A). We then used DAVID (http://david.abcc.ncifcrf.gov/) server to identify the gene 
ontology (GO) and significantly enriched canonical pathways (P<0.01) in these 
conserved targets. As shown in Figure 4.6 B, although there are no overlaps at 
differentially regulated miRNA levels (Table 4.2), there is a much higher degree of 
convergence at pathway levels regulated by differentially expressed miRNAs and up-
regulated miRNAs of growing oocyte (BCB-) group (Figure 4.6 B). 
 
 
 
 
 
 
 
 
 
 
Figure 4.7: Pathways enriched by genes predicted to be targeted by miRNAs highly 
abundant in exosomal of follicular fluid derived from follicles with growing oocytes 
(BCB-) compared to fully grown oocytes (BCB+) group. The bars represent the –log(p-
value) for each pathway. The red irregular line is a graph of the ratio (number of genes 
from the data set / total number of genes involved in respective pathways). 
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Figure 4.8: Pathways enriched by genes predicted to be targeted by miRNAs highly 
abundant in non exosomal of follicular fluid derived from follicles with growing 
oocytes (BCB-) compared to fully grown oocytes (BCB+) group. The bars represent the 
–log (p-value) for each pathway. The red irregular line is a graph of the ratio (number of 
genes from the data set / total number of genes involved in respective pathways). The 
common pathways affected by differentially expressed miRNAs in exosomal and non-
exosomal fraction of follicular fluid are underlined. 
 
Our analysis for GO revealed that the genes targeted by up-regulated miRNAs in both 
exosomal and non-exosomal fraction of follicular fluids of the growing oocyte group 
were associated with transcriptional categories (such as transcription, regulation of 
transcription, transcription factor activity), transport, secretion and gene expression 
(Table 4.4). As shown in Figure 4.7, ubiquitin-mediated proteolysis, neurotrophin 
signaling pathway, and MAPK signaling pathway are the most enriched pathways for 
the target genes of differentially expressed upregulated exosomal miRNAs. On the other 
hand, WNT signaling pathway, pathways in cancer and focal adhesion are the most 
enriched pathways for the genes potentially targeted by non-exosomal miRNAs (Figure 
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4.8). Furthermore, pathways involved in various signal transduction and cell-cell 
interactions such as VEGF signaling pathway, insulin signaling pathway, focal 
adhesion, pathways in cancer, and oocyte meiosis TGF-beta signaling pathways are also 
significantly enriched in both exosomal and non-exosomal fraction of follicular fluid 
from follicles containing growing oocytes.  
  
Table 4.4: Gene ontology analysis of potential target genes of miRNAs differentially 
expressed in exosomal and non-exosomal fraction of follicular fluid derived from 
follicles containing growing vs. fully grown oocytes. 
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4.6 Expression analysis of candidate miRNAs in surrounding follicular cells 
Based on their expression profile in both exosomal and non-exosomal fraction of the 
follicular fluid containing growing oocytes, we selected 8 candidate miRNAs to 
investigate in the surrounding follicular theca cells (TC), granulosa cells (GC) and 
cumulus oocyte complex (COCs). From the PCR array results we revealed that, in 
follicular fluid from follicles with growing oocytes (BCB-), miR-654-5p and miR-640 
(in exosomal) and miR-19b-1* and miR-29c (in non exosomal) were highly abundant 
(Table 4.3). Similarly, miR-526b* and miR-373 (in exosomal) and miR-381 and miR-
30e* (in non-exosomal) were more abundant in follicular fluid from follicles with a 
fully grown oocyte (BCB+) (Table 4.3).   
 
 
Figure 4.9: Analysis of exosomal miRNAs in follicular cells. Expression patterns of 
miR-654-5p and miR-640, which are up-regulated in follicular fluid of BCB- vs. 
BCB+ follicles (Figure 4.9 A), and miR-526b-1* and miR-373, which are down-
regulated in BCB- vs. BCB+ follicles (Figure 4.9 B) were investigated in 
surrounding follicular cells namely cumulus oocyte complex (COCs), granulosa 
cells (GC) and theca cells (TC) from the same category of follicle which were 
used for PCR array analysis.  The data is presented as relative abundance of 
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different miRNAs in different cell types compared to their expression in COCs 
as a control.  Means with SD, three biological replicates and bars with different 
superscripts are different (P<0.05). 
 
 
 
 
Figure 4.10: Analysis of non-exosomal miRNAs in follicular cells. Expression of two 
up-regulated namely miR-19b-1*& miR-29c (Figure 4.10 A) and two down-
regulated namely miR-381 & miR-30e* (Figure 4.10 B) non-exosomal miRNAs 
were investigated in surrounding follicular cells namely cumulus oocyte 
complex (COCs), granulosa cells (GC) and theca cells (TC) from the same 
category of follicle which were used for PCR array analysis. The data is 
presented as relative abundance of different miRNAs in different cell types 
compared to their expression in COCs as a control.  Means with SD, three 
biological replicates and bars with different superscripts are different (P<0.05). 
Comparative expression analysis of 8 candidate miRNAs in follicular cells showed that 
they are present in all cell types with different expression level. While exosomal 
miRNAs namely, miR-640 and miR-526b* were more abundant in theca cells, miR-373 
was detected at higher level in COCs. However, no significant difference was observed 
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in the expression level of miR-654-5p across different cell types (Figures 4.9 A & B). 
Similar analysis for non-exosomal miRNAs shows that miR-19b-1* and miR-30e* were 
highly abundant in cumulus oocyte complex (COCs) where as miR-381 was highly 
abundant in theca cells. However, no significant difference was observed for miR-29c 
across the cell types (Figures 4.10 A & B). 
 
4.7 Stability of exosomal miRNAs under culture conditions 
To demonstrate the stability of exosomes under culture condition (F-12 media + 10% 
exosomes free FBS, 37°C and 5% CO2) we investigate the expression of four candidate 
exosomal miRNAs at three different time points (6 hr, 12 hr and 24 hr) and compared 
with freshly isolated exosomes (0 hr) samples derived from follicular fluid irrespective 
of oocyte competence. We choose miR-654-5p, miR-640, miR-526b-1* and miR-373 
because these miRNAs were differentially expressed in exosomal fraction of follicular 
fluid and they were also substantially expressed in exosomes.  
 
Figure 4.11: Stability of exosomal miRNAs under in vitro culture conditions. Exosomes 
from follicular fluid were incubated under in vitro cell culture conditions (37°C 
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& 5% CO2) for 6 hr, 12 hr and 24 hr in a exosome-free culture medium in order 
to determine the stability of exosome miRNAs by  quantitative real time PCR. 
Non-cultured exosomes (0 hr) were used as reference control to check the 
stability of exosomes coupled miRNAs in different time points. The data are 
presented as means with ± SD of three biological replicates. 
 
The results indicate that the exosomal miRNAs of bovine follicular fluid shows more or 
less stable expression under culture conditions at different time points (Figure 4.11). As 
in vitro culture temperature is similar to body temperature of bovine, thus the results 
indicate that exosomal miRNAs may stable in follicular fluid long time (up to 48 hrs, 
data not presented) and may have potential role during follicular development.  
 
4.8 Exosomes can be taken up by follicular cells and increase endogenous miRNA 
abundance 
To evaluate the possibility of exosomes from follicular fluids can be taken up by 
recipient cells, granulosa cells were collected and 50,000 viable cells were seeded to 
each well of 8-well chamber slide. Purified bovine follicular fluid exosomes were 
labeled with PKH67 dye (a green fluorescent dye) and added to the culture media of 
granulosa cell. Following an incubation period of 24 hr, labeled exosomes treated 
granulosa cells were washed and fixed and examined by a confocal microscope. The 
PKH67 labeled exosomes were taken up by cultured bovine granulosa cells (Figures 
4.12 A, B & C) and were located around the nucleus. More importantly, granulosa cells 
that cultured with PKH67 treated sterile PBS showed no signals for green fluorescence 
(Figure 4.12 D).  
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Figure 4.12: Uptake of PKH67-labeled exosomes by bovine granulosa cells in vitro. 
Exosomes, purified from follicular fluid, were labeled with PKH67 dye and 
added to primary culture of granulosa cells. Granulosa cells were co-cultured 
with labeled exosomes isolated from follicular fluid in exosome-free medium for 
22 hours under optimum cell culture conditions (37°C & 5% CO2). Nuclei are 
stained blue using DAPI (Figure 4.12 A, C & D) while PKH67-labeled 
exosomes are stained green (Figures 4.12 A, B). Arrows indicate exosomes that 
were taken up by granulosa cells. Granulosa cells cultured in exosomes free 
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medium containing PKH67-labeled sterile PBS served as a negative control 
(Figure 4.12 D). Scale bar: 10,000 nm. 
4.9 Exosome mediated transport of miRNAs can increase the endogenous population of 
miRNAs at cellular level 
To determine whether exosomes mediated transfection of miRNAs could increase the 
endogenous level of miRNA, we first purified exosomes from follicular fluid of BCB+ 
or BCB- oocyte source to check the abundance of candidate miRNAs in fresh 
exosomes. Importantly, we found that miR-654-5p, miR-640 and miR-526b*, and miR-
373 were more abundant in exosomes from follicular fluid of follicles containing BCB- 
and BCB+ oocytes, respectively (Figure 4.13). Then a  of exosomes from BCB+ and 
BCB- follicular fluid was co-cultured separately with primary granulosa cells in vitro 
for 24 hours, after which the expression level of those miRNAs was investigated. 
Granulosa cells co-cultured with same volume of sterile PBS were used as negative 
control. The results revealed that the level of endogenous miRNAs in exosome co-
cultured granulosa cells was significantly increased compared to controls (Figures 14 A 
& B).  
 
Figure 4.13: Validation of the enrichment of candidate miRNAs in exosomes taken up 
by granulosa cells. Purified exosomes from follicular fluid of follicles with 
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growing (BCB-) or fully grown (BCB+) oocytes were subjected to total RNA 
extraction. Then the expression level miR-654-5p and miR-640 (enriched in 
exosomes derived from BCB- follicular fluid) and miR-256b-1* and miR-373 
(enriched in follicular fluid derived from follicles with BCB+ oocyte) were 
investigated by real time PCR. Different superscript letters (a,b) denote a 
significant difference between groups (P<0.05).  The data is presented as means 
± SD of three biological replicates. 
 
 
Figure 4.14: Exosome mediated delivery of miRNAs in bovine granulosa cells in vitro. 
Purified exosomes from follicular fluid of follicles from growing (Figure 4.14 
A) or fully grown (Figure 4.14 B) oocytes were co-cultured with bovine 
granulosa cells. After 24 hrs of incubation at 37°C in a humidified incubator, 
cells were collected and subjected to total RNA extraction. The expression levels 
of selected miRNAs were investigated by real time PCR. In both cases the 
miRNAs the levels of endogenous miRNAs were significantly increased 
compared to untreated controls. Bars with different superscripts are different 
(P<0.05).  The data is presented as means with SD of three biological replicates. 
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4.10 Changes in expression of target genes following treatment of exosomes in 
granulosa cells 
To determine whether exosome-mediated delivery of miRNA can alter the mRNA 
abundance of selected target genes, we examined the expression of seven transcripts in 
granulosa cells collected after treatment with exosomes enriched by candidate miRNAs 
compared to untreated controls. Based on the criteria mentioned in material and 
methods part that we analyzed ITGA3 (as target of miR-654-5p), SOCS4 & MAP3K1 
(as target of miR-640), BRMS1L & ZNFX1 (as target of miR-526b*) and CD44 & 
VEGFA (as target of miR-373). As shown in Figure 4.15, treatment of granulosa cells 
with exosomes enriched with candidate miRNAs down-regulated ITGA3, SOCS4, 
MAP3K1, BRMS1L, YNFX1 and CD44 genes by 20-65% compared to the untreated 
control. However, the relative abundance of VEGFA has increased in granulosa cells 
transfected with exosomes compared with untreated controls (Figure 4.15 B) 
 
 
 
 
Figure 4.15: Changes in expression of target genes following exosomes transfection. 
Quantitative real-time PCR were carried out using gene-selective primers. miRNA 
target genes were selected using seed match and their involvement in important 
pathways. To elucidate the exosome mediated uptake of circulatory miRNAs can alter 
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the abundance of target mRNAs we used the same exosome co-cultured granulosa cells 
which was used for miRNA abundance study. The histogram (Figure 4.15 A & B) 
indicate that significantly lower expression of target mRNAs except VEGFA, 
suggesting possible involvement of transcriptional regulation of circulating miRNA. 
Different superscript letters (a, b) denote a significant difference between groups, such 
that groups not sharing a similar letter are significantly different form each other 
(P<0.05).  The data is presented as means ± SD of three biological replicates. 
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5 Discussion 
 
5.1 Extra-cellular miRNAs and follicular oocyte development 
The follicular oocyte derived from slaughtered animals that is commonly used for in 
vitro maturation and subsequent embryo production is commonly heterogeneous in 
terms of developmental competences. This is because of the fact that the follicular 
population of the ovary may consist of oocytes that are either in the growing phase or 
already fully grown stage. It has been reported that a fully grown oocyte shows better 
competency than a growing oocyte in terms of in vitro maturation, fertilization and 
blastocyst rate (Mohammadi-Sangcheshmeh et al. 2012; Silva et al. 2011). In addition, 
there is a coordinated communication between follicular cells, which is done in terms of 
exchange of signaling molecules among them. To attain competence there is a higher 
degree of transcription and translation occurred during oocyte growth (Tatemoto and 
Horiuchi 1995). In this regard follicular fluid plays a significant role in mediating the 
transport of nutrients and signals from and to granulosa cells, theca cells and cumulus 
oocyte complex. This process demanded a high degree of miRNA management to 
support further development or attaining competence. Several studies have been 
conducted to correlate the dynamic process of oocyte development and gene regulatory 
network that include oocyte specific transcripts as well as regulators of transcripts like 
miRNA (Ghanem et al. 2007; Tesfaye et al. 2009; Torner et al. 2008). We hypothesized 
that mRNA regulatory molecules namely miRNAs as circulatory RNA in follicular fluid 
may play a significant role in this regard. The presence of certain circulatory miRNAs 
in follicular fluid may be associated with the oocyte growth phase. Therefore, we have 
profiled the expression of circulatory miRNAs in follicular fluid using a custom miRNA 
PCR array. However, our understanding of composition of the oocyte transcriptome and 
the regulatory role of key oocyte-expressed genes and miRNAs in folliculogenesis is far 
from complete. Recently miRNAs have been detected in extracellular environment 
mainly in different bio-fluids and their spectra could reflect altered physiological and 
pathological conditions (Gilad et al. 2008; Hunter et al. 2008; Schrauder et al. 2012; 
Valadi et al. 2007; Weber et al. 2010; Yamaura et al. 2012). To our knowledge, this 
study is the first to report on the presence of circulatory miRNAs in bovine follicular 
fluid that may be associated with oocyte growth. The results of this study clearly 
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support our hypothesis that miRNAs are also present in bovine follicular fluid in 
association with either exosomes or non-exosomal fractions and their signature may 
represent the altered physiological conditions.  
 
5.2 Specificity of exosomes isolation procedure 
Recent studies have demonstrated that circulating miRNAs are coupled with either 
exosomes (Taylor and Gercel-Taylor 2008; Thery 2011) or Ago2 protein complex 
(Arroyo et al. 2011) to bypass the high RNases activity in blood stream. By using a 
systemic approach, we have revealed that there are at least two population of circulating 
miRNAs in follicular fluid, namely exosomes and non exosome associated, in which the 
exosome-coupled represent the majority of miRNAs in follicular fluid. The specificity 
of exosome isolation was confirmed by the presence of CD63 in isolated exosomes 
(Gallo et al. 2012; Logozzi et al. 2009; Valadi et al. 2007). It has been well documented 
that platelet-derived exosomes are enriched in CD63. However, this tetraspan protein is 
also found in exosomes from other cell types. Tetraspan proteins have been implicated 
in adhesive as well as costimulatory and signaling functions. To support the hypothesis 
that along with exosomes Argonaute2 protein complex also carry a sub set of miRNA in 
follicular fluid, we checked the presence of Ago2 protein abundance in non-exosomal 
portion of follicular fluid. Recent reports have suggested that a common source of 
unwanted bias in miRNA profiles in serum or plasma samples is cellular contamination 
of the samples with various cell types from blood or their donor cells (McDonald et al. 
2011). It is crucial for any biomarker discovery project utilizing cell free microRNA 
from serum or plasma that the cellular content of the bio-fluid is minimized, that 
miRNA expression levels are interpreted in light of blood cell counts, or that miRNA 
biomarkers are sought among miRNAs that are not expressed in cells. Minimizing 
cellular content can be done by standardizing the sampling procedure as well as the 
handling of the material. After collection of follicular fluid we followed several 
spinning and filtration procedures which allow complete removal of cellular fraction 
from follicular fluid which might present during sampling. In order to demonstrate the 
purity of follicular fluid we further performed immunoblotting using CYCS which is 
exclusively expressed in cytosol/mitochondria. As expected, the result revealed that 
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both exosomal and non-exosomal protein preparation were negative for CYCS (da 
Silveira et al. 2011; Torri and Hajduk 1988).  
 
5.3 Quality control of total RNA 
Another source of possible variation in miRNA profiles from serum and plasma is the 
RNA isolation procedure and specifically the presence of inhibitors that affect the 
cDNA synthesis and/or real time PCR reactions (Blondal et al. 2013). As cell-free 
miRNA concentrations are low in these samples, it is tempting to try to maximize the 
amount of sample used per reaction. In practice increasing the amount of RNA input 
could also lead to an increased concentration of inhibitors which may be derived from 
the bio-fluid or introduced via reagent carry-over during sample preparation and 
suboptimal RNA isolations. Reliable results in real-time RT-PCR array and microarray 
analysis depend on the quality of the RNA sample. Traditionally, RNA integrity is 
determined by denaturing agarose gel electrophoresis, where intact RNA is indicated by 
a 2:1 ratio of the bands for 28S and 18S rRNA. However, agarose gel analysis is time-
consuming and also hazardous, as ethidium bromide staining is required to visualize 
RNA bands. RNA purity is generally determined spectrophotometrically. The ratio of 
absorbances at 260 nm and 280 nm (A260:A280) determines the degree of protein 
contamination and the A260:A230 ratio is used to identify any contamination by 
organic solvents. These ratios should be >1.8. Standard methods for measurement of the 
RNA yield and quality are inappropriate for use with bio-fluid samples. The presence of 
carrier RNA in these samples makes measuring the low levels of endogenous RNA by 
OD260 impossible. Even if the carrier was not included during the isolation, the RNA 
concentration in the eluate would still be too low for reliable OD260 quantification on a 
NanoDrop or other spectrophotometer. Therefore, an extensive alternative quality 
control of total RNA has been implemented to secure technical soundness. In order to 
check the quality of total RNA extracted from follicular fluid, we investigated two 
crucial parameters- presence of typical miRNAs which are abundantly present in bio-
fluids and absence of inhibitors of cDNA synthesis and the PCR enzyme. These two 
parameters we investigate using a small set of single qPCR assays where cDNA was 
synthesized with different total RNA input volume to make a dilution curve (e.g. 0.5 μl, 
1.0 μl, 2.0 μl, and 4.0 μl in a 10 μl reaction). Before committing sample RNA to 
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profiling on miRNA qPCR panels, this pre-examination allowed us to discharge the 
samples which fail to generate a dilution curve with expected linear relationship 
between sample input and signals. 
 
5.4 Differentially expressed miRNAs in exosomal and non-exosomal portion of 
follicular fluid 
Recently RNAs, including miRNAs were detected in blood serum in association with 
microvesicles/exosomes (Hunter et al. 2008; Taylor and Gercel-Taylor 2008) and non-
vesicle-associated (Ago2 complex associated) (Arroyo et al. 2011). Very recently, one 
report shows that miRNAs may be present in blood plasma in association of High 
Density Lipoprotein (HDL) and delivered to recipient cells with functional capabilities 
(Vickers et al. 2011). Indeed numerous studies have shown that secreted microRNAs 
can be implicated in pathogenic conditions such as various cancers, coronary heart 
disease and organ damage (Kosaka et al. 2010; Mitchell et al. 2008; Wang et al. 2010b). 
The precise role of circulating miRNAs is still largely unknown. Circulating or 
extracellular miRNAs have been shown to be stabilized and protected from RNAse 
degradation by inclusion in various protein complexes or membranous particles such as 
exosomes or microvesicles (Arroyo et al. 2011; Valadi et al. 2007). There seems to be a 
subset of cell-free microRNAs present in normal blood with possible functions within 
the circulatory and immune systems (Vasilatou et al. 2010). The miRNA profile in 
serum and plasma has been shown to reflect disease states such as cancer (Bryant et al. 
2012) as well as organ damage and injury (Wang et al. 2010b). It has also been shown 
that miRNA containing subcellular vesicles can be taken up by cells and cause changes 
in cellular gene expression during pathological conditions (Kosaka et al. 2010; Vickers 
et al. 2011). These findings suggest a biological function for extra-cellular miRNA yet 
to be fully described. In the present study, in addition to the exosomal portion, miRNAs 
coupled with Ago2 protein were found in the non-exosomal portion (supernatant) of the 
follicular fluid. Subsequently, we have confirmed the presence of miRNAs in both 
exosomal and non-exosomal portion of the follicular fluid using a Human miRNome 
PCR array platform. Despite using a heterologous approach, the quantitative real time 
PCR analysis shows detection of the majority of miRNAs in both portion of follicular 
fluid indicating the cross species conservation feature of miRNAs between human and 
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bovine as it has been observed in a wide range of species (Bentwich et al. 2005). Of the 
total of 750 miRNAs in the PCR array panel, a total of 509 and 356 miRNAs were 
detected in the exosomal and non-exosomal portion of follicular fluid respectively 
(Figure 4.5). Among the detected miRNAs, 331 were commonly found in both portions, 
while 178 and 25 miRNAs were detected only in exosomal and non-exosomal portion 
of follicular fluid, respectively. This shows exosome mediated transport of miRNAs is 
the dominant pathway in bovine follicular fluid compared to the non exosomal way 
(Ago2 & HDL) as observed previously in blood plasma and saliva (Gallo et al. 2012). 
To explore the possible association of exosomal and non exosomal miRNA expression 
with oocyte growth in the follicle, we examined the relative miRNA expression level in 
exosomal and non exosomal portion of bovine follicular fluid collected from follicles 
containing growing (BCB-) and fully grown (BCB+) oocytes. Subsequently we found 
25 and 32 miRNAs to be differentially regulated in exosomal and non-exosomal 
portion, respectively between two oocyte groups (BCB- vs. BCB+). The higher number 
of up-regulated miRNAs in both exosomal (16 miRNAs) and non-exosomal (21 
miRNAs) portion of follicular fluid of growing oocyte group may indicate a higher 
degree of transcriptional activity during the growth phase of oocytes. In order to 
evaluate the potential role of these differentially expressed miRNAs, the target genes 
were predicted bioinformatically and their biological function and gene ontology was 
determined. The most dominant categories enriched by predicted genes are related to 
transcription and transport which may indicate that, growing oocytes have higher degree 
of transcription and translation resulting in efficient RNA management and storage in 
oocytes as maternal resource (Fair et al. 1995).  Furthermore, the most significant 
pathways enriched by predicted targets for up-regulated exosomal miRNAs include 
ubiquitin-mediated pathway, neurotrophin signaling, MAPK signaling and insulin 
signaling pathways. All these pathways are known to be involved in ovarian follicular 
growth and many developmental processes.  The ubiquitin mediated pathway modulates 
oocyte meiotic maturation (Huo et al. 2004), early mitotic division in developing 
embryos (Suzumori et al. 2003) and plays important role in many cellular processes 
(Ciechanover and Schwartz 1994). While Neurotrophin signaling pathway reported to 
be important in regulation of oogenesis and follicle formation (Dissen et al. 2009), the 
MAPK signaling has certain role in oocyte and cumulus cells (Zhang et al. 2009). 
Similarly, the overrepresented pathways in non-exosomal portion were WNT signaling 
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pathway and pathways in cancer and focal adhesion. WNT molecules are glycoproteins 
involved in fetal ovarian development and adult ovarian function including follicular 
growth, oocyte growth or maturation, steroidogenesis, ovulation and luteinization 
(Boyer et al. 2010; Harwood et al. 2008; Zheng et al. 2006). Moreover, the higher 
number of common pathways in both exosomal and non-exosomal portion may indicate 
that, miRNAs associated with either exosomes or Ago2/HDL have a complementary 
function in follicular microenvironment or the same miRNA species can be carried by 
both exosomes and Ago2/HDL components. 
 
5.5 Expression of candidate miRNAs in surrounding follicular cells 
To validate the hypothesis that circulating miRNAs in follicular fluid originate from 
different cell types within follicular microenvironment we investigated the expression 
of 8 selected candidate miRNAs in granulosa cells (GCs), theca cells (TCs) and 
cumulus oocyte complex (COCs). Results revealed that all these miRNAs are detected 
in all follicular cell types with varying expression level. MicroRNAs like miR-640, 
miR-526b* and miR-381 were abundant at higher levels in theca cells, while miR-373, 
miR-30e* and miR-19b-1* expressed more in COCs. However, no significant 
differences were observed between cell types in the expression of miR-654-5p and miR-
29c. Although the origin of circulating miRNAs in body fluids remains elusive, several 
reports demonstrated that the origin of circulating miRNAs is closely related to the 
surrounding cells. For example, while a common set of miRNAs were found in equine 
follicular fluid and surrounding follicular cells (da Silveira et al. 2011), blood cells are 
reported to be the major contributor of circulating miRNAs in serum (Pritchard et al. 
2011). Therefore, the presence of a significant level of candidate circulatory miRNAs in 
the surrounding follicular cells could enable us to postulate that the majority of 
circulatory miRNAs in follicular fluid originated from various cell types in the course of 
their communication during oocyte growth.  
 
5.6 Functional delivery of miRNAs via exosomes  
Cells release different types of vesicles into the extracellular space. Two types of 
vesicles can be distinguished depending on their cellular origin. Shedding vesicles are 
generated by budding from the plasma membrane into the extracellular space (Booth et 
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al. 2006; Cocucci et al. 2009), whereas exosomes have an endosomal origin in MVBs: 
MVBs either fuse with lysosomes for degradation or with the plasma membrane to 
release their intraluminal vesicles (ILVs) as exosomes. Mixed populations, containing 
shedding vesicles and exosomes, are referred as microvesicles. Microvesicles are 
increasingly recognized as important mediators of cell-to-cell communication. They can 
transfer receptors, proteins, mRNA and miRNA to target cells via interaction with 
specific receptors. Microvesicles derived from embryonic stem cells have been reported 
to reprogramme haematopoietic progenitors through the delivery of mRNA (Ratajczak 
et al. 2006a). The transfer of RNA species via microvesicles to endothelial cells induces 
angiogenesis (Deregibus et al. 2007), and progenitor mobilization (Zernecke et al. 
2009). In the immune system, exosomal transfer of mRNA occurs between mast cells, 
and viral miRNAs secreted by EBV-infected cells can be taken up by uninfected 
recipient cells (Pegtel et al. 2010; Valadi et al. 2007). Synthetic miRNA mimetics and 
viral miRNAs have been reported to be transferred between leukocytes, although the 
direct involvement of exosomes/microvesicles in this case was not demonstrated 
(Rechavi et al. 2009). Exchange of proteins between immune cells has been extensively 
reported, but the mechanism of this transfer remains unclear (Davis 2007).  
In order to elucidate the possible exchange of molecular signals in form of exosome 
coupled miRNAs between follicular cells, we have investigated the ability of granulosa 
cells to take up exosomes isolated from follicular fluid. Prior to uptake experiment, the 
stability of exosome coupled miRNA under in vitro culture environment was 
determined and result showed that exosome coupled miRNAs were stable not only up to 
24 hours (Figure 7) but even until 48 (data not shown).  Similar studies have also shown 
the stability of circulating serum miRNAs (Gilad et al. 2008) and breast milk exosomal 
miRNA stability in room temperature and multiple freeze-thaw cycle (Zhou et al. 2012). 
Following the confirmation of exosomal miRNA stability under culture conditions, we 
performed exosomes uptake experiment by primary granulosa cells. Fresh exosomes 
isolated from follicular fluid and labeled by PKH67 fluorescent dye were co-cultured 
with bovine primary granulosa cells in vitro for 24 hrs. The fluorescent microscopy 
observation of labeled exosomes co-cultured granulosa cells revealed the presence of 
green fluorescent exosomes in cultured primary granulosa cells. A similar observation 
was reported in equine granulosa cells (da Silveira et al. 2011), microglial cell line 
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(Fitzner et al. 2011), immune cells (Mittelbrunn et al. 2011) and other cell lines (Valadi 
et al. 2007). Fluorescent microscopy results also showed that majority of the exosomes 
taken up by granulosa cells were gathered around perinuclear region (Tian et al. 2010). 
Importantly, there were no fluorescent signals in plasma membrane indicating that 
exosomes were internalized in to granulosa cells via endocytosis. If fusion is the 
dominant pathway for exosomes uptake, plasma membrane would contain fluorescent 
signal after co-culture of cells and labeled exosomes. Similar results were observed in 
exosome internalization by resting PC12 cells (Tian et al. 2010). The consequence of 
transfection of exosome coupled miRNAs in endogenous miRNA abundance in 
granulosa cells was investigated by expression analysis of candidate miRNAs in 
exosomes derived from follicular fluid of either BCB+ or BCB- oocyte groups. Results 
have evidenced increased level of endogenous miRNA in exosome transfected 
granulosa cells compared to the control ones. This could enable us to conclude that 
exosome mediated exchange of miRNAs in follicular microenvironment is a route of 
communication between follicular cells. 
In conclusion, to the best of my knowledge, this thesis reported for the first time 
the presence of circulatory miRNAs in bovine follicular fluid and also demonstrated the 
exosome and non-exosome mediated transport of miRNAs in follicular 
microenvironment. The stability of exosome coupled miRNA under in vitro culture 
condition will pave the way for functional analysis of cell to cell communication under 
in vitro environment. Finally, by the comparison of the miRNA expression profiles in 
follicular fluid of growing and fully grown oocyte source, we have identified several 
miRNAs which may be associated with growth status of oocyte. However, further 
functional investigation based on this data could help to find out key regulatory 
circulating miRNAs controlling oocyte developmental competence by facilitating cell to 
cell communication in follicular environment. 
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6 Summary  
Growth and development of bovine ovarian follicles and oocytes is the result of series 
of complex and coordinated processes that involves extensive cell-to-cell 
communication in the follicle. This phenomenon involves enormous complex and 
heterogeneous biochemical substances existing in the oocytes and its surrounding cells 
and the follicular fluid. Thus, the dynamic chemical interactions signaled between these 
entities will determine the fate of follicular development, follicular cell proliferation and 
oocyte growth. It has been speculated that follicular fluid influence follicular 
development by facilitating the transportation and uptake of small membrane-enclosed 
vesicles called exosomes by surrounding follicular cells. In addition, reports also 
indicated that exosomes harbour a variety of miRNAs that are implicated in cell to cell 
communication. Indeed, investigating the presence and source of miRNAs in the 
follicular fluid will give insight into the role of miRNA in follicular cell development 
and function. Therefore, the present study was conducted to investigate the presence 
and expression pattern of circulating miRNA in exosomes and non-exosomal portion of 
bovine follicular fluid, in follicles containing fully grown and growing oocytes. In 
addition, this study also addressed the exosome mediated transfer of miRNAs in 
follicular microenvironment by using a granulosa cell culture model. For this purpose, 
follicles ranging from 4-8 mm in diameter were blunt-dissected and follicular fluid and 
cumulus oocyte complex (COCs) were collected from individual follicles, then the 
COCs were subjected to brilliant cresyl blue (BCB) staining and classified as BCB+ 
(fully grown oocytes) and BCB- (growing oocytes). The corresponding follicular fluid, 
granulosa cells and theca cells were also classified accordingly. A total of three 
replicate pools each containing follicular materials from 20 follicles from both BCB+ 
and BCB- oocyte category were used in this experiment. The follicular fluid was 
fractioned in to exosomal and non-exosomal portion using Exoquick
TM
 (Exosome 
precipitation kit) and used for total RNA isolation using miRNeasy
®
 mini kit. From 
each exosome and non-exosome portion, 100 ng of total RNA was reverse transcribed 
using Universal cDNA synthesis kit. The resulted cDNA from total RNA was 
subsequently diluted 100 fold and the human miRCURY (Human Panel I+II, V2.M) 
Ready-to-Use PCR array (Exiqon) consisted of 748 miRNAs, was used for the 
expression profile of circulatory miRNA in both portion of follicular fluid. The qPCR 
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data was analyzed using a comparative threshold cycle (ΔCT) method after 
normalization by global normalization method. To minimize potential noise, miRNAs 
with Ct value of > 35 were filtered out.  
The presence of miRNAs in cell-secreted exosomes and non-exosomal portion of 
follicular fluid was examined by real time qPCR. miRNAs were considered to be 
present when the Ct value of the corresponding miRNA was < 35. Thus, of 748 miRNA 
probes on the PCR array platform, 509 miRNAs and 356 miRNAs were detected in 
exosomes and non-exosomal portion respectively. While 331 miRNAs were commonly 
detected in both portion of the follicular fluid, 178 miRNAs were detected only in 
exosomes and 25 miRNAs were detected in the non-exosomal portion. These finding 
indicate that miRNAs are transported through exosomes and non-exosomal structures 
(i.e. Ago2 protein complexes & HDL) in bovine follicular fluid where exosomes 
mediated transportation of circulatory miRNAs is the dominant pathway. 
The results of PCR array revealed that 25 and 30 miRNAs were differentially regulated 
(≥2 fold change, P< 0.05) in the exosomal and non-exosomal portion respectively 
between follicular fluids from BCB+ & BCB- oocyte origin. Of the 25 differentially 
expressed exosomal miRNAs, 16 miRNAs were elevated in the growing oocyte (BCB-) 
group and 9 miRNAs were elevated in fully grown oocyte (BCB+) group. In order to 
identify the potential target genes of 16 exosomal miRNAs elevated in BCB- group, we 
used in silico analysis based on target prediction software miRecord and subsequently 
we found 7960 genes were predicted to be targets of miRNAs enriched in the exosomal 
portion of BCB- group. The regulator pathway annotation analysis based on the Kyoto 
encyclopedia of genes and genome database revealed that the genes targeted by the 
miRNAs were mainly involved in ubiquitin-mediated proteolysis, neurotrophin 
signaling pathway, and MAPK signaling pathway, VEGF signaling pathway, focal 
adhesion and TGF-β signaling pathway. Furthermore, ontological classification 
revealed that the genes targeted by enriched miRNAs in exosomal portion of follicular 
fluids of the growing oocyte group were associated with transcriptional categories (such 
as transcription, regulation of transcription, transcription factor activity), transport, 
secretion and gene expression. On the other hand, among the 30 differentially expressed 
non-exosomal miRNAs, 21 miRNAs were highly abundant in growing oocyte (BCB-) 
category whereas 9 miRNAs were found to be highly expressed in fully grown oocyte 
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category (BCB+). In silico target prediction revealed that 4948 genes were potentially 
targeted by the non-exosomal portion of follicular fluid derived from growing oocyte 
(BCB-) origin and pathway analysis showed that those genes were found to be involved 
in WNT signaling pathway, pathways in cancer, focal adhesion, axon guidance, MAPK 
signaling pathway, regulation of actin cytoskeleton and oocyte meosis. In addition to 
pathway analysis gene ontological classification showed that potential target genes of 
enriched non-exosomal miRNAs of growing oocyte group were found to be involved in 
regulation of transcription, protein transport, establishment of protein localization, 
positive regulation of nitrogen compound metabolic process, positive regulation of gene 
expression and positive regulation of transcription. The differences in regulatory 
pathways and biological processes indicated the transcriptomic and molecular signaling 
alteration between exosomal and non-exosomal portion of follicular fluid containing 
growing oocyte. Based on expression intensity four exosomal miRNAs (miR-654-5p, 
miR-640, miR-526b* and miR-373) and four non-exosomal miRNAs (miR-19b-1*, 
miR-29c, miR-381 and miR-30e*) were selected for further characterization in 
surrounding follicular cells. Comparative expression analysis of eight candidate 
miRNAs in follicular cells using quantitative real time PCR showed that they are 
present in all cell types with different expression level. This finding may reflect the 
origin of circulating miRNAs in follicular fluid. 
Following investigating the expression analysis of miRNas in follicular fluid (associated 
with exosomes & non-exosomal means) and surrounding follicular cells next we 
examined the function of follicular fluid exosomes. For this purpose, a granulosa cell 
culture model was used. First, exosomes from follicular fluid were isolated and checked 
for stability under culture condition by real time expression analysis of selected 
exosomal miRNAs. The result demonstrated that isolated follicular fluid exosomes were 
stable under culture conditions not only 24 h, but also up to 48 h. Once stability of 
exosomes was confirmed, next we checked the possibility of uptake of exosomes by 
recipient cells. For this, follicular fluid exosomes were labelled with PKH67 dye and 
co-cultured with granulosa cells for 24 hr. Confocal microscopy results revealed that the 
green fluorescent labelled exosomes were taken up by the granulosa cells. Furthermore, 
to determine the exosome mediated transport of miRNAs could increase the endogenous 
level of miRNAs in recipient cells, we isolated the exosomes from follicular fluid of 
growing oocytes (BCB-) and fully grown oocyte (BCB+) origin and co-cultured with 
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primary granulosa cells separately for 24 hr. Following this we investigated the 
expression of miR-654-5p & miR-640 in granulosa cells co-cultured with BCB- oocyte 
origin exosomes and miR-526b* & miR-373 in granulosa cells co-cultured with BCB+ 
oocyte origin exosomes using quantitative real time PCR. The results revealed that the 
level of endogenous miRNAs in exosome co-cultured granulosa cells was significantly 
increased compared to controls. Once the enrichment of endogenous miRNA levels in 
exosome co-cultured granulosa cells was uncovered, the mRNA expression pattern of 
some candidate target genes were assessed by quantitative real time PCR in the same 
pools of granulosa cell samples used for miRNA enrichment experiment. Based on 7-
mer seed match with the 3´ untranslated region of target gene, we selected ITGA3 (as 
target of miR-654-5p), SOCS4 & MAP3K1 (as target of miR-640), BRMS1L & 
ZNFX1 (as target of miR-526b*) and CD44 & VEGFA (as target of miR-373). 
Subsequently the expression analysis revealed that treatment of granulosa cells with 
exosomes enriched with candidate miRNAs down-regulated ITGA3, SOCS4, MAP3K1, 
BRMS1L, YNFX1 and CD44 genes by 20-65% compared to the untreated control. 
However, the relative abundance of VEGFA has increased in granulosa cells transfected 
with exosomes compared with untreated controls.  
In conclusion, the present study reported for the first time the presence of extra-cellular 
miRNAs in bovine follicular fluid and those could be coupled with exosomes or non-
exosomal structures (i.e. Ago2, HDL). This data highlights a number of differentially 
expressed circulatory miRNAs in bovine follicular fluid in relation to oocyte 
development competence, which is a step forward in developing non invasive bio-
markers for selecting competent oocytes. Moreover, this thesis also documented the 
exosome mediated transfer of miRNAs and alteration of endogenous levels of mRNAs 
and miRNAs in recipient cells which reflect the cell-cell communication during 
follicular development. Although this data open a new area of extra-cellular miRNA 
research regarding follicular microenvironment, in-depth functional studies will be 
required to understand the functional contribution of differentially expressed miRNAs 
to acquire oocyte developmental competence. 
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7 Zusammenfassung 
Wachstum und Entwicklung boviner Follikel und Eizellen ist das Ergebnis einer Reihe 
von komplexen und koordinierten Prozessen die eine umfangreiche Zell-Zell-
Kommunikation innerhalb der Follikel beinhaltet. Dieses Phänomen beruht auf 
komplexen und heterogenen biochemischen Vorgängen sowohl in den Eizellen, den 
umliegenden Zellen als auch in der Follikelflüssigkeit. Dementsprechend werden durch 
die dynamischen chemischen Wechselwirkungen zwischen diesen Einheiten die 
Follikelreifung, die follikuläre Zellproliferation und das Wachstum der Eizelle 
beeinflusst.  
Das Ziel der vorliegenden Studie war es die Präsenz und Expression von zirkulierenden 
miRNA in exosomalen und nicht-exosomalen Teilen boviner Follikelflüssigkeit und in 
Follikeln mit ausgewachsenen und wachsenden Eizellen zu untersuchen. Zusätzlich 
sollte durch diese Studie mittels eines Granulosazellkulturmodells auch der durch 
Exosomen vermittelte miRNA Transfer in follikulärer Mikroumgebung untersucht 
werden.  
Für diese Fragestellungen wurden Follikel mit einer Größe von 4-8 mm Durchmesser 
gewonnen und die Follikelflüssigkeit und der Cumulus-Oozyten-Komplex (COC) aus 
individuellen Follikeln gesammelt. Durch eine Brilliantkresylblau (BCB)-Färbung der 
COCs fand eine Unterteilung in BCB + (ausgewachsenen Eizellen) und BCB- 
(wachsenden Eizellen) statt. Die entsprechende Follikelflüssigkeit, Granulosazellen und 
Thekazellen wurden ebenfalls entsprechend klassifiziert. Insgesamt drei Pools mit 
jeweils follikulären Material aus 20 Follikeln sowohl aus der Kategorie BCB + und 
BCB- Eizellen wurden in diesem Experiment als Ausgangsmaterial verwendet. Die 
Fraktionierung der Follikelflüssigkeit in ihre exosomalen und nicht-exosomalen 
Bestandteile erfolgte mittels des ExoquickTM (Exosome Niederschlag kit) und die 
Total-RNA Isolierung mit dem miRNeasy ® Mini Kit. Nach der cDNA-Synthese wurde  
mittels des human miRCURY (Human Panel I+II, V2.M) Ready-to-Use PCR array 
(Exiqon), welcher 748 miRNAs enthält, miRNA Profile in beiden Bestandteilen der 
Follikelflüssigkeit erstellt werden. Die qPCR Daten wurden mit einer vergleichenden 
Schwellenwert-Zyklus (ΔCT)-Methode nach der Normalisierung mit dem globalen 
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Normalisierungsverfahren analysiert. Um mögliches Hintergrundrauschen zu 
minimieren, wurden miRNAs mit einem Ct-Wert > 35 herausgefiltert. 
Die Ergebnisse zeigten, dass von 748 miRNA Sonden auf der PCR-Array-Plattform 509 
miRNAs im exosomalen und 356 miRNAs im nicht-exosomalen Teil detektiert wurden. 
Davon konnten 331 miRNAs in beiden Bestandteilen nachgewiesen werden, während 
178 miRNAs dem exosomalen und 25 miRNAs dem nicht-exosomalen Teil zugewiesen 
wurden. Unter den detektierten miRNAs waren 25 miRNAs unterschiedlich im 
exosomalen und 30 miRNAs unterschiedlich im nicht-exosomalen Bestandteil reguliert 
(≥ 2-fache Veränderung, P <0,05) im Vergleich zu BCB + und BCB- Eizellen. Von den 
25 differentiell exprimierten miRNAs des exosomalen Teils waren 16 miRNAs in der 
Gruppe der wachsenden Eizelle (BCB-) und 9 miRNAs  in der Gruppe der 
ausgewachsen Eizelle (BCB +) erhöht. Um potenzielle Zielgene dieser 16 exosomalen 
miRNAs zu identifizieren, welche in der BCB- Gruppe in ihrer Expression erhöht 
waren, verwendeten wir eine in silico Analyse. Diese basierte auf einer speziellen 
"target prediction software" und fanden somit 7960 Gene als mögliche Zielgene für die 
miRNAs in dieser Gruppe. Eine Signalwegsanalyse mit der Kyoto-Enzyklopädie von 
Genen und Genom-Datenbank ergab, dass diese 7960 Gene hauptsächlich an den 
Signalwegen in der Ubiquitin-vermittelten Proteolyse, Neurotrophin, MAPK, VEGF, 
fokale Adhäsion und TGF β beteiligt sind. Darüber hinaus ergab eine ontologische 
Klassifizierung, dass die Gene der miRNAs aus dem exosomal angereicherten Teil der 
Follikelflüssigkeiten der wachsenden Eizelle mit transkriptionalen Kategorien (z. B. 
Transkription, Regulation der Transkription, Transkriptionsfaktor-Aktivität), Transport, 
Sekretion und Genexpression assoziiert waren. 
Auf der anderen Seite wurden unter den 30 unterschiedlich exprimierten nicht-
exosomalen miRNAs eine übermäßig hoch Expression von 21 miRNAs in der 
Kategorie wachsender Eizellen (BCB-) gefunden, während 9 weitere miRNAs hoch in 
der Kategorie ausgewachsener Eizellen (BCB+) exprimiert waren. Die In silico 
Analysen offenbarten 4948 potenzielle Gene im nicht-exosomalem Teil der 
Follikelflüssigkeit aus der Gruppe der wachsenden Eizellen (BCB-). Analysen der 
Signalwege zeigten, dass diese Gene in WNT Signalweg, Krebssignalweg, fokale 
Adhäsion, Axonleitung, MAPK Signalweg und Eizellmeiose involviert sind. Zusätzlich 
zur Signalwegsanalyse erbrachten genontologische Klassifikationen der potentielle 
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Zielgene von nicht-exosomalen miRNAs wachsender Eizellengruppen das diese Gene 
nachweislich an der Regulation der Transkription, dem Proteintransport, der 
Feststellung der Proteinlokalisation sowie an einem positiven Einfluss auf Nitrogen 
zusammengesetzte metabolische Prozesse und eine positive Regelung der 
Genexpression und Transkription beteiligt sind. Der Unterschied zwischen 
regulatorischen Signalwegen und biologischen Prozessen ist gekennzeichnet durch die 
transkriptionalen und molekularen Signalveränderungen zwischen exosomalen und 
nicht-exosomalen Bestandteilen aus der Follikelflüssigkeit wachsender Eizellen. Eine 
vergleichende Expressionsanalysen dieser acht Kandidaten miRNAs in folikulären 
Zellen mittels quantitativer Real-Time PCR zeigte unterschiedliche Expressionsniveaus 
dieser in allen Zelltypen. Dieses Ergebnis gibt eine mögliche Erklärung über den 
Ursprung der zirkulierenden miRNAs in der Follikelflüssigkeit.  
In einem zweiten Experiment wurde der miRNA Transfer mittels Exosomen in vitro 
untersucht. Als erstes wurden Exosomen aus der Follikelflüssigkeit isoliert. Das 
Ergebnis demonstrierte, dass die isolierten Exosomen aus der Follikelflüssigkeit bis zu 
48 h unter Zellkulturbedingungen stabil waren. Nachdem die Exosomstabilität bestätigt 
war, wurde als nächstes die Möglichkeit der Aufnahme von Exosomen in die 
Empfängerzelle überprüft. Die Ergebnisse des Konfokalmikroskops ergaben, dass eine 
Aufnahme der PKG67 markierten Exosome von Granulosazellen statt gefunden hat. 
Darüber hinaus sollte der durch die Exosomen vermittelte Transport von miRNAs sowie 
der dadurch erhöht endogene Level der miRNAs in den Empfängerzellen bestimmt 
werden. Dafür isolierten wir Exosomen unterschiedlichen Ursprungs aus 
Follikelflüssigkeiten von wachsenden Eizellen (BCB-) sowie von ausgewachsen 
Eizellen (BCB+) und co-kultivierten diese seperat für 24 h mit primären 
Granulosazellen. Die Ergebnisse zeigten, dass das Niveau von endogenen miRNAs in 
Exosomen co-kultivierten Granulosazellen signifikant erhöht war im Vergleich zur 
Kontrolle. Nachdem die Anreicherung der endogenen miRNA Level in Exosomen co-
kultivierten Granulosazellen aufgeklärt war, wurden in den selben Granulosazellproben 
die mRNA Expressionsmuster von einigen Kandidatengenen mittels quantitativer Real-
Time PCR bestimmt. Die Expressionsanalyse zeigte, dass die Behandlung der 
Granulosazellen mit Exosomen im Vergleich zur unbehandelten Kontrolle eine 
Runterregulierung von 20-65% der miRNA Kandidatengene ITGA3, SOCS4, 
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MAP3K1, BRMS1L, YNFX1 und CD44 erbrachte. Allerdings kam es zu einem 
relativen Überschuss von VEGFA in Granulosazellen die mit Exosomen transfiziert 
waren im Vergleich zur unbehandelten Kontrolle. 
Schlussfolgernd berichtet die vorliegende Studie das erste Mal über das Vorkommen 
von extra-zellulären miRNAs in bovinen Follikelflüssigkeiten und dieses könnte mit 
exosomalen und nicht-exosomalen Strukturen (z.B. Ago2, HDL) in Verbindung stehen. 
Diese Daten heben eine Anzahl von unterschiedlich exprimierten zirkulierenden 
miRNAs in boviner Follikelflüssigkeit bezüglich der Eizellkompetenzentwicklung 
hervor. Diese ist ein Schritt vorwärts in der Entwicklung von nicht invasiven 
Biomarkern für die Selektion kompetenter Eizellen. Darüber hinaus dokumentiert diese 
Doktorarbeit einen Exosomen vermittelten Transfer von miRNAs und eine Veränderung 
endogener Level von mRNAs und miRNAs in Empfängerzellen welches die Zell-Zell-
Kommunikation während der follikulären Entwicklung reflektiert. Obwohl diese Daten 
ein neues Gebiet in der extra-zellulären miRNA Forschung im Bereich der follikulären 
Mikroumgebung eröffnen, wird eine in die Tiefe gehende Studie für das Verständnis 
über den funktionellen Beitrag der unterschiedlich exprimierten miRNAs beim Erlangen 
der Eizellentwicklungskompetens benötigt. 
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